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Summary 
 
 
 
    Dopamine is one of the main neurotransmitters in the central nervous system involved in 
neuroendocrine, motivational/emotional and, especially, cognitive and motor functions. These 
processes are mediated by the stimulation of the principal dopamine receptors: D1 (D1R) and D2 
(D2R). In this doctoral dissertation we studied the role of both receptors in learning and memory 
processes, as well as their regulation of striatal TH-immunoreactive (TH-ir) neurons and the 
involvement in motor response.  
     To elaborate this project we used knock-out mice for D1 (Drd1a
-/-) and D2 (Drd2
-/-) receptors 
because there are no pharmacological agents that effectively differentiate between dopamine 
receptors of the same family. In addition, for the striatal TH-ir neurons study, we used mice 
with striatal unilateral 6-OHDA lesions, chronically treated with L-DOPA, this being the most 
effective mechanism to induce the expression of striatal TH-ir neurons. To complete this work, 
we carried out behavioral tests that analyze the motor response, e.g. cylinder test, and different 
types of learning and memory process, e.g. Barnes maze. 
   
The role of D1R is essential in the learning and memory processes. 
  
    The results in behavioral test for Drd1a-/- mice showed that the dopaminergic signal mediated 
by D1R is essential in learning and memory functions for spatial, associative and recognition 
types. Mutant animals were unable to respond correctly in these tests, showing a complete ina-
bility to spatial navigation, understand basic associations between stimuli or recognize familiar 
objects. All of these indicate the importance of the D1R mediated dopaminergic response in the 
memories of past experiences. Therefore, our experiments indicate that the role of D1R is essen-
tial in all described processes of learning and memory consolidation. 
 
The D2R absence affects learning and synaptic plasticity processes associated. 
  
    In the present work we analyzed the role of D2R in learning and memory process as well as 
changes in hippocampal plasticity associated. The obtained results showed that D2R is im-
portant but not decisive for spatial learning. However, Drd2-/- mice were unable to perform as-
sociative tasks such as the active avoidance. Afterwards, we investigated the disturbances in 
hippocampal synaptic plasticity process, which are the basis of the previously described altera-
tions. For this purpose, experiments of long-term synaptic potentiation (LTP) in vivo were car-
ried out. In this study, it was included a new experimental group: WT mice with the expression 
of the D2R silenced through the hippocampal injection with lentiviral particles, that carries of  
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interference RNA (Drd2-siRNA). Records in Drd2
-/- and Drd2-siRNA animals showed that 
high frequency stimulation in the hippocampus did not produce synaptic potentiation. Also, we 
use the eyeblink conditioning to relate the differences in associative learning and the effective-
ness of the CA1-CA3 synapses. Control mice increased their number of conditioned responses 
during all sessions, but Drd2-/- and Drd2-siRNA mice only increased their conditioned respons-
es during the first days. The results indicate that the learning deficits of Drd2-/- mice are due to 
the D2R absence in the hippocampal region. 
     
Striatal TH-ir neurons expression are induced by L-DOPA and mediated by D1R and D2R 
activation.   
 
    In this work we study the role of D1R and D2R in the expression of striatal TH-ir cells in-
duced by chronic L-DOPA administration and its influence on motor behavior.  
    This study recorded an increase of TH-ir cells in hemiparkinsonian mice after L-DOPA treat-
ment in a dose-dependent manner. Moreover, it was observed that the number of striatal TH-ir 
neurons descends to be virtually undetectable after the end of treatment. These experiments 
support the hypothesis that levels of TH-ir cells expression appears to be regulated by extrasyn-
aptic dopamine levels, and therefore by the D1R and D2R action. To study this phenomenon, 
three different models were used: the genetic and pharmacological inactivation of D1R and D2R 
receptors in mice, and Bac-transgenic mice, which express Drd1a-Tomato or Drd2-GPF pro-
teins. We did not observe changes respect to D2R actions, however both genetic inactivation 
and pharmacological blockade of D1R caused a significant decrease in the TH-ir neurons. How-
ever, it was found that none of the striatal TH-ir neurons expressing D1R or D2R, it is suggest 
that the TH-ir cells indirectly depend on the activation of these receptors. 
    Next, a series of experiments were conducted to investigate the phenotype of striatal TH-ir 
neurons. We observed that TH-ir neurons have morphological characteristics of striatal inter-
neurons and were not positive for markers such as Pitx3 and Nurr1. These results indicate that 
the origin of TH-ir neurons is not common to the rest of mesencephalic dopaminergic neurons 
and could be a subpopulation of striatal interneurons. 
    Finally, we studied the role of the TH-ir neurons on the motor behavior using two experi-
ments: cylinder test and voltammetry. Both tests were carried out in different phases of the ex-
periment: basal, post-lesion and post-treatment. The results showed a spatio-temporal correla-
tion between the presence of TH-ir neurons and the release of dopamine in the striatum, as well 
as an improvement on the exploratory behavior after chronic L-DOPA treatment. These neurons  
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would maintain the levels of dopamine in the striatum after completing the treatment, and 
would be involved in the maintenance of the long-term effects of L-DOPA on motor function. 
 
    In summary, this doctoral dissertation has proved the decisive performance of D1R and D2R 
in learning and memory tasks of spatial, associative and recognition types. Moreover, our find-
ings about the role of hippocampal D2R in synaptic plasticity processes show it is critical for in 
vivo LTP and the effectiveness evolution of CA3-CA1 synapses during a conditioning task. In 
addition, we proved that D1R is involved in the regulation of the TH-ir neurons expression in 
the striatum of lesioned mice after L-DOPA treatment, and it is implicated in the maintenance 
of long-term therapeutic effects of L-DOPA on motor behavior. 
  
  
 
 
                                                                                                                                                                                                         7 
       
 
Resumen 
 
                                                                                                                                                                        Resumen  
 
 
 
    La dopamina es uno de los principales neurotransmisores del sistema nervioso central y 
desempeña un papel esencial en diferentes funciones: neuroendocrinas, motivacionales/
emocionales y, especialmente, motoras y cognitivas. Las funciones de la dopamina están media-
das en gran medida por la estimulación de sus principales receptores D1 (D1R) y D2 (D2R). En 
esta tesis hemos estudiado el papel que ambos receptores desempeñan en los procesos de apren-
dizaje y memoria, así como la regulación que ejercen sobre las neuronas estriatales TH-
immunoreactivas (TH-ir) y su posible implicación en la respuesta motora.  
    Para abordar este proyecto hemos utilizado ratones knock-out para el receptor D1 (Drd1a
-/-) y 
D2 (Drd2
-/-) ya que no existen compuestos farmacológicos capaces de diferenciar eficazmente 
entre receptores dopaminérgicos de la misma familia. Además, para el estudio de las neuronas 
TH-ir realizamos lesiones con 6-OHDA a ratones que posteriormente recibieron un tratamiento 
crónico con L-DOPA, siendo este el mecanismo más eficaz para inducir la expresión de las 
neuronas TH-ir objeto de nuestro estudio. Para completar todo ello realizamos test conductuales 
que evalúan respuesta motora, como el test del cilindro, y diferentes tipos de aprendizaje y me-
moria para los cuales utilizamos test específicos. Entre estos test se encuentran: los laberintos 
de Barnes y Morris para memoria espacial, evitación activa/pasiva y condicionamiento del mie-
do para el aprendizaje asociativo, y el reconocimiento de objetos para la memoria de reconoci-
miento. 
 
El papel de D1R es esencial en los procesos de adquisición y consolidación de la memoria. 
 
    Los resultados de las pruebas conductuales para los ratones Drd1a-/- demostraron que la señal 
dopaminérgica mediada por D1R es esencial en los procesos de aprendizaje y consolidación de 
la memoria espacial, asociativa y de reconocimiento. Los animales mutantes fueron incapaces 
de realizar correctamente los test conductuales evaluados, mostrando una incapacidad casi com-
pleta para orientarse espacialmente, comprender asociaciones básicas entre estímulos o recono-
cer un objeto conocido, lo que indica la importancia de la respuesta dopaminérgica mediada por 
D1R en el recuerdo de experiencias pasadas. Por ello, podemos concluir que el papel del  D1R 
es esencial en los todos los procesos de aprendizaje y consolidación de la memoria descritos. 
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La ausencia de D2R afecta al aprendizaje y los procesos de plasticidad sináptica asociados. 
 
    Analizamos el papel del D2R en la función cognitiva así como los cambios en los procesos de 
plasticidad hipocampal asociados. Los resultados obtenidos en los ratones Drd2-/- muestran un 
retraso significativo en el aprendizaje espacial con respecto al grupo control. Sin embargo, es en 
el aprendizaje de tipo asociativo donde estos animales presentan mayores dificultades ya que 
son incapaces de desempeñar tareas como la evitación activa.  
     Además, estudiamos los procesos de plasticidad sináptica hipocampal implicados realizando 
experimentos de potenciación sináptica a largo plazo (LTP) in vivo.  Para ello, además emplea-
mos un grupo experimental nuevo formado por animales WT con el D2R silenciado en CA1 me-
diante vectores lentivirales portadores de RNA interferente (Drd2-siRNA). Los registros mos-
traron que los animales Drd2-/- y Drd2-siRNA no tienen LTP. También utilizamos el condicio-
namiento palpebral para relacionar las diferencias en aprendizaje asociativo y la eficacia de la 
sinapsis CA1-CA3. Los ratones control aumentaron el número de respuestas condicionadas du-
rante todas las sesiones, pero los ratones Drd2-/- y Drd2-siRNA solo mejoraron durante los pri-
meros días. Los resultados indican que la respuesta conductual observada se debe a la ausencia 
de D2R en el hipocampo. 
     
Expresión de neuronas TH-ir inducida por L-DOPA y su modulación por D1R y D2R.  
 
    En este trabajo estudiamos la regulación que ejercen D1R y D2R sobre la expresión de células 
TH-ir estriatales inducidas por la administración crónica de L-DOPA y su influencia sobre la 
conducta motora. En este trabajo encontramos que el tratamiento crónico con L-DOPA produjo 
un incremento dosis-dependiente del número de neuronas TH-ir estriatales y finalizado el trata-
miento, el número de células desciende hasta ser prácticamente indetectables a los 10 días. Es-
tos resultados pueden indicar que la expresión de neuronas TH-ir estriatales está sujeta a los 
cambios en la homeostasis dopaminérgica, y probablemente mediado por la acción de D1R y 
D2R. Para analizarlo utilizamos 3 modelos: inactivación genética y farmacológica, y ratones Bac
-transgénicos Drd1a-Tomato y Drd2-GFP. La inactivación de D2R no produjo cambios, sin em-
bargo con la inactivación de D1R se observó un descenso del número de neuronas TH-ir estria-
tales. Sin embargo, en los animales BAC-transgénicos no observamos que las neuronas TH-ir 
colocalizaran con los marcadores rojo-tomate o verde fluorescente bajo el promotor Drd1a o 
Drd2 respectivamente, por lo que es posible que la expresión de las neuronas TH-ir dependa de 
forma indirecta de la activación de estos receptores. 
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    Finalmente, estudiamos la posible función e influencia de las neuronas TH-ir sobre la con-
ducta motora mediante el test del cilindro y medimos la dopamina vesicular por voltametría. 
Ambas pruebas se llevaron a cabo en diferentes fases del experimento: basal, post-lesión y post-
tratamiento. Los resultados mostraron una correlación espacio-temporal entre la presencia de 
neuronas TH-ir y la liberación de dopamina en el estriado, así como una mejora de la conducta 
exploratoria tras el tratamiento crónico con L-DOPA. Estos resultados indican que las neuronas 
estriatales TH-ir mantendrían los niveles de dopamina en el estriado tras haber finalizado el tra-
tamiento y estarían implicadas en el mantenimiento de los efectos a largo plazo de la L-DOPA 
sobre la función motora. 
 
    En resumen, la realización de esta tesis ha demostrado el papel determinante de los recepto-
res D1R y D2R en el aprendizaje y la memoria espacial, asociativa y de reconocimiento. Ade-
más destaca la importancia del papel de D2R en los procesos de plasticidad sináptica hipocam-
pal donde se encontró que este receptor es crítico en el establecimiento de la LTP in vivo y la 
evolución de la eficacia de las sinapsis CA3-CA1 durante una tarea de condicionamiento. Por 
otro lado, D1R ha demostrado estar implicado en la regulación de la expresión de neuronas TH-
ir en el estriado de ratones lesionados tras el tratamiento con L-DOPA, y que estas neuronas 
junto con las terminales que sobreviven a la lesión están implicadas en el mantenimiento a largo 
plazo de los efectos terapéuticos de la L-DOPA sobre la conducta motora. 
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1. DOPAMINERGIC SYSTEM. 
 
     The dopaminergic system consists mainly of neurons that synthesize dopamine in the mid-
brain nuclei and project to different regions of the brain, resulting in three different pathways: 
nigostriatal, mesolimbic-mesocortical and tuberoinfundibular.  
 
    1.1. Dopaminergic pathways. 
 
     1.1.1. Nigrostriatal pathway. 
 
This pathway originates from the substantia nigra (SN), a core of midbrain neurons project-
ing to the dorsal striatum (caudo-putamen) (Fig. 1). Their efferents provide a dense innervation 
to the striatum; this structure has approximately the 80% of all dopamine found in brain. SN is 
divided into two parts: pars compacta (SNc) formed by dopaminergic neurons, and pars reticu-
lata (SNr) mostly formed by GABAergic neurons. This system is mainly involved in motor 
control  and coordination, allowing the movement to take place harmoniously and conforming a 
particular program or pattern well established (Pavón et al., 2006; Darmopil et al., 2008). 
 
           1.1.2. Mesolimbic-Mesocortical pathways. 
 
    These pathways come from the ventral tegmental-area (VTA) in the midbrain (Fig. 1). The 
mesolimbic pathway innervates the ventral striatum (nucleus accumbens, NAc) and limbic 
structures (hippocampus, central amygdaloid nucleus, olfactory tubercle, lateral septum and 
stria terminalis) (Fig. 1). In addition, the mesocortical pathway projects to sensoriomotor and 
associative frontal cortex areas (Fig. 1). These systems mainly help to sustain attention, idea-
tion, correct reality assessment, motivation and thought control (directionality of behavior).  
 
           1.1.3. Tubero-infundibular pathway. 
 
    The origin of this pathway is the cells from the periventricular hypothalamic nuclei and arcu-
ate nucleus. Afferents from this pathway originate in the median eminence of hypothalamus and 
are projected to the pituitary. These neurons play an important role regulating the release of pi-
tuitary hormones, especially inhibiting the release of prolactin. 
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Figure 1. Principal dopaminergic inputs in the mouse brain. Visualization of monosynaptic inputs to a genet-
ically defined population of neurons using rabies virus and cre/loxP recombination system. Direct inputs to dopa-
mine neurons: green dots represent neurons providing inputs to dopamine neurons in the VTA, while red dots rep-
resent neurons providing inputs to SN dopamine neurons. OB: olfactory bulb. PFc: prefontal cortex. Hp: hippo-
campus. Str: striatum. NAc: nucleus accumbens. AMG: amigdala. STh: subthalamic nucleus. PAG: periaqueductal 
gray. Adapted from Mitsuko-Watabe-Uchida & Sachie Ogawa, 2012. 
    1.2. Brain structures of dopaminergic system involved in cognitive and motor function. 
 
            1.2.1. Basal Ganglia. 
 
   In the mid-1950s, Nauta and colleagues adopted the term Basal Ganglia (BG) to refer a group 
of subcortical structures that includes striatum, globus pallidus (GP), subthalamic nucleus 
(STh) and SN (Fig. 2). The major task of the BG is to integrate sensory, motor, associative and 
limbic signals to produce context-dependent behavior (Nakano, 2000). BG alterations are in-
volved in many disorders such as Parkinson´s disease (PD), Huntington´s disease, schizophre-
nia, autism, depression, obsessive-compulsive disorder and other compulsive and motivational 
alterations (Nieullon, 2002).  
   Multisensory integration is considered an essential function of the BG, necessary to determine 
the cause of environmental changes and respond to them appropriately. This function can be 
carried out thanks to BG connections with other structures like cortex and thalamus. 
18 
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                  1.2.1.1. Striatum. 
 
    The largest nucleus in BG is the striatum, which can be further divided into the caudate nu-
cleus and putamen, undifferentiated in rodents but separated by the internal capsule in primates. 
The striatum has been described as an integrative center for sensory information from cerebral 
cortex and thalamus (Reig & Silberberg, 2014).  
 
    Heimer & Van Hoesen (1979), adopted two topographically terms for the striatum: 
Ventral striatum: It delineates the most ventral aspects of the striatum and includes the 
NAc and portions of the olfactory tubercle. It processes mostly reward-related infor-
mation. 
Dorsal striatum: For more dorsal regions (caudate-putamen nucleus). It receives cortical 
input from neocortex and processes sensorimotor information. 
 
    Other topographical and neurochemical organization of the striatum divided this structure in 
striosomes and matrix (Graybiel, 1990): 
Striosomes are characterized by low levels of acetylcholine and high levels of opiates and 
substance P. They represent approximately the 15% of the total striatal volume, and re-
ceives and processes limbic and reward-related information (White & Hiroi, 1998). 
Matrix compartment is composed by cholinergic and somatostatin-containing neurons. It 
mainly receives associative and sensorimotor information from cortex and thalamus. This 
area represent the 85% of striatum (Gerfen, 1992). 
 
    In terms of neurons, the striatum distinguish two large populations: 
Projection neurons, called Medium Spiny Neurons (MSNs). In rodents they represent 90-
95% of total and in primates they are 75-80%. All of these neurons are GABAergic, and 
are divided in two subpopulations on the basis of their projection targets, that shaping two 
parallel and diametrically opposed pathways (Gerfen & Surmeier, 2011) (Fig. 2): 
 Direct pathway or striatonigral neurons: projecting to the SNr and GP pars interna 
(GPi). They express substance P, dynorphin and D1 dopamine receptor (D1R). The 
activation of this pathway facilitates the movement. 
 Indirect pathway or striatopallidal neurons: projecting to the SNr and GP pars interna 
via GP pars externa (GPe). They express enkephalin, A2A adenosine receptors and D2 
dopamine receptor (D2R). Conversely to the direct pathway, the activation of stri-
atopallidal neurons inhibits the movement.  
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The direct and indirect pathways exert opposing effects on movements thus an imbal-
ance in their activity is believed to lead hypokinetic (i.e., Parkinsonism) or hyperkinec-
tic (i.e., dyskinesia) movement disorders. 
 
Interneurons, involve only the 5-10% of the total striatal neurons in rodents and are impli-
cated in regulation of striatal projection function. Striatal interneurons may be classified 
into two subpopulations: Cholinergic interneurons and GABAergic neurons, which are in 
turn divided into: 1) parvalbumin-containing, 2) calretinin-containing and 3) somatostatin-, 
neuropeptide Y- and nitric oxide synthase-containing. 
 
 
Figure 2. Schema of the basal ganglia motor circuit in the mouse brain. Sagital section of mouse brain stained 
with inmufluorescent tyrosine hydroxylase antibody. Blue arrows indicate glutamatergic excitatory projections and 
pink arrows the GABAergic inhibitory projections. Str: striatum. GP: globus pallidus. SN: substantia nigra. STh: 
subthalamic nucleus. Adapted from Granado et al., 2011 
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1.2.2. Limbic system. 
 
    Limbic system is a set of cortical, diencephalic and brainstem structures, which forms com-
plex circuits involved in emotional aspects and cognitive functions such as learning and 
memory. This system includes: cingulate gyrus, hippocampus, parahippocampal gyrus, amyg-
dala, anterior-thalamic nucleus, mammillary bodies and orbitofrontal cortex.  
 
1.2.2.1. Hippocampus. 
 
    The hippocampus is localized in the medial temporal lobe, across and inferior to lateral ven-
tricles. It is essential to elaborate new memories and to detect new environmental elements. 
Among other mechanisms, hippocampus have the ability to retrieve and compare environmental 
elements with others previously stored in different brain regions. Therefore, a disturbance in 
this structure can produce anterograde and retrograde amnesia, without compromising other 
types of memory as procedural. Also, hippocampus plays an important role in spatial orienta-
tion and memory, since it has “place cells” that can trigger action potentials when the animal 
passes through or is in a particular novel or familiar location (O´Keefe & Dostrovsky, 1971; 
Nadel et al., 2012; Moser et al., 2013).  
    Topographically, hippocampus is divided in three parts: subiculum, dentate gyrus (DG) 
which is consisting of fascia dentata and hilus, and cornu ammonis (CA). CA is divided into  
different regions: CA1, CA2 and CA3. CA3 pyramidal cells have a dendritic tree with numer-
ous spines connected to granular cells of DG (mossy fibers system). Granular cells receives ex-
citatory innervation and their axons innervate the CA1 pyramidal layer (Schaffer collaterals 
system) (Fig. 3). 
 
    From the histological point of view, CA1 has four regions: 
Stratum oriens: Located in the dorsal hippocampus, containing different interneurons ar-
borizing around basal dendrites of pyramidal neurons that release GABA. These cells re-
ceive input from the contralateral hippocampus, usually recurrent connections, especially in 
CA3 and CA2.  
Pyramidal: Ventral to stratum oriens. This layer contains the soma of pyramidal cells. In 
this region starts his apical dendrite that branching the molecular layer, and several den-
drites which emerge from the basal pole. The axon starts on basal pole and goes to alveus 
to exit from hippocampus. This layer is the main hippocampal efference. 
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Stratum Radiatum: Similar to oriens. Containing Schaffer collateral fibers that project from 
CA3 to CA1.  
Stratum Moleculare: It is the most ventral one and is composed by granular cells. Here, the 
perforant path fibers form synapses onto distal, apical dendrites of pyramidal cells. 
Figure 3. Hippocampus illustration of Santiago Ramón y Cajal (1901). Sketch of the structure and connnec-
tions of the Hippocampus. Ink on paper. Adapted from: Cajal Legacy, Instituto Cajal (CSIC) 
       
    Connections from hippocampal formation are mainly unidirectional and generate a closed 
loop that begins in the entorhinal cortex where afferent information converges from the associ-
ative cortex, orbitofrontal, insular and cingulated cortex. The hippocampus and DG also receive 
significant inputs from amygdala, thalamus, septum, hypothalamus and monoaminergic brain-
stem nuclei through the entorhinal cortex and commissural afferents from contralateral hippo-
campus.  
    Principal afferent pathways of the hippocampus: 
Perforant pathway: The primary glutamatergic afferent of hippocampus, between the 
entorhinal cortex and granule DG.  
Pathway from entorhinal cortex which comes from the molecular layer of subiculum, 
reaching apical dendrites of CA3. 
22 
                                                                                                                                    Introduction 
 
 
Modulatory pathway: It is derived from septum, hypothalamus and brainstem through 
the fornix to connect with basal dendrites from pyramidal neurons of CA1 (Peterson, 
1989; Dutar et al., 1995). Cholinergic neurons modulate the activity of pyramidal neu-
rons and GABAergic interneurons. GABAergic neurons project to interneurons disin-
hibiting pyramidal neurons activity (Gulyas, 2003). 
 
    On the other hand, the hippocampus main efferent comes from pyramidal neurons to entorhi-
nal cortex and lateral septal area, which maintain a reciprocal relationship. In addition, there are 
connections to other regions through the fornix and medial prefrontal and frontal cortex, septal 
nuclei, hypothalamus, anterior nuclei of thalamus, striatum and SN (Dutar, 1995). These large 
interconnections from hippocampal system synchronize the excitation and inhibition of pyrami-
dal cells. 
 
1.2.2.2. Amygdala. 
 
    The amygdala is a structure found in front and above of the anterior horn of the lateral ventri-
cle, inner side of temporal lobe. Among its main functions, it is responsible for integrating ex-
plicit information from emotional processes with trends of implicit actions mediating in transla-
tion to the corresponding somatic response. It is therefore responsible for the formation and 
storage of associative memories especially related to emotional events (implicit memory) 
(LeDoux, 1999). 
 
     Topographically, the amygdala consists in different complex:     
Basolateral complex: It receives inputs from sensory systems and has an important role in 
the acquisition of associations. 
Centromedial complex: It is connected with hypothalamus, basal forebrain and brainstem 
(LeDoux, 1999). This nucleus is responsible for the emission of conditioned responses. 
Cortical complex: It is connected to the OB and implicated in different social behaviors. 
 
    Although the amygdala is connected with almost the whole brain, this structure has several 
efferences to VTA, locus coeruleus, trigeminal nuclei and facial nerve (facial expression of 
fear), reticular nuclei (scape/avoidance responses, paralysis and vigilance) and from centrome-
dial complex to hypothalamus. In adition, the amygdala receives excitatory afferents from cor-
tex with emotional information, and inhibitory afferents from prefrontal and orbitofrontal cor-
tex. 
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    Previous studies have shown that amygdala lesion has variable effects in the acquisition pro-
cesses but does not prevent learning. It is involved in fear, appetitive and place conditionings, 
and the consolidation of long-term memory as it is essential in the emotional aspect of the 
memory (McGaugh, 2015). Amygdala lesion leds to a mismatch between conscious and uncon-
scious information processing of emotional stimuli and the inability to generate an unconscious 
emotional response (somatic), especially when the stimulus is emotionally charged of fear 
(Kandel, 2001). 
    In addition, emotional coordination function exerted by the amygdala is regulated by a paral-
lel control system: the meso-limbic dopaminergic pathway (from SN and VTA). It attenuates 
the inhibition from the prefrontal cortex on the amygdala, releasing its sensory input, and there-
by emotional perception, especially of stimuli associated with anger and fear (thus altered in 
cases of dopaminergic depletion and PD).        
 
2. DOPAMINE. 
 
    Ever since the dopamine was described in 1957 by Carlsson (Carlsson et al, 1957), it has 
been extensively studied, demonstrating their involvement in a wide variety of processes: cardi-
ovascular regulation, motor control and neuroendocrine functions, multidimensional brain fea-
tures such as learning and memory (Grecksch & Matties, 1981), motivation (Everitt & Robbins, 
2005) and emotional behaviors (Nader & LeDoux, 1999). 
 
 2.1. Synthesis, transport and storage of dopamine. 
 
    Dopamine biosynthesis occurs in the cytoplasmic region of dopaminergic terminals from the 
precursor aromatic amino acid tyrosine, which is generated through the amino acid phenylala-
nine or directly through food ingested (Levitt et al, 1965).  
 
   In neurons, two reactions transform tyrosine into dopamine (Fig. 4): 
- First, the cytosolic enzyme tyrosine hydroxylase (TH) turns tyrosine to L-3,4-
dihydroxyphenylalanine (L-DOPA). TH is considered the “limiting enzyme” in this path-
way (Levitt et al., 1965). 
- The second step is the decarboxylation of L-DOPA, catalyzed by the enzyme aromatic  
L-amino acid decarboxylase (AADC), that produces dopamine in the cytosol (Elsworth & 
Roth, 1997). 
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     In dopaminergic neurons, dopamine is transported by the vesicle monomamine transporter 
(VMAT-2) from the cytosol to specialized vesicles in dendritic terminal buttons where it is 
stored. Besides these vesicles, dopamine may also appear stored in smooth endoplasmic reticu-
lum (Elsworth & Roth, 1997).  
 
Figure 4. Dopaminergic synapse. The presyn-
aptic terminal releases dopamine (orange cir-
cles), and regulates extracellular dopamine lev-
els through several mechanisms: dopamine 
reuptake from the extracellular fluid (via  
DAT), dopamine transport into synaptic vesi-
cles (via VMAT-2), dopamine synthesis (which 
is subjected to autoregulatory control via pre-
synaptic D2R), and dopamine metabolism (via 
MAO-B and COMT). The postsynaptic neuron 
responds to dopamine via two main types of 
receptors. The D1R-like is coupled to Golf and 
activates c-AMP-dependent intracellular signal-
ing pathways. The D2R-like is coupled to 
Gi and inhibits the same pathways. AADC, aro-
matic L-amino acid decarboxylase; AC, adenyl-
ate cyclase; COMT, catechol-O-methyl-
transferase; DAT, dopamine transporter; MAO-
B, monoamine oxidase B; TH, tyrosine hydrox-
ylase; VMAT-2, vesicular monoamine trans-
porter 2. Image ®ByRibosoma. 
 2.2. Release, reuptake and degradation of dopamine. 
 
    Dopamine released into the synaptic cleft is carried out by the calcium input into the cell 
through voltage-dependent channels that activate exocytosis of dopamine transport vesicles into 
the synaptic cleft. 
    To finish neurotransmitter action and to sustain the homeostasis, dopamine is reuptaken to be 
metabolized or stored and released again. Reuptaking process is carried out by specific dopa-
mine transporter (DAT) protein located in the dopaminergic terminal which can transport dopa-
mine bidirectionally based on the concentration gradient (Amara & Kuhar, 1993). In addition, 
and in small amounts, glia and no-dopaminergic neurons can collect and metabolize extracellu-
lar dopamine (Elsworth & Roth, 1997).           
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    The biodegradation of dopamine is performed by two different enzymes (Fig. 4): 
1- Dopamine may experience oxidative deamination and become in 3,4-
dihydroxyphenylacetic acid (DOPAC) by the action of monoamine oxidase (MAO) located 
in the mitochondrial external membrane. There are two isoforms, A and B: MAO-A is 
found in dopaminergic and adrenergic neurons and MAO-B in glial cells, astrocytes and 
serotonergic neurons. Overall 70% of the human brain dopamine is degraded by MAO-B. 
2- Dopamine can also be converted into 3-methoxytyramine through catechol-O-
methyltransferase (COMT) outside the central nervous sistem. It is important in the break-
down of dopamine in the bloodstream.  
    The dopamine products of degradation, DOPAC and 3-methoxytyramine, have an enzymatic 
transformation giving rise to the homovallinic acid (HVA), an inactive metabolite (Elswoth & 
Roth, 1997). 
 
    2.3. Dopamine receptors. 
   
           2.3.1. Classification and activity regulation. 
 
    Dopamine exerts its action by binding to specific membrane receptors, which belong to the 
family of seven transmembrane domain G-protein-coupled receptors (GPCRS). Five distinct 
dopamine receptors have been isolated, characterized and subdivided into two subfamilies for 
its biochemistry and pharmacological characteristics (Vallone et al., 2000).  
    The D1-like receptors subfamily comprises D1R and D5R, associated with excitatory func-
tion. This subfamily is coupled to Gαs/olf, positive regulator of adenilil cyclase (AC) that trans-
forms ATP into cyclic AMP (cAMP), resulting in the activation of the protein kinase A (PKA) 
(Vallone et al., 2000) (Fig. 4). In turn, activated PKA can regulate the synthesis of nuclear and 
cytoplasmic proteins, the membrane channels function and the sensibilization or desensitization 
of GPCRS. D1-family receptors are located postsynaptically and are responsible for the action 
of dopamine.  
     D2-like receptors subfamily includes D2R, D3R and D4R. They are negatively coupled to AC 
and  have inhibitory function, inhibiting PKA through Gαi/o protein, they can also inhibit calci-
um entry, by activating potassium channels (Fig. 4). The D2R subtype has two splice variants 
coded by the same gene, the long form (D2L) and the short form (D2S). D2-like receptors are 
presynaptic and postsynaptic receptors. The presynaptic receptors, called autorreceptors, are 
more sensitive to dopamine action than the postsynaptic receptors (Elsworth & Roth, 1997).  
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These receptors regulate the synthesis and release of dopamine. When dopamine is released in 
extrasynaptic spaces, it stimulates somatodendritic regions and decreases the neuronal sponta-
neous activity, while the stimulation of nerve terminals results in an inhibition of dopamine re-
lease (Bowyer & Weiner, 1987; Tepper et al, 1984). Both processes are the result of the open-
ing of potassium channels. 
 
 
           2.3.2. Localization and basic functions. 
 
 
    In the central nervous system D1-like receptors family predominate over D2-like receptors, 
and within these, D1R is the most abundant. The highest density of D1R is found in projection 
field areas of nigroestrital and mesolimbic pathways: striatum, NAc, SN, hippocampus, amyg-
dala, olfactory tubercle, hypothalamus, thalamus and prefrontal cortex (Fremeau et al., 1991; 
Weiner et al., 1991; Ares-Santos et al., 2013) (Fig. 5).  
 
    Pharmacological experiments involve D1R in locomotor activity (Xu et al., 1994; Moratalla 
et al., 1996) and in cognitive processes, including learning and memory, especially in spatial, 
reverse, extinction and incentive types (El-Ghundi et al., 1999; Granado et al., 2008; Ortiz et 
al., 2010). 
    D5R have a more restricted pattern of expression and is primarily found in hippocampus, hy-
pothalamus, lateral mammillary and thalamic nuclei, and his presence in striatum and neocortex 
is more limited than his presence in striatum and neocortex (Khan et al., 2000; Rivera et al., 
2002; Ares Santos et al., 2013). Its main functions are learning and memory processing 
(Wiescholleck & Manahan-Vaughan, 2014). 
Figure 5. Expression of the D1R in the brain. Pictures of brain sagittal sections from Drd1a-Tomato Bac-
transgenic mouse illustrating D1R is expressed in the striatum, NAc and olfactory tubercule (A) and in the hippo-
campal region (B) High magnification of CA1 region (C) and dentate gyrus (D) Scale Bars: A, B = 200 µm; C, D 
= 100 µm 
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    D2R expression predominates in D2-like receptors family. D2R is mainly expressed in stri-
atopallidal indirect pathway and cortex (Le Moine et al., 1990; Xu et al., 1994; Rivera et al., 
2002). It is also abundant in other regions rich in dopamine as olfactory tubercle, NAc, cortex 
and VTA (Ares-Santos et al., 2013) (Fig. 6). Also, previous experiments demonstrated the pres-
ence of D2R in hippocampal regions, DG and CA1-stratum radiatum of mice (Higuera-Matas et 
al., 2010; Gangarosa et al., 2012) and humans (Camps et al., 1989). D2R is involved in prolactin 
secretion, certain aspects of behavior and in the regulation of motor function. Stimulation of 
D2R results in the inhibition of striatopallidal pathway activity (Selemon et al., 1990; Gerfen, 
2000). 
    Distribution of D3R and D4R is predominantly found in limbic areas. The D3R is mainly lo-
cated in NAc, olfactory tubercle, putamen, cerebral cortex and islands of Calleja  (Diaz et al., 
2000; Ares-Santos et al., 2013). This receptor would be involved in regulation of motor func-
tion and behaviors associated with drug-abuse (Collins & Woods, 2007; John et al., 2015). The 
D4R is primarily expressed in frontal cortex, amygdala, hippocampus, hypothalamus and mid-
brain, and practically does not exist in the striatum (Rivera et al., 2002; Ares-Santos et al., 
2013). D4R is usually implicated in attentional process, memory, emotional response and novel 
ty seeking (Floresco & Magyar, 2006; Wells et al., 2013; Xie et al., 2015; Thanos et al., 2015). 
Figure 6. Expression of D2R in the brain. Pictures of brain sagittal sections from D2R-GFP Bac-transgenic 
mouse illustrating D2R is expressed in striatum, NAc and olfactory tubercule (A) and in the hippocampal region 
(B). High magnification of mossy neurons in hilus, (C) CA1 region and (D) the GFP positive neurons in pyrami-
dal cell layer (white arrows) (E). Scale Bars: A, B = 200 µm; C, D, E = 100 µm. 
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3. ROLE OF D1R AND D2R IN COGNITIVE FUNCTION. 
 
3.1. Definition and basic concepts. 
 
 
         3.1.1. Learning and memory. 
 
 
     We understand Learning as a set of processes that produce changes in the central nervous 
system, modifying the behavior of an organism as a result of environmental experience and 
stimulate the adaptation to the environment.       
    Associated to this concept, we found the functions of retention, storage and retrieval of infor-
mation that we describe as Memory. Memory is not a unitary process; it consists in several pro-
cesses that depend on different brain areas and conform a complex system (Squire et al., 1995).  
 
    For these reasons, memory can be classified into different forms: 
Immediate memory or sensory memory:  It is responsible for defining the ability to remem-
ber all no-attending information for a short time. Its storage capacity is very large and can 
concentrate multitude of different information and even different sensory modalities. 
Short term memory (STM)/ Working memory (WM): Its main function is to establish con-
nections with incoming and existing information to facilitate recognition and reviewing 
processes for their subsequent consolidation in long term memory. Its capacity is limited 
and, if information is not reinforced, it is lost in minutes. 
Long term memory (LTM): Here is stored and consolidated information of interest to the 
STM, can stay from days to months or even for the rest of  life.  
 
    Other memory classification depending of conscious/unconscious processes: 
Declarative or explicit: The neural basis is in the hippocampal system. The hippocampus is 
the main mediator of relational learning. It is based on information stored about the envi-
ronment or personal experience that can be evoked deliberately and consciously. It allows 
to do comparisons and generalizations to similar situations.  
 Implicit or procedural: When a continuous and repetitive learning occurs, declarative 
memory can turn into non-declarative or implicit, this second type is “unconsciously”. 
Therefore, it relates to the basic forms of learning as may be habituation, sensitization, per-
ceptual learning, classical conditioning and motor learning. It is dependent on regions of 
the neocortex and subcortical nuclei which receive significant input from the brainstem, 
thalamus and cortex.  
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3.2.1. Synaptic plasticity and LTP  
 
 
    The learning and memory processess described above would not be possible to carry out 
without several changes that occur in our brain, falling under the concept of “Synaptic plastici-
ty” (Morris, 2006). There are changes in the strength of synaptic connections induced by experi-
ence (Bliss & Collingridge, 1993) and involving behavioral changes that may be or not be bene-
ficial to the individual (Malenka & Bear, 2004). 
    Long-term change in synaptic potentiation (LTP) has been frequently regarded as an elemen-
tary model to study the mechanisms of neuronal plasticity. LTP is an artificial modification of 
induced synaptic transmission, consisting of a lasting increase of a postsynaptic response for 
presynaptic stimulus. This change of basal condition to enhance condition is usually induced by 
the application of a high frequency stimulus (tetanizationg). Other studies have shown that this 
phenomenon may occur in almost all neuronal inputs in the hippocampus and may last for sev-
eral weeks or through life. Hippocampus LTP is considered the base of memory processes.  
    In mammals, the explicit memory is related to hippocampal LTP. LTP, as memory storage, 
has two phases: an early transitory effect (E-LTP) and a late phase of consolidation (L-LTP). E-
LTP lasts at most 3-4 h. This is not long enough for a hippocampal memory trace to guide sys-
tems-level consolidation. However, protein synthesis-dependent L-LTP lasts longer. This phase 
can last 24 h and uses transmission routes of cAMP-dependent signals, PKA-CREB pathway 
and the MAP kinases to transform the STM in LTM (Kelleher et al., 2004).  
    Although the glutamatergic system has been the main object of study in learning processes 
and memory consolidation, now we have more evidences of the importance of the dopaminer-
gic system in these processess. It is known that integration of glutamate- and dopamine-
mediated signals is necessary to induce effective LTP in different brain areas, including cere-
bral cortex (Gurden et al., 1999; Granado et al., 2008; Ortiz et al., 2010; Xu et al., 2010), stria-
tum (Calabresi et al., 1992; Kim et al., 2013) and especially the hippocampus (Huang & Kan-
del, 1995; O´Carroll & Morris, 2004; Gangarossa et al., 2014). Hippocampus receives im-
portant afferents of dopaminergic neurons in the SN (A8,9) and VTA (A10) (Scatton et al., 
1980; Gasbarri et al., 1997; Lisman & Grace, 2005) necessaries to induce changes in synaptic 
plasticity. Interestingly, the exposure to a novel environment provokes an increase in dopamine, 
that facilitates LTP (Li et al., 2003), linking dopamine signaling with enhances LTP and with 
the new information acquisition and storage (Lisman & Grace, 2005). 
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    3.2. Role of dopamine in cognitive process. 
 
    Dopamine is involved in the elaboration, control and acquisition of new information. Neuro-
computational models described its role as a neuromodulator of major cognitive functions 
(Dreher & Burnod, 2002; Goto et al., 2007). Dopaminergic fibers innervate different structures 
related with emotional, motivational, learning and memory processes as hippocampus, prefron-
tal cortex, striatum and amygdala, and it is related with associated synaptic plasticity processes. 
For example, it is known that the activation of striatal dopaminergic input serves as entry door 
for function information on the working memory (O'Reilly, 2006). 
    Dopaminergic dysfunction significantly alters spatial learning and short and long-term 
memory in rodents and in non-human primates (Wishaw & Dunnett, 1985; Williams & Gold-
man-Rakic, 1995). An elegant series of studies have definitively implicated the dopamine in 
learning, using dopamine-deficient mutant mice (DD), which lack TH in dopaminergic neurons 
(Zhou & Palmiter, 1995). The DD mice are impaired in spatial, procedural and associative 
learning (Fadok et al., 2009; Darvas & Palmiter, 2009, 2010; Darvas et al., 2011). Therefore, 
these results evidenced that dopamine is crucial for associative learning, instrumental learning, 
and for spatial and working memory tasks. 
    Additionally, similar results were found in PD patients and in animal models of PD, where 
dopamine depletion causes cognitive deficits (Dubois & Pillon, 1997; Levin & Katzen, 2005). 
For example: MPTP-treated monkeys fail in operant task performances of visual discrimination 
(Scheneider & Roeltgen, 1993) and other studies indicated that hemiparkinsonian rats show an 
impairment in the Morris water maze, the two way active avoidance task (Da Cunha et al., 
2002) and spatial discrimination (De Leonibus et al., 2007).  
    In humans over age and in the course of certain psychiatric and neurological diseases such as 
PD, Hungtinton disease, schizophrenia or depression, where there is an alteration of dopaminer-
gic signal, cognitive ability decreases (Brown & Marsden, 1990; Okubo et al, 1997; Bäckman 
& Farde, 2001). In addition, fluctuations in execution and information processing have been 
strongly and linearly associated with a decline of dopaminergic activity, especially in relation to 
the age of subjects (Volkow et al., 1998; Ma et al., 1999; Kaasinen et al., 2000a; Reeves et al., 
2002; Bäckman et al., 2010; Nevalainen et al., 2014) (Fig. 7). 
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           3.3. Previous studies about the role of D1R and D2R in learning and memory process.  
 
    Since dopamine is directly involved in cognitive processes as previously reviewed, the study 
of D1R and D2R is of paramount importance. Their function play an essential role in dopamine 
response and maintenance within optimal levels for the development of cognitive performance, 
without necessarily having opposite consequences.       
    D1R has been implicated in mediating dopamine effects especially in spatial and associative 
learning and memory processes, as well as in synaptic plasticity and in the associated gene ex-
pression (Müller et al., 1998; El-Ghundi et al., 1999; O'Carrol & Morris, 2004; Granado et al., 
2008; Ortiz et al., 2010). It has been shown that exposure to a new situation, a phenomenon 
closely related to dopamine (Ljungberg et al., 1992), facilitates the induction of LTP dopamine-
dependent through D1R family (Li et al., 2003). 
    Previous studies with D1R knock-out mice (Drd1a
-/-) showed impaired spatial learning and 
memory. In these mice, genetic deletion of D1R induced a decrease in the different phases of 
LTP, E-LTP and L-LTP, and altering the transition from onte to other. Previous works form our 
laboratory and others have shown that D1R is required for the maintenance of L-LTP throught 
the early genes ARC and Ziff 268 expression in CA1 region (Matthies et al., 1997; Smith et al., 
1998; El-Ghundi et al., 1999; Granado et al., 2008; Ortiz et al., 2010). 
Figure 7. DAT and D2R decrease 
with age. A comparison of PET 
scans  from three subjects showing 
the concentration of D2R and dopa-
mine transporters in the brain. Red 
indicates highest concentrations, 
purple indicates lowest. Adapted 
from Volkow ND, 1998. 
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    In line with these results, in vivo and postmortem studies in human and rodent found a de-
cline in cognitive functions associated with a decrease in D1R density (Cortés et al., 1989; 
Rinne et al., 1990; Sunahara et al., 1991; Wang et al., 1998) and further in D2R. Moreover, D2R 
shows an exponential age-related path which is exacerbated after reaching middle age and a de-
cline rate estimated at 10% per decade (Rinne et al., 1990; Nordström et al. 1992; Volkow et 
al., 1998; Ichise et al., 1998; Bäckman et al., 2000) (Fig. 7). PET studies found a clear D2R loss 
in prefrontal, temporal, parietal, anterior cingulate and occipital cortex, as well as in hippocam-
pus, amygdala and thalamus, which appears to be part of normal aging decline. This D2R de-
crease is associated with changes in executive function, episodic memory and speed of response 
(Inoue et al., 2001; Kaasinen et al., 2000a, 2002). In addition, studies that eliminate the age fac-
tor found a correlation between D2R binding and glucose consumption, in the execution of cer-
tain tasks, especially in episodic memory (Bäckman et al., 2000; Volkow et al., 2000). These 
results indicate that the cognitive deficits are directly related with the D2R decrement and it is 
not due exclusively to the aging.  
     Further, D2R density decreases in several brain areas, included hippocampus, correlates with 
cognitive dysfunctions in neurodegenerative diseases such as PD, Alzheimer and Lewy bodies 
dementia (Joyce et al., 1993, 1998; Kemppainen et al., 2003; Tanaka et al., 2003; Piggott, 1999, 
2007; Christopher et al., 2014, 2015). In addition, some studies reported that the use of major 
tranquilizers, in particular D2R antagonists, deteriorates cognitive function in patients with de-
mentia (McShane et al., 1997). 
    Despite of the evidence provided for these studies about the role of D2R in cognitive perfor-
mance, results obtained in genetic and pharmacological models are contradictory, since show 
both, dysfunctions (Glickstein et al., 2002; Fadok et al., 2009) and improvement(Setlow & 
McGaugh, 2000) of cognitive performance. For these reasons, in this work we present data and 
discuss the role of the main dopamine receptors in cognitive functions. 
 
 
4. PARKINSON´S DISEASE. 
 
 
    In 1817 James Parkinson published an essay about a disease that defined as “shaking palsy”, 
a clinical syndrome that presents: “involuntary tremulous motion, propensity to bend the trunk 
forward and senses and intellects uninjured”. Seventy years later, Charcot defined this illness as 
“Parkinson´s disease”. Nowadays, we know that the cause of this disorder is a progressive neu-
rodegenerative loss of nigrostriatal dopaminergic neurons in the SNc particularly. Also new 
studies show that PD may cause non-motor signs and symptoms such as cognitive, psychiatric, 
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autonomic and sensory disturbances. 
 
4.1. Epidemiology and etiology. 
 
 
    PD is the second most common age-related neurodegenerative disorder after Alzheimer´s 
disease, affecting more than 4 million people worldwide and it is estimated to affect 9 million 
people by 2030 (Dorsey et al., 2007).   
    About 90% of idiopathic PD cases are sporadic with unknown etiology and the 10% have a 
genetic origin. Genetic influences would be greater in the early-onset (≤50 years) compared 
with late-onset PD (>50 years) (Marder et al., 2003). The etiology of sporadic PD still remains 
uncertain but points to multifactorial causes, combining genetic and environmental factors.  
    Previous works indicated that free cytosolic dopamine auto-oxidizes spontaneously and 
forms different toxic products and reactive oxygen species (Muñoz et al., 2012; Goldstein et al., 
2014) which may induce the loss of dopaminergic neurons together with increases in oxidative 
stress and neuroinflammation processes caused by environmental toxins, infections…. In addi-
tion, alterations in cell function caused by genetic mutations as those in which mitochondrial 
action is compromised (Schapira, 2008), associated to the aggregation of α-synuclein (Dauer & 
Przedborski, 2003) or related with this, as in the case of glucocerebrosidase enzyme action 
(Murphy & Halliday, 2014). All these factors lead to an alteration of the cell homeostasis and 
the autophagy processes leading to the degeneration of dopaminergic neurons. It is possible that 
the SNc neurons, that have a extreme bioenergetics demand of maintain the massive number of 
synapses and the immense axonal field, are more vulnerable to these effects than other regions 
(Bolam & Pissadaki, 2012). 
 
4.2. Neuropathological features. 
 
 
    In connection with the loss of dopaminergic neurons in SNpc, PD is neuropathologically 
characterized by the presence of Lewy Bodies (LBs) and Lewy neurites in vulnerable neuron 
populations. LBs are intracytoplasmic insoluble protein inclusions, whose principal component 
is α-synuclein (Braak et al., 2002; Bellucci et al., 2012).  
       The neurodegeneration in PD is not limited to dopaminergic neurons, but it also occurs in 
other brain regions, which may account for both motor and non-motor symptoms of the disease. 
The presence of LBs can also appear in other areas such as amygdala, dorsal motor nucleus of 
vagus nerve, locus coeruleus, hippocampus, OB and neocortex. In addition, the degeneration 
also affects noradrenergic, serotonergic and cholinergic systems. 
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    Besides, when a loss of dopaminergic fibers in the striatum takes place, a variety of compen-
satory adjustments occur and consist of: sprouting of surviving dopaminergic axons (Song & 
Haber, 2000), increased firing of spared dopaminergic terminals (Grace, 2008), decreased activ-
ity of the DAT (Sossi et al., 2008), increased dopamine synthesis via TH (Bezard et al., 2000), 
up regulation of D2R receptors in striatopallidal neurons (Kaasinen et al., 2000b; Cai et al., 
2002) and increased excitability of the target striatal MSNs (Azdad et al., 2009). All this results 
in a profound imbalance between the two main striatal pathways as we can see in the following 
scheme (Fig. 8): 
 
Figure 8. The schemes represent models of the basal ganglia motor circuit in healthy (A), and parkinsonian 
(B) states. Cortical motor areas project glutamatergic axons to the putamen, which sends GABAergic projections 
to the GPi and the SNr by two pathways: the monosynaptic GABAergic “direct circuit” (putamen-GPi) and the 
“indirect circuit” (putamen-GPe-STh-GPi/SNr). Dopamine from the SNc facilitates putaminal neurons in the direct 
pathway and inhibits those in the indirect pathway. Activation of the direct pathway leads to reduced neuronal fir-
ing in the GPi/SNr and movement facilitation, while activation of the indirect pathway suppresses movements. The 
STh is also activated by an excitatory projection from the cortex, a connection that was not included in the original 
model. In PD (B), dopamine deficit leads to increased activity in the indirect circuit, in which STh hyperactivity is 
a key characteristic, and hypoactivity in the direct circuit. Together, these actions result in increased GPi/SNr out-
put inhibition of the VL nucleus of the thalamus and reduced activation of cortical and brainstem motor regions. 
Green arrows indicate excitatory activity and red arrows indicate inhibitory activity. GPe=globus pallidus pars ex-
terna. GPi=globus pallidus pars interna. SNc=substantia nigra pars compacta. SNr=substantia nigra pars reticulata. 
STh=subthalamic nucleus. VL=ventrolateral nucleus. Adapted from: Rodriguez-Oroz et al., 2009. 
                                                                                                                                                                                                       35 
 Introduction 
 
 
 
 
 
    4.3. Clinical features. 
 
    Both, the course of the disease and the symptomatology as well as their qualitative and quan-
titative aspects, show great variability between patients. PD clinical manifestations begin when 
dopamine concentrations fall below 60-70% in striatum (Rodriguez-Oroz et al., 2009). If PD is 
untreated, approximately 80% of patients with subsequently diagnosed with PD become severe-
ly disabled or die 10-14 years after onset of disease. 
 
       4.3.1. Motor features. 
 
    The accepted criteria for a clinical diagnosis of PD includes the presence of two of the three 
classical motor features (rest tremor, rigidity and bradykinesia), unilateral onset, a strong clini-
cal response to L-DOPA and the absence of features suggestive of any other motor disorders. 
 
    The more frequently motor features are: 
 
          Bradykinesia is considered the cardinal feature of PD. This symptom appears as a gener-
alized movement slowness, especially in the initiation of movement, which critically can-
not be explained by an intrinsic limitation in execution, but rather is a problem of scaling 
speed to movement distance. The severity of bradykinesia has a positive correlation with 
the dopaminergic depletion which in extreme induces Akinesia or inability to initiate 
movement. 
           Rest tremor is the most common type of tremor in PD, resulting from alternant contrac-
tions of agonist and antagonist muscles. It often starts asymmetrically and affects one 
side of the body more than other.  
           Rigidity, beside to bradikynesia and tremor, is included in the classic triad of motor 
symptoms in PD. Rigidity emerges as an increase in muscle tone at rest and augmented 
resistance to passive displacement. In many cases it is associated with pain. 
Postural instability appears in advanced PD due to the loss of postural reflexes. Over 
time it often becomes resistant to therapy and it is the most common cause of falls. 
           Other motor symptoms: re-emergence of primitive reflexes for a breakdown of the 
frontal lobe inhibitory mechanisms, bulbar dysfunction (dysarthria, hipophonia, etc.), res-
piratory disturbances and neuro-ophthalmological abnormalities. 
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       4.3.2. Non-motor features. 
 
 
    Non-motor symptoms are unresponsive to dopamine replacement therapy and they can be-
come very exacerbated (Weintraub et al., 2008). The most common include: depression and 
anxiety, sleep REM disturbance, olfactory dysfunction, behavioral and cognitive impairment 
and autonomic dysfunction, such as urinary difficulties, constipation, sexual disturbances and 
cardiovascular changes.   
    Neuropsychiatric symptoms affect quality of life for patients and caregivers. They may pre-
cede motor symptoms and are common in PD. Hospitalization for delirium, depression, psycho-
sis and anxiety is sometimes necessary. Prevalence levels in psychiatric symptoms may oscil-
late depending on methodology: depression (40-56%), apathy (38.8-60%) and anxiety (16.7-
43%) (Borek et al., 2006; McKinlay et al., 2008; Leentjens et al., 2011). Other symptoms are 
derived from the use of dopamine agonists, as the impulse control disorders (ICDs) (Weintraub, 
2009; Ceravolo et al., 2010) and psychotic symptoms (Borek et al., 2006).  
    Cognitive deficits has been associated with hypodopaminergic states, even before the appear-
ance of the first motor symptoms, in domains such as executive dysfunction, decreased mental 
flexibility (Floresco & Magyar, 2006), processing information (Zalla et al., 1998), and serious 
difficulties of associative learning and working memory (Sprengelmeyer et al., 1995; Dubois & 
Pillon, 1997, Sarazin et al., 2002), particularly habit learning requiring a high number of associ-
ations (Knowlton et al., 1996).  
    Mild-cognitive impairment (MCI) appear in approximately 20-50% of individuals with PD in 
early stages of the disease. Symptomatology, in many cases can go unnoticed and it represents a 
degree of cognitive impairment that is not normal for age. These patients exhibit non amnesic 
deficits in cognitive domains such as executive function, psychomotor speed, language, atten-
tion and visuospatial function. However, the cognitive phenotype of PD-MCI is heterogeneous 
because some patients demonstrate grater amnestic deficits. MCI has been increasingly recog-
nized as a distinct entity and a potential prodromal state as well as a risk factor for developing 
PD dementia (PDD) in a 80% of prevalence, particularly those with posterior cortical profiles 
(Borek et al., 2006; Monastero et al., 2012). Knowledge of MCI in early-stages of PD is essen-
tial in understanding and predicting PDD process (Goldman & Litvan, 2011). 
    PDD typically reflects a “subcortical dementia” syndrome with greater impairment in non-
amnestic cognitive domains (executive and visuospatial functions) and less impairment in de-
clarative memory, language and praxis. Epidemiological studies suggest that the point preva-
lence rate of dementia in PD is about 40% (Aarsland et al., 2005). 
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4.4. L-DOPA treatment. 
 
    The treatment options for patients with PD include non-pharmacological measures, pharma-
cotherapy and surgical therapy. Nevertheless, there is no treatment to solve or delay the curse of 
the disease. Treatment is usually palliative and includes: 
Pharmacologic agents: L-DOPA, dopamine agonists, dopamine metabolism inhibitors 
(in conjunction with L-DOPA), Amantadine (the only antidyskinetic agent), anticholin-
ergic agents and genetic therapies. 
Surgical treatments: Ablation for stereotaxic surgery, deep brain stimulation and in-
trastriatal transplants of fetal mesencephalic tissue. 
 
 
    However only L-DOPA, a precursor of dopamine, remains the single most effective agent in 
the treatment of PD. This drug is usually administered with carbidopa or benserazide, a periph-
eral decarboxylase inhibitor which blocks peripheral conversion of L-DOPA to dopamine thus 
allowing dose reduction and also minimizing peripheral adverse effects (nausea, hypotension, 
etc.). L-DOPA can cross the blood-brain barrier to the brain where is decarboxylated and stored 
in synaptic vesicles for subsequent release in dopaminergic terminals or in other catechola-
minergic cells when the last terminals disappear.  
    In spite of the advantage of L-DOPA therapy, its chronic administration and the pulsatile 
stimulation that dopamine produces in the last terminals provoke the appearance of side effects 
after 6 years. The complications include a decrement in the effect called “wearing off” period, 
when the PD symptoms returns for decrease of L-DOPA plasma levels and abnormal stereotyp-
ic movements, “dyskinesias”, specially in the peak-dose of drug (Pavón et al., 2006; Cenci, 
2007; Kakkar et al., 2015).  
 
 
4.5. Animal models of PD. 
 
   The neuroanatomical characteristics of human and the unknown specific mechanism implicat-
ed in origin of PD make that any animal model for PD research, directly replicate all the fea-
tures of human disease. Normally, the election of a specific PD model depends on the aspect to 
the disease studied. Animal models generally include: pharmacologically-induced models (e.g. 
reserpine), neurotoxicant-induced models (e.g. MPTP and 6-OHDA), genetic models (Pitx3-/-) 
and viral models (e.g. viral particles with mutant α-synuclein). The 6-OHDA model and 
Aphakia mice (Pitx3-/-) were used for this study: 
38 
                                                                                                                                    Introduction 
 
 
4.5.1. Model of 6-hydroxydopamine (6-OHDA). 
 
    This model consists in stereotaxic injections of 6-OHDA in the nigrostriatal pathway, median 
forebrain bundle or striatum, because 6-OHDA cannot cross the blood-brain barrier. When the 
6-OHDA is injected into the striatum, it is taken up by dopaminergic and noradrenergic trans-
porters into monoaminergic neurons and retrogradly transported to the dopaminergic cell bodies 
of the SN, where is accumulated in the cytosol. There, it autooxided generating reactive oxygen 
species and producing mitochondrial dysfunction. This causes a partial and slow degeneration 
of dopaminergic nigrostriatal neurons lasting 1-3 weeks. 
 
 4.5.2. Aphakia Model. 
 
    In some circumstances, genetic models provide a more reliable approach to human disease 
(Dauer & Przedborski, 2003). Pitx3-deficient aphakia mouse  is usually used as a model of PD 
to study the principal motor disturbances. Pitx3 is a homeodomain transcription factor expres-
sed in dopaminergic neurons in the brain and is essential for the normal development of the 
midbrain dopaminergic system (Jacobs et al., 2009). Inactivation of Pitx3 induces selective loss 
of dopaminergic neurons in the SNc and, as a consequence, major dopamine depletion in the 
striatum, providing a genetic model of PD (Nunes et al., 2003; Hwang et al., 2003, 2005; Ding 
et al., 2007).  
 
    4.6. Tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the denervated striatum. 
 
    The presence of TH-ir straital  neurons was described for the first time in 1987 by Dubach 
and colleagues (Dubach et al., 1987). In this pioneer paper the authors described these cells in 
the primate brain but subsequent works demonstrated that these neurons also exist in the stria-
tum of rodents and humans (Betarbet et al., 1997; Cossette et al., 2005; Hout & Parent, 2007; 
Busceti et al., 2008). The number of these neurons increases significantly in PD patients (Porritt 
et al., 2000; Hout et al., 2007) and in animal models of PD (Mura et al., 1995, 2000; Betarbet et 
al., 1997; Lopez-Real et al., 2003; Jollivet et al., 2004; Darmopil et al., 2008), but their origin 
and function are poorly understood. 
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 4.6.1. Phenotype of TH-ir neurons. 
 
    Striatal TH-ir neurons were identified based on TH expression. Convincing evidence with 
BrdU experiments demonstrated that the striatal TH-ir neurons that appear in rodents and mon-
keys following dopaminergic denervation result from a phenotypic shift in which pre-existent 
GABAergic interneurons begin to express TH, rather than from the birth of new neurons (Mao 
et al., 2001; Darmopil et al., 2008; Tande et al., 2006).  
    These neurons express GAD-67 in rodents in a 99% (Betarbet et al., 1997; Tande et al., 2006; 
San Sebastián et al., 2007; Busceti et al., 2012) and GAD-65 in human brains (Cossette et al., 
2005). Other studies show that only 1% is positive for calbindine, a marker for striatal projec-
tion neurons, or parvoalbumin, nNOS, neuropeptide Y and less than 10% express calretinine, 
for striatal interneurons (Betarbet et al., 1997; Mazloom & Smith 2006; Tande et al., 2006; Dar-
mopil et al., 2008).  
    In addition, 26% of the TH-ir neurons in primates express the NMDA glutamate receptor 
subunit NR1, while 75% express the GluR1 subunit of AMPA glutamate receptors. Virtually 
none of the TH-ir cells express the GluR2/3 subunits of the AMPA receptor or the mGluR1/5 
subunits of the metabotropic glutamate receptor (Betarbet & Greenamyre, 1999). 
    The first study demonstrating that these neurons are functionally active, comes from the 
group of Rosario Moratalla (Darmopil et al., 2008). They showed that L-DOPA treatment in 
parkinsonian animals induced FosB expression in these TH-ir striatal neurons. Other groups 
showed that TH-ir neurons in the intact striatum exhibit electrical activity profiles characteristic 
of GABAergic neurons (Ibáñez-Sandoval et al., 2010; Masuda et al., 2011). Also, some of these 
striatal TH-ir neurons express AADC, the enzyme required for dopamine production. This fea-
ture makes these neurons a potential striatal stores for exogenously administered L-DOPA 
where it may be converted into dopamine (Tashiro et al., 1989; Mura et al., 1995; Lopez-Real et 
al., 2003; Darmopil et al., 2008; Busceti et al., 2012).  
    In addition, VMAT-1 has been detected in EGFP-TH-BAC-transgenic mice (Ibáñez-
Sandoval et al., 2010), and VMAT-2 in 50% of TH-ir neurons in monkey striatum (San Sebas-
tián et al., 2007), indicating that these neurons can produce and store dopamine. Furthermore, in 
PD patients (Porritt et al., 2000), MPTP-treated monkeys (Tandé et al., 2006) and neonate mice 
lesioned with 6-OHDA (Busceti et al., 2012) these neurons also express DAT. However, in oth-
er study co-localization of these markers was not found (Weihe et al., 2006; Darmopil et al., 
2008), suggesting that TH-ir can release dopamine in non-vesicular manner. 
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    4.6.2. Morphology of TH-ir neurons.  
 
 
    Striatal TH-ir neurons are more abundant in primates than in rodents and display a more var-
ied morphology, although there are also conflicting data about the morphology of TH-ir neu-
rons between both species. 
    In monkeys, many TH-ir neurons are small (6-16 µm), bipolar, oval or round perykarion with 
small and aspiny dendrites (Dubach et al., 1987, Bertabet et al., 1997; Levesque et al., 2003; 
Cossette et al., 2004, 2005) and only few (<1%) are large (15-25 µm), multipolar with spiny 
dendrites (Bertabet et al., 1997) (Fig. 9). These dendrites sometimes have TH-ir spines and in-
puts to dendritic shafts are either symmetrical or asymmetrical, while inputs onto the perikaryon 
mainly form symmetrical synapses (Meredith et al., 1999). Besides, these studies in monkey 
found a deeply invaginated membrane surrounding their large nucleus (6-10 µm), typical of 
striatal interneurons.  
 
     
 
    In rodents lesioned with 6-OHDA, most TH-ir neurons have a smaller diameter (6–12 µm), 
oval perikaryon with a few varicose aspiny dendrites (Tashiro et al., 1989; Meredith et al., 
1999; Lopez-Real et al., 2003; Jollivet et al., 2004), although some of them have spines 
(Darmopil et al., 2008). A small number of larger (10–15 μm), multipolar TH-ir neurons with 
spiny dendrites have also been reported in the 6-OHDA-lesioned rat striatum (Lopez-Real et al., 
2003; Jollivet et al., 2004).   
Figure 9. Aspiny and spiny TH-ir neurons in the striatum of MPTP-treated monkeys. A. Photomicrograph of 
an aspiny oval-shaped neuron with smooth dendrite. These TH-ir neurons were observed much more frequently 
than the spiny neurons after MPTP treatment. B. Photomicrograph of a spiny TH-ir neuron with a number of pri-
mary dendrites that are densely covered with spines. The insets in A and B show a magnified image of a portion of 
the dendrite denoted by the arrows. Scale bar: 30 µm. Adapted from Betarbet et al., 1997. 
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4.6.3. Regulation of TH-ir neurons expression in lesioned striatum. 
 
    The effect of L-DOPA on striatal TH-ir neurons in humans is somewhat controversial. In one 
study, PD patients treated with L-DOPA showed a marked increase in the number of striatal TH
-ir neurons compared to controls (Porritt et al., 2000), in accordance with findings in animal 
models of PD (Tashiro et al., 1989; Betarbet et al., 1997; Meredith et al., 1999; Mao et al., 
2001; Nakahara et al., 2001; Palfi et al., 2002; Lopez-Real et al., 2003; Jollivet et al., 2004; 
Mazloom & Smith, 2006; Tandé et al., 2006; Darmopil et al., 2008). In contrast, another study 
reported a reduction in the number of TH-ir neurons in the striatum of MPTP-lesioned monkeys 
and PD patients treated with L-DOPA (Hout et al., 2007, 2008). 
    However, it is clear that TH-ir neurons are markedly increased in rodent striatum after rapid 
dopamine fluctuation, as it has been observed after 6-OHDA lesion (Meredith et al., 1999; 
Lopez-Real et al., 2003; Mura et al., 2000; Depboylu et al., 2014) or MPTP (Nakahara et al., 
2001; Bubak et al., 2015) and methamphetamine treatment (Meredith et al., 1999). Also, studies 
in the new born striatum of mice reported an increase of TH-ir neurons in early postnatal devel-
opment of the dopaminergic striatal innervation, and found that the number of these cells de-
crease when dopamine axons develop a full pattern of striatal innervation (Baker et al., 2003; 
Busceti et al., 2008; 2012). This further supports the concept that the expression of TH-ir neu-
rons in the striatum is determined by the fluctuations of local dopamine levels. 
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Hypotheses: 
 
Principal objectives:  
 
1. To analyze the role of D1R in spatial, associative and recognition processes of learning 
and memory mediated by the hippocampus. 
 
2. To analyze the role of D2R in spatial and associative learning and memory process, and 
its effects in the underlying synaptic plasticity in the hippocampus. 
 
3. To study the dopaminergic regulation, mediated by D1R and D2R in the appearance of 
striatal TH-ir neurons, and its possible influence in motor response. 
 
Sub-objectives:  
 
1.1. To determine the role of the D1R in spatial learning and memory function. 
 
1.2. To study the role of the D1R in associative learning and memory function. 
 
1.3. To analyze the role of the D1R in recognition memory process. 
 
14. To study potential motor, emotional, motivational and pain sensitivity alterations in 
Drd1a-/- mice. 
———————————————————————————————————— 
2.1. To study the consequences of the D2R absence in spatial learning and memory func-
tion. 
 
2.2. To determine the D2R functions in associative learning and memory consolidation. 
 
2.3. To study potential motor, emotional, motivational and pain sensitivity alterations in 
Drd2-/- mice which will influence in test response. 
 
2.4. To analyze the role of the D2R in eyeblink conditioning mediated by hippocampus. 
 
2.5. To study the role of dopamine D2R in CA3-CA1 synaptic plasticity changes induced by 
LTP in Drd2-/- mice and mice with intrahippocampal injections of Drd2-siRNA. 
———————————————————————————————————— 
 
3.1. To study the influence of L-DOPA treatment on TH-expression in striatal neurons. 
 
 
 
3.2. To study the role of D1R and D2R on the expression of TH-ir striatal neurons. 
 
 
3.3. To study the phenotype and morphology of TH-ir neurons in the striatum. 
 
 
3.4. To study the possible role of TH-ir striatal neurons in motor behavior. 
 
1. Dopaminergic signaling through D1R and D2R activation in the hippocampus regulate 
learning and memory processess. 
 
2. Dopaminergic signaling through D1R and D2R activation in the striatum regulates the phe-
notypic shift of a small population of striatal neurons to express TH. 
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& Methods 
  
 
Materials & Methods 
 
 
1. ANIMALS. 
 
This study was carried out in adult male mice C57/BL6, and in mice lacking D1R (Drd1a
-/-); 
(Moratalla et al., 1996; Centonze et al., 2003; Granado et al., 2014) or D2R (Drd2
-/-); (Kelly et 
al., 1997; Granado et al., 2011) and Pitx3 deficient aphakia mice (Pitx3-/-) (Smidt et al., 2004; 
Beeler et al., 2010; Espadas et al., 2012; Cremer et al., 2015). Wild-type (WT) and homozygous 
Drd1a -/- or Drd2-/- and Pitx3-/- mice used in this study were derived from the mating of hetero-
zygous mice and their genotype was determined by PCR analysis. Another group is composed 
by bacterial artificial chromosome (BAC)-transgenic mice used to show the co-localization 
study for striatal TH-ir neurons: Drd1a-Tomato or Drd2-enhanced green fluorescent protein 
[eGFP] (Suárez et al., 2014). 
Adult mice weighting 24-30 g (3-6 months old at the start of the experiment) were housed in 
standard Plexiglas cages with maximum of 6 animals per cage. Environmental conditions were 
strictly controlled; light/dark cycle of 12 h, temperature (22 ± 1°C) and humidity (55 ± 9%).  
Food and water were available ad libitum. For all behavioural test were used a 26 lux intensity 
of illumination. Animal maintenance and all experimental procedures were performed in ac-
cordance with the guidelines of the European Union (2010/63/UE) and Spanish regulations 
(Real Decreto 53/2013). All efforts were made to minimize the number of animals used in this 
study and their suffering. The experimental protocols involving animals were approved by the 
CSIC Bioethical Committee. 
 
2. LEARNING AND MEMORY MODELS. 
 
    2.1. Behavioral test. 
 
 
2.1.1. Spatial learning  
 
 
    Barnes Maze. In this test, Drd1a-/-, Drd2-/- and their corresponding WT animals (n= 10 for 
each group) received reinforcement to escape from the open platform surface to a small dark 
recessed chamber located under the platform called “escape box” (Ortiz et al., 2010). The para-
digm consists of a circular platform (92 cm diameter) with 20 holes (hole diameter: 5 cm) along 
the perimeter (Fig. 10). Spatial cues were placed in the walls of the room during the experiment. 
The experiment was divided in three different phases. During the first 11-14 days, mice were 
trained to enter into the escape box; in the second part, mice rested for 3 days and were tested 
for long-term spatial memory. In the last phase, animals were trained again in the Barnes maze 
for 3 days, but the escape box was placed in a new position 180º from the original position. The  
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task conditions during all phases were identical; each animal was placed in the middle of the 
maze in a black cylindrical start. After 10 s elapsed, the cylinder was lifted, and the mouse was 
free to explore the maze. The trial ended when the mouse entered the escape box or after 2 min 
had elapsed; in this case, mice was guided to the escape box. In all cases, mice were allowed to 
stay 30 s in the escape box. All animals were given four training trials per day, and trials were 
separated by 20 min. After each trial, the maze was cleaned with 70% alcohol to eliminate the 
use of intramaze cues. The parameters recorded were: latency time to scape box, immobility 
time and number of holes exploring (to study motivational and emotional aspects). 
     
 
    Morris Water maze (MWM). Previous studies describe that Drd2-/- mice have motor coordina-
tion problems and explore poorly the environment (Baik et al., 1995). To discard the influence 
of these motor problems we use caffeine (an A2A receptor antagonist) to facilitate motor execu-
tion of these mice. Previously to the training (day 0), each mouse received a trial of 1 min into 
the MWM, with free exploration. 2 h after de habituation, each animal received 15 mg/kg of 
caffeine intraperitoneal; 5 min after the injection mice explored the maze free 1 min. During the 
training, spatial learning and memory were assessed in Drd2-/- mice (n=9) and WT (n=10) litter-
mates using the MWM as described previously (Granado et al., 2008), without caffeine. The 
maze consisted of a circular tank (100 cm of diameter) filled with 21 ºC water located in a room 
with visible external cues. During the acquisition trials (days 1 to 12), mice were trained to  
Figure 10. Barnes Maze. The picture illustrates a photograph (A) and scheme (B) of the Barnes maze used for 
spatial learning. Sizes and distances are described in the scheme. The position of the target and opposite holes  
is indicated. 
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escape from water by swimming from variable starting points around the tank to the hidden 
platform and allowed to remain there for 15 s. Mice that failed to find the platform within 60 s 
were guided to the platform and placed on it for 15 s. After each trial, mice were dried and re-
turned to their home cages. All sessions were recorded by a video camera located above the 
tank. Mice received 4 trials per day, for 12 consecutive days, with an inter-trial interval of 5-7 
min, and their escape latency was recorded for each trial. In the probe trials (no platform), con-
ducted on the first day (day 0), 48h (with caffeine) and 72h (without caffeine) after the last ac-
quisition trial (day 15), mice were allowed to swim for 60 s (Fig. 11). Spatial learning was 
measured by latency to platform, distance, duration of time spent in the target quadrant and the 
number of platform crosses. 
 
2.1.2.  Associative Learning. 
 
     Active avoidance. For this test, we used a two-way shuttle-box (AccuScan Instruments, Inc. 
Columbus, Ohio) with acrylic walls and stainless steel bars in the floor controlled by a program-
ming/recording unit with a shock generator (AccuScan Instruments, Inc.) (Ortiz et al., 2010). 
Drd1a-/-, Drd2-/- and their corresponding WT mice (n= 10 for each group) were given one train-
ing session each day for 8 consecutive days. Each training session consisted of an adaptation 
period of 3 min, in which animals were allowed to move freely from one compartment to the 
other, followed by 20 trials separated by an inter-trial interval (ITI) of 20 s (± 5 to counteract 
any time associations). In each trial, a red light and a tone (100 GHz, 100 dB) were presented 
simultaneously for 10 s in the compartment where the animal stayed and were used as condi-
tioned stimulus (CS). After 5 s of the CS, mice received a 0.2 mA electric foot-shock as uncon-
ditioned stimulus (US) for a maximal duration of 10 s. An avoidance response was defined as 
when the animal crossed to the opposite compartment of the box after the CS started but before 
the US was delivered. Crossings while the shock was being delivered were considered escape  
Figure 11. Experimental design. The arrow represents the time-course of Morris water maze experiment. In the 
first phase of experiment (habitation, day 0), mice freely explored the maze, 1 minute after saline administration 
and then 2 h later with caffeine (15 mg/kg). All mice performed the training phase without caffeine (days 1 to 12). 
After a 24 h break (day 13), mice were tested in two different moments: at day 14 after caffeine administration and 
at day 15 with saline. Caffeine was given to increase motor ability, impaired in Drd2-/- mice. 
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responses. Response latencies were counted as the time (in seconds) from the onset of the CS 
until the animal crossed into the opposite compartment. The number of crosses during the ITI 
was determined as a measure of general activity. The test session was performed three days af-
ter the end of the training phase. The apparatus was cleaned after each animal trial. 
 
    Passive Avoidance. This test was performed as previously described (Pittenger et al., 2006; 
Ortiz et al., 2010). Drd1a -/- (n=10) and WT (n= 10) mice were placed into the passive avoid-
ance box (Ugo Basile) with two different compartments, one dark and the other illuminated and 
white. On the first test day, we measured the time that each mouse spent in the white compart-
ment. As soon as the animal crossed to the black compartment, the automatic door was closed, 
and animal received an electrical foot-shock (0.4 mA or 0.8 mA, 1s). The test was repeated 1 
and 24 h after the first trial with foot-shock in the same conditions. 
 
 
      Fear Conditioning-Extinction. To assess contextual fear conditioning in Drd2-/- and their 
corresponding WT mice (n= 10 per group), we used a fear conditioning task as previously de-
scribed (Alarcón et al., 2004; Ortiz et al., 2010). On training day, mice were placed in the con-
ditioning chamber for 2 min before onset of the CS (a 30 s tone). During the last 2 s, the US, an 
electrical shock of 0.7 mA, was presented paired with the CS. Animals were maintained in the 
chamber for an additional 30 s before returning to home cage. Conditioning was tested 24 h lat-
er by measuring the freezing behaviour with a tracking video system (Panlab, Barcelona, 
Spain). To check hippocampal-dependent conditioning, each mouse was placed into the same 
context where trained (5 min) and any tone were presented. Mice were re-placed into the condi-
tioning chamber, and the freezing time was measuring for 5 min without the tone to assess con-
textual conditioning. Animals were returned to home cages for 3 h and placed into a novel 
chamber to test cued fear conditioning. After 1 min in the novel context, the tone was presented 
for 30 s, and freezing time was measured for 2 min. 
    To study fear extinction, the US was modified because mice of different genotypes acquired 
different levels of freezing behaviour with the original paradigm. The new US consisted of 3 
consecutive electrical shocks (0.7 mA for 2 s, with 2 min inter-shocks intervals) delivered in the 
conditioning chamber followed by a 2 min measurement of freezing time before returning ani-
mals to home cages, which resulted in similar freezing times for all mice. Extinction was stud-
ied for 6 consecutive days, by placing animals for 5 min in the same context used for condition-
ing. 
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2.1.3. Recognition Memory. 
 
          Object recognition test. Object recognition testing (ORT) was performed in Drd1a-/-  
(n=10) and WT mice (n= 10), as previously described (Puzzo et al., 2013). One day before 
training, mice were allowed to familiarize with the apparatus (a plastic box 40 cm long, 30 cm 
wide and 30 cm high) for 15 min. The ORT consisted in a trial of 10 min. This protracted expo-
sure has been shown to allow the animals to learn the task. On the first day, two identical ob-
jects were placed in the central part of the box, equally distant from the perimeter. Each mouse 
was placed in the apparatus and allowed to explore them. Exploration was defined as the mouse 
pointing its nose toward the object from a distance of no more than 2 cm. Then, each animal 
was then returned to its cage. The trial test was performed 24 h later to test memory retention. 
Mice were presented with two objects, a “familiar” and a “novel” object. To avoid olfactory 
cues, the objects and the apparatus were cleaned with 70% ethanol after each trial. The follow-
ing parameters were evaluated: time of exploration of each object and total time of exploration 
of the two objects expressed as percentage of exploration of novel and familiar object.  
 
 
 2.1.4. Emotional response. 
 
 
    Elevated-plus maze (P-maze). To measure anxiety-related behaviour, an P-maze was used for 
Drd1a-/-, Drd2-/- and their corresponding WT mice (n= 10 for each group). The maze was ele-
vated 40 cm above the floor level and consisted of two open and two closed arms of the same 
size (30 x 5 cm); closed arms were surrounded by walls of 15 cm high. The arms were con-
structed of grey Plexiglas slabs radiating from a central platform (5 x 5 cm) to form a plus sign  
Figure 12. Elevated-plus maze. The picture illustrates a photograph (A) and scheme (B) of the elevated-plus 
maze used for measure anxiety-related behaviour. Sizes an distances are described in the scheme. The initial posi-
tion of mice in the maze is indicated. 
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(Fig. 12). All arms were illuminated equally. Mice were placed in the central platform, between 
open and closed arms, and were free to explore freely for 5 min. We measured: time spent in 
the open sections and the number of crossings between open and closed arms. 
 
 
    Porsolt test. This test was performed as previously described by Porsolt et al., 1978. Drd1a-/-, 
Drd2-/- and WT mice (n= 10 for each group) were given in a single trial in which they were 
forced to swim inside narrow Plexiglas cylinders (height, 25 cm; diameter, 10 cm) containing 
10 cm water, maintained at 24-25ºC, an left there for 6 min. The total immobility time was 
measured during the last 4 min of the trial .  
 
2.1.5. Sensorimotor test 
 
 
    Sensitivity to electric shock. This test was performed as described by El-Ghundi et al., 2001.  
Briefly, mice were subjected to a series of mild foot-shocks with gradually increasing amperage 
(0.02, 0.04, 0.06, 0.08, 0.1, 0.15, 0.2, 0.25, 0.3, 0.4, 0.5, 0.6 mA). Duration of foot-shock was 1 
s with 20 s inter-shock intervals. For each group (n=10) of mice (Drd1a-/-, Drd2-/- and WT 
mice), we determined the shock intensity that produced each of the following initial sensation 
responses: sniffing and staring at the floor bars, licking and biting the floor bars, alternate stand 
on the paws, startle response, jumping and vocalization (Ortiz et al., 2010). 
 
 
     Nociceptive thresholds. We used three different acute nociceptive test: hot plate, plantar test 
and tail immersion test. In all test cut-off time of 20 s was used to prevent tissue damage in the 
absence of response. We used the plantar test apparatus (Ugo Basile) to measure peripheral 
pain responses with paw withdrawal latencies in response to radiant heat (55ºC). Mean paw 
withdrawal latencies were determined from the average of three separate trials, taken at 5 min 
intervals in each group of mice. The hot plate test was used to investigate central supraspinal 
nociception. This test was performed with a hot plate apparatus (Ugo Basile) at 52ºC. We meas-
ured the time (in seconds) to paw licking or paw withdrawal in response to heat. For tail immer-
sion test, about 3 cm of the distal part of the tail was immersed into a temperature-controlled 
water bath (52 ± 0.5ºC). Latency was the time from tail immersion until it was removed or vig-
orously pulled away. This test was used to assess the nociception at central spinal level. 
 
 
    Cylinder test. Spontaneous forelimb use was evaluated in the cylinder test in WT and WT-
6OHDA-lesioned mice (n=11) (Espadas et al., 2012; Ruiz-DeDiego et al., 2015). Each animal 
was placed in a 10 cm diameter glass cylinder and videotaped for 3 min. The number of ipsi- 
and contra-lateral forepaw touches to the cylinder was counted by an observed blind to the  
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Figure 13. Cylinder test. Photographs of a beaker with a naïve mouse (A) that typically use both paws to explore 
the wall of cylinder and a lesioned mouse (B) that mainly use the ipsilateral paw of the lesion to explores the wall 
of cylinder. 
 
 
experimental conditions of the animals (Fig. 13). Data are expressed as percentage of contra-
lateral touches. Mice were tested 3 weeks after the 6-OHDA lesion, and 1, 4, 7 and 10 days af-
ter chronic L-DOPA treatment (25 mg/kg, i.p., daily for 21 days).  
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2. Electrophysiology.  
 
2.2.1. Lentivirus  
 
     Lentivirus constructuion. To silence the mouse Drd2 (GenID: 13489) in vivo, three different 
sequences were designed and cloned into BamHI and XhoI sites of pRNAT-U6.2 by GenScript 
Corporation USA. The 3 siRNA used were: 5’GAT CCC GCG TAG CAG CCG AGC TTT 
CTT CAA GAG AGA AAG CTC GGC TGC TAC GCT TTT TTC CAA CTC GAG 
3’ (D2RNAi01), 5’ GGA TCC CGC GCC GAG TTA CTG TCA TGT TCA AGA GAC ATG 
ACA GTA ACT CGG CGC TTT TTT CCA ACT CGA G 3’ (D2RNAi02), 5’ GGA TCC CGC 
TAC CTG ATA GTC AGC CTC TTC AAG AGA GAG GCT GAC TAT CAG GTA GTT 
TTT TCC AAC TCG AG 3’ (D2RNAi03). As control, we used a mock siRNA with no target in 
mouse: 5’ GGA TCC CGA CGT CCA GGC TGC TTC GAT TGA TAT CCG TCG AAG CAG 
CCT GGA CGT CTT TTT TCC AAC TCG AG 3’ (Control RNAi). 
 
    Lentivirus production. Each lentiviral vector plasmids (pRNAT-U6.2-D2RNAi01,-
D2RNAi02, -D2RNAi03; Genscript, USA), together with the packaging plasmid psPAX2 and 
the envelope plasmid pMD2G were co-transfected into human embryonic kidney (HEK) 293T  
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cells to produce viral particles. High-titer stocks [1×107 transduction units (TU) per microliter] 
were obtained by ultracentrifugation and resuspension of the viral pellet in TNE buffer (in mM: 
50 Tris-HCl, pH 7.5, 130 NaCl, and 1 EDTA). Viral stocks were stored at −80°C. 
    Determination of lentivirus silencing efficiency in vitro. The efficiency of the lentiviruses at 
silencing was tested in vitro in STHdh+/Hdh+ cells because this cell line expressed D2R (Kiyomi 
et al., 2006). Cells were obtained from the Coriell Institute, New Jersey, USA (CH00097). Cells 
were grown at 33°C in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bo-
vine serum, 1% non-essential amino acids, 2 mM L -glutamine, 1% penicillin-streptomycin, 0.8 
mg/ml Geneticin, and 40g/ml puromycin (Invitrogen). The cells remain proliferative under 
these conditions (Cattaneo & Conti, 1998; Trettel et al., 2000). A total of 1 × 105 STHdh+/Hdh+ 
cells were plated per well in six-well plates. The next day, lentivirus (Lv) stocks were mixed 
with 10 μg/ml Polybrene (Sigma), incubated for 30 min at room temperature, added to the cells, 
and incubated at 37°C. After 48 h, the medium was replaced with normal growth medium, and 
cells were left for an additional 48 h. Cells were solubilized in lysis buffer for Western blot (see 
below). For in vitro silencing of Drd2 cells were infected with 4 μl of Lv preparation, either 4 
μl of Lv-Mock-GFP used as control or 4 μl of one of the three Lenti-Drd2-siRNA or 4 μl of all 
three Lenti-Drd2siRNAs together.  
          Quantitative real-time PCR. Primer sets for rat and mouse Drd2, and Gapdh were designed to 
amplify 100 to 200 bp products. The following specific primer pairs were used: Drd2, 5′-
CATTGTCTGGGTCCTGTTCCT-3′ and 5′-GACCAGCAGAGTGACGATGA-3′; Gapdh, 5′-
ATGACTCTACCCACGGCAAG-3′ and 5′-CATACTCAGCACCAGCATCAC-3′. Gapdh was 
used as an endogenous control for normalization. Total RNA was extracted from the STHdh+/
Hdh+ cells (for in vitro quantification) or from the brains of treated animals (for in vivo quantifi-
cation) using Illustra RNAspin kit (GE Healthcare). First-strand cDNA was generated from 1 μg 
of total RNA with iScript™ cDNA Synthesis kit (Bio-rad) in a total volume of 20 μl. For Real-
Time PCR analysis, the reaction was performed in 25 μL using the fluorescent dye Power 
SYBER Green PCR Master Mix (Applied Biosystem, Foster City, CA) and a mixture of 5 pmol 
of reverse and forward primers. Quantification was performed on a StepOne detection system 
(Applied Biosystem, Foster City, CA). PCR cycles proceeded as follows: 3 min at 95°C (initial 
denaturation); 20°C/s temperature transition up to 95°C for 45 s, 45 s at 62°C, repeated for 40 
cycles (amplification). 
         The melting-curve analysis showed the specificity of the amplications. Threshold cycle,  
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which inversely correlates with the target mRNA level, was measured as the cycle number at 
which the reporter fluorescent emission appears above the background threshold. To ensure that 
equal amounts of cDNA were added to the PCR, the Gapdh housekeeping gene was amplified. 
Data analysis is based on the ΔΔCt method with normalization of the raw data to housekeeping 
genes as described in the manusfacturer's manual (Applied Biosystem, Foster City, CA). All 
PCRs were performed in triplicates. 
    Western blotting. To check silencing efficiency following striatum injection of lentivirus, 
striatum was dissected, homogenized in lysis buffer (50 mM Tris, 300 mM NaCl, 1% Triton X-
100, 25 mM NaF, 1 mM sodium orthovanadate, 4 mM sodium pyrophosphate, 1 mM EDTA, 
and 1 tablet of Complete protease inhibitor; Roche). The samples were centrifuged at 10.000g 
at 4ºC for 15 min. Supernatants were placed into new tubes and protein concentration was 
quantified by BCA (Sigma) method. Solubilized extracts were resolved in sodium dodecyl sul-
phate-polyacrylamide gel electrophoresis (SDS-PAGE). Membranes were blocked with 5% 
BSA in Tris-Buffered Saline, 0.2% Tween-20 for 1 h at room temperature and incubated over 
night at 4ºC with primary antibody against D2R (1:1000, Millipore, Temecula, California, 
USA). Membranes were washed and incubated for 1 h at room temperature with peroxidise-
conjugated secondary anti-rabbit antibody (1: 20000, Vector, Burlingame, California, USA). 
Proteins were visualized using Super Signal West Pico Chemiluminescent Substrate (Pierce). 
Then, membranes were stripped in 0.5 M Tris-HCl buffer, pH 6.8; containing 10% SDS, 100 
mM β-mercaptoethanol for 20 min at room temperature, washed with TBS-tween and incubated 
with anti-Actin antiserum (1:1000, Sigma Aldrich, St. Louis, Missouri, USA) as a control for 
protein loading. Signals were detected with films that were exposed and digitized and quanti-
fied with Quantity One software (Bio-Rad Laboratories). 
 
 2.2.2. Surgery.  
 
 
    To carried out input/output curves, paired-pulse facilitation, LTP and classical eyeblink con-
ditioning were used a set of four groups of animals: WT, Drd2-/-, WT-GFP and Drd2-siRNA (n 
= 10 animals per group). Mice were anesthetized with 0.8-1.5% isoflurane, supplied from a cal-
ibrated Fluotec 5 (Fluotec-Ohmeda, Tewksbury, MA, USA) vaporizer, at a flow rate of 1–2 
min oxygen (AstraZeneca, Madrid, Spain) and delivered by a mouse anaesthesia mask (David 
Kopf Instruments, Tujunga, CA). In the first surgical step, animals from groups WT-GFP and 
Drd2-siRNA received a unilaterally stereotaxic injection of 2µl of Lv-Mock-GFP or a mix of Lv 
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-Drd2-siRNAs of concentrated lentiviral stocks (0.2µg/µl) into the hippocampus. The injection 
was carried out with a Hamilton syringe and performed unilaterally at the following coordi-
nates, calculated from Bregma and skull surface: anterior -2.4; lateral +1.5 (right side); ventral -
2.0 (Paxinos & Franklin, 2004).  
    3 Weeks later, as illustrated in Figure 14, all animals included in the groups mentioned above 
were implanted with bipolar stimulating electrodes in the right Schaffer collateral-commissural 
pathway of the dorsal hippocampus (2 mm lateral and 1.5 mm posterior to Bregma; depth from 
the brain surface, 1.0-1.5 mm) (Paxinos & Franklin, 2004) and with a recording electrode in the 
ipsilateral stratum radiatum underneath the CA1 area (1.2 mm lateral and 2.2 mm posterior to 
Bregma; depth from the brain surface, 1.0-1.5 mm). These electrodes were made of 50-µm, Tef-
lon-coated tungsten wire (Advent Research Materials, Eynsham, UK). The final position of hip-
pocampal electrodes was determined as described previously (Gruart et al., 2006; Ortiz et al., 
2010). The recording electrode was implanted in the CA1 area using as a guide the field poten-
tial depth profile evoked by paired (40-ms interval) pulses presented to the ipsilateral Schaffer 
collateral pathway. The recording electrode was fixed at the site where a reliable monosynaptic 
(≤ 5 ms) fEPSP was recorded (Gruart et al., 2006). Evoked fEPSPs presented a large negative 
wave when the recording electrode was located at the stratum radiatum or a positive shape when 
recorded near the pyramidal cell layer (Schwartzkroin, 1986; Gruart et al., 2006; Ortiz et al., 
2010).  
    Animals selected for the classical eyeblink conditioning were also implanted with stimulating 
electrodes on the left supraorbital nerve and with recording electrodes in the ipsilateral orbicu-
laris oculi muscle (Fig. 14). Electrodes were made of 50-µm, Teflon-coated, annealed stainless 
steel wire (A-M Systems, Carlsborg, WA, USA) bared at the tips for ~0.5 mm. The tips were 
bent into a hook to facilitate stable insertion in the upper eyelid. 
    A 0.1-mm bare silver wire was affixed to the skull as a ground. All the wires were connected 
to two four-pin sockets (RS-Amidata, Madrid, Spain). The sockets were fixed to the skull with 
the help of two small screws and dental cement. The implantation procedures used in this 
chronic preparation have been described in detail (Gruart et al., 2006). Experimental sessions 
started one week after surgery.   
    To verify location of stimulating and recording electrodes after completion of experiments, 
mice were deeply re-anesthetized (sodium pentobarbital, 50 mg/kg), and perfused/fixed trans-
cardially with saline and 4% phosphate-buffered paraformaldehyde (PFA). Selected brain sec-
tions (50-µm thick) including the dorsal hippocampus were obtained in a microtome (Leica, 
Wetzlar, Germany), mounted on gelatinized glass slides, and Nissl stained with 0.1% toluidine. 
58 
Materials & Methods 
 
Figure 14.  Experimental design for classical conditioning and LTP. Classical eyelid conditioning was 
achieved with a trace paradigm, using a tone as a CS. The loudspeaker was located 30 cm from the animal’s head. 
Animals were implanted with bipolar stimulating electrodes on the left supraorbital nerve for US presentations. 
Eyelid conditioned responses were recorded with EMG electrodes implanted in the ipsilateral orbicularis oculi 
(O.O.) muscle. The top diagram illustrates that animals were also implanted with stimulating (St.) and recording 
(Rec.) electrodes to activate Schaffer collaterals and to record fEPSPs evoked at the pyramidal CA1 area of the 
right hippocampus and indicates the injection point for Drd2-siRNA or Lv-Mock. A. Photomicrographs illustrating 
the location of stimulating and recording electrodes and lentivirus injection site. Scale bars: 200 µm. DG= dentate 
gyrus; Sub= subiculum; D, L, M, V= dorsal, lateral, medial, and ventral. B. The two sets of traces on the left illus-
trate: 1, a fEPSP evoked at the CA3-CA1 synapse; and, 2, an EMG recording evoked at the O.O. muscle by a sin-
gle suprathreshold pulse presented to the supraorbital nerve. Both traces were collected during a conditioning ses-
sion of a control animal. Calibrations as indicated. Adapted from Ortiz et al., 2010. 
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2.2.3. Electrophysiology study. 
 
 
    Recordings were made using six differential amplifiers with a bandwidth of 0.1 Hz to 10 kHz 
(P511, Grass-Telefactor, West Warwick, RI, USA; Fig. 14B). Hippocampal recordings were 
made with a high impedance probe (2 × 1012 W, 10 pF; Fig. 14B).  
    For input-output curves, the stimulus intensity was raised to 0.4 mA in steps of 20 mA. The 
selected inter-stimulus interval was 40 ms, because it results in maximum facilitation of the 
CA3-CA1 synapse (Madroñal et al., 2007). For paired-pulse facilitation, pulse intensity (50-400 
µA) was set at 30-40% of the amount necessary to evoke a maximum fEPSP response, and the 
following inter-stimulus intervals were used: 10, 20, 40, 100, 200, and 500 ms (Gureviciene et 
al., 2004). In order to avoid unwanted interactions between successive pairs of stimuli, the inter
-pulse delay was always ≥ 20 s. 
     For evoking LTP, we used a high-frequency stimulation (HFS) train consisting of five 200-
Hz, 100-ms trains of pulses at a rate of 1 per second (1/s). This protocol was presented six 
times, at intervals of 1 min. As indicated above for paired-pulse facilitation, pulse intensity was 
set at 30-40% of the amount necessary to evoke a maximum fEPSP response for baseline re-
cordings and after the HFS train. In order to avoid evoking a population spike and/or unwanted 
hippocampal seizures, the stimulus intensity during the HFS train was set at the same intensity 
used for generating baseline records. Before presenting the animals with the HFS train, we col-
lected baseline records for 15 min, by presenting using single pulses (a 100-µs, square, negative
-positive pulse) at a rate of 1 per 2 s  (1/20 s). Following the HFS train, we presented the same 
set of pulses for 30 min. An additional recording session lasting for 15 min was carried out 24 h 
after the HFS session. 
 
2.2.4. Classical eyeblink conditioning.  
 
Trace eyeblink conditioning, a form of associative learning, was shown to induce a progres-
sive increase in strength at the hippocampal CA3-CA1 synapse in awake mice (Gruart et al., 
2006; Madroñal et al., 2009) that correlates with the progressive increase in conditioned re-
sponses. LTP is well-established as a form of synaptic memory, but is usually studied under 
non-physiological conditions. Here, we simultaneously assess trace eyeblink conditioning and 
synaptic efficiency by measuring changes in evoked extracellular field excitatory postsynaptic 
potentials (fEPSPs) at the CA3-CA1 synapse in behaving animals during conditioning. 
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    For classical conditioning, using a trace paradigm, a total of three animals at a time were 
placed in separate small (5 × 5 × 10 cm) plastic chambers located inside a larger (30 × 30 × 20 
cm) Faraday box. Classical conditioning was achieved using a trace paradigm consisting of a 
tone (20 ms, 2.4 kHz, 85 dB) presented as a CS. The US consisted of a cathodal, square pulse 
applied to the supraorbital nerve (500 µs, 3 times the threshold) 500 ms after the end of the CS. 
A total of two habituation and 10 conditioning sessions were carried out for each animal. A 
conditioning session consisted of 60 CS-US presentations, and lasted ~30 min. For proper ob-
servation of CR profiles, the CS was presented alone in 10% of the cases. CS-US presentations 
were separated at random by 30 ± 5 s. For habituation sessions, only the CS was presented, at 
the same frequency of 30 ± 5 s. As a criterion for “CR” we consider the presence, during the CS
-US interval, of EMG activity lasting > 10 ms and initiated > 50 ms after CS onset. In addition, 
the integrated EMG activity recorded during the CS-US interval had to be at least 2.5 times 
greater than the averaged activity recorded immediately before CS presentation (Porras-García 
et al., 2005). The total number of CRs per session was computed and expressed as a percentage 
of the maximum (60 CRs per session = 100%). 
   Synaptic field potentials in the CA1 area were evoked during habituation and conditioning 
sessions by a single 100-µs square, biphasic (negative-positive) pulse applied to the ipsilateral 
Schaffer collaterals 300 ms after CS presentation. Stimulus intensities ranged from 50 to 250 
mA. For each animal, the stimulus intensity was selected according to data collected from the 
input-output curves, usually at ~30% of the intensity necessary for evoking a maximum fEPSP 
response (Gureviciene et al., 2004). An additional criterion for selecting stimulus intensity was 
that a second stimulus, presented 40 ms after a conditioning pulse, evoked a larger (> 20%) 
synaptic field potential (Bliss & Gardner-Medwin, 1973).  
 
3. PARKINSON MODELS. 
 
 
 
3.1. Striatal unilateral 6-OHDA lesion and L-DOPA treatment. 
 
 
Mice were anesthetized with 0.8-1.5% isoflurane, supplied from a calibrated Fluotec 5 
(Fluotec-Ohmeda) vaporizer, at a flow rate of 1–2 L/min oxygen (AstraZeneca) and delivered 
by a mouse anaesthesia mask (David Kopf Instruments). Vaseline was used to protect the eyes  
during surgery. Thirty minutes before lesion, the mice received an intraperitoneal injection of 
20 mg/kg of the noradrenaline reuptake inhibitor desipramine hydrochloride (Sigma-Aldrich) to 
protect the noradrenergic neurons from 6-OHDA neurotoxicity (Breese & Traylor, 1971).  
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Figure 15. Denervation after unilateral lesion. Photomicrographs of coronal brain sections from a 6-OHDA le-
sioned animal immunostained with tyrosine hydroxylase, illustrating the TH loss in the striatum (A) and the sub-
stantia nigra (B). Images from: Darmopil et al., 2008. 
    Using a Hamilton syringe (Hamilton, Bonaduz, Switzerland), 4 μl of 6-OHDA-HBr solution 
(5 mM) in 0.1 % ascorbic acid (Sigma-Aldrich) was injected in the left striatum in two different 
deposits (DV1 = -4 mm and DV2 = -3 mm) 2µl each though a single needle penetration at the 
following stereotaxic coordinates relative to bregma and dural surface; AP = 0.65; L = 2.0 
(Paxinos & Franklin, 2004) (Fig. 15). After the injection, the skin was sutured and the animals 
were removed from the stereotaxic instrument and placed on a heating pad for 30 min. During 
the first week after surgery animals received injections of saline solution to prevent dehydration, 
as well as supplementary food. 
Mice were left 3 weeks for recovery after the lesion and then submitted to L-DOPA methyl 
ester (Sigma-Aldrich) treatment for 3 weeks. 6-OHDA or sham operated Drd1a-/- and Drd2-/- 
mice and their WT littermates, along the Pitx3-/- mice received daily intraperitoneal injections of 
25 mg/kg of L-DOPA, with an injection of 10 mg/kg Benserazide hydrochloride (Sigma-
Aldrich), a peripheral blocker of L-DOPA decarboxylase, 20 min prior to L-DOPA injection. 
The D1R and D2R antagonist SCH23390, (3 mg/kg) or Raclopride (2 mg/kg), and simvastatine 
(20 mg/kg) were administered in a group of 6-OHDA-lesioned mice, 30 min before L-DOPA 
treatment. 
 
3.2. Histological studies. 
 
 
 
 3.2.1.Tissue preparation  
 
Adult animals were sacrificed by an overdose of pentobarbital (Laboratorios Normon, Ma-
drid, Spain) and they were injected intracardially with 0.5 ml of 1% heparin (Rovi, Madrid,  
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Spain), which was followed by the perfusion of 10 ml of saline and 60 ml of 4 % paraformalde-
hyde pH 7.4. Animals that received L-DOPA were sacrificed 1 h after the last L-DOPA injec-
tion. The animal’s brains were post-fixed for 24 h and they were then transferred to a solution of 
0.1 M PB containing 0.02% sodium azide for storage at 4 °C. To obtain regular blocks, brains 
were further immersed in 3% agarose and cut at a thickness of 30 μm using a vibratome (Leica, 
Microsystems).  
 
 3.2.2. Immunohistochemistry  
 
 
    Immunostaining was carried out in free-floating sections using a standard avidin–biotin im-
munocytochemical protocol (Rivera et al., 2002; Grande et al., 2004). Endogenous peroxidase 
activity was quenched by incubation for 10 min in 0.1 M PBS containing 0.2% Triton X-100 
(PBS-TX) with 3% hydrogen peroxide. Non-specific binding sites were blocked for 60-90 min 
with 5%-10% of the appropriate serum in PBS-TX. Sections were incubated overnight with spe-
cific primary antibodies. 
 
Table 1. Primary antibodies for immunohistochemistry 
    All primary antibodies were diluted in 0.1 M PBS-TX and 1% serum of the animal in which 
the secondary antibody was produced. For immunohistochemistry with monoclonal antibodies, 
we used a mouse on mouse kit (Vector Laboratories, Inc. Burlingame, CA, USA) to block 
mouse IgGs in the tissue according to the manufacturer’s instructions. After incubation with the 
primary antibody (usually overnight), the sections were washed and incubated with the appro-
priate biotinylated secondary antibody 1:500 (all from Vector Laboratories) for 1-2 h at room 
temperature. After washing, the sections were incubated with streptavidin-peroxidase complex 
(1:5000, Zymed, San Francisco, CA, USA) for 1 h. Peroxidase reactions were developed in 
0.05% 3,3´ - diaminobenzidine (DAB) (Sigma-Aldrich) and 0.002% H2O2. After developing the  
reaction, stained sections were mounted, dried, dehydrated and coverslipped with Permount 
mounting medium (Fisher Chemicals, Fair Lawn, NJ; USA) and examined using a light micros- 
Host Source Made Dilutions 
TH Rabbit polyclonal Millipore, Temecula, CA, USA 1:1000 
TH Mouse Monoclonal Millipore 1:250 
Nurr1 Rabbit polyclonal Millipore 1:1000 
Pitx3 Rabbit polyclonal Invitrogen, Paisley, UK 1:500 
Tomato (Ds-Red) Rabbit polyclonal Invitrogen 1:1000 
GFP Rat monoclonal Nacalai, Tesque, Kyoto, Japan 1:1000 
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cope (Leica, Heidelberg, Germany).  
    Double-labeling fluorescent immunohistochemistry was performed as before (Granado et al., 
2011). Sections were incubated for 2 h at room temperature with the appropriate Alexa-
conjugated (1:500, all from Molecular Probes, Invitrogen, Eugene, OR, USA). Sections were 
mounted in fluorescent mounting medium (DABCO, Fluka, Buchs, Switzerland), coverslipped, 
kept in the dark at 4 °C until they were examined by laser confocal microscopy (Leica). The 
specific immunofluorescence of the Alexa 488 (green) or Alexa 594 (red) fluorophores was vis-
ualized by excitation at 488 nm or 594 nm, respectively. 
 
3.2.3. Transmission Electron Microscopy 
 
        Striatal TH-ir neurons were ultrastructural described by TEM following the immunohisto-
chemistry protocol. We lesioned 5 C57BL6 mice with 6-OHDA and treated with L-DOPA dur-
ing 25 days, after were perfused with PFA 4% and Glutaraldehide 2.5%. We cryoprotected the 
tissue in sacarose solution (2%) 24 h and before the brains were frozen with liquid nitrogen and 
thawed in cold 0,1M PB. Sections (30 µm thick) were cut with a vibratome (Leica Microsys-
tems) and immunostained for TH (polyclonal primary antibody 1:1000). After DAB reaction, 
sections were washed with PBS, post fixed in 1% osmium tetroxide in 0,1M PB, dehydrated in 
graded ethanol’s (1% uranyl acetate was included at the 70% ethanol), the last ethanol (100º) 
was mixed with 50% of Durcupan, and finally mounted on Durcupan ACM resin (Fluka) slides 
under a plastic coverslip, and cured for 48 h at 57ºC. Selected areas with TH-ir neurons of the 
striatum were dissected out, re-embedded in Durcupan, and cut in ultrathin sections (70 nm) 
with ultramicrotme Leica EM UC6 (Leica Microsystems). Finally, the sections were mounted 
on Formvar-coated 200 mesh grids stabilized with evaporated carbon film (Ted Pella Inc., CA, 
USA), stained with lead citrate, and examined in a Jeol JEM1200 EX-II electron microscope 
(Fig. 16). 
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Figure 16. Transmission electron microscope. The picture illustrated a photograph of a Transmision electron 
microscope model Jeol JEM1200 EX-II (A) and an scheme illustrating the internal composition of a standard trans-
mission electron microscope with his different parts (B). 
3.2.4. Image analysis 
 
    Stereological quantification of TH-ir neuronal density in the 6-OHDA-lesioned mice stria-
tum. TH-ir neurons in the striatum were quantified in coronal sections through the striatum of 
mice using the optical fractionator, Stereo investigator program (Microbrightfield, Colchester, 
VT, USA) as described before (Ares-Santos et al., 2012). All stereological analyses were car-
ried out in a Nikon Eclipse 80i microscope, with the aid of an interactive computer system com-
prising a high-precision motorized microscope stage, a 0.5 µm resolution microadaptor 
(Heidenhain VZR401), a solid-state Microbrightfield CX9000 videocamera and a high resolu-
tion video monitor. TH-ir neurons were counted in the lesioned area, on every 10th section 
throughout the striatum, yielding 6-8 sections per animal. Each brain section was viewed at low 
power (2x objective) in which the striatum and the lesioned area of the striatum outlined. Then, 
starting at a random microscope visual field, the number of TH-ir cells was counted at higher 
power (10x). The nucleus´s equatorial plane was used as counting unit. The data were then ex-
ported to Neuroexplorer (Microbrightfield) and Convex Hull Analysis was performed to deter-
mine the cross-sectional area of the striatum and the relative density of TH-ir neurons. Data 
were expressed as the number of TH-ir neurons per mm3 of striatum (Fig. 17). We analyzed 6-8 
animals per group, except for the aphakia mice, for which we analysed 3 animals per group.  
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Figure 17. Example of stereological quantification for TH-ir neurons in the lesioned striatum. Image illus-
trating the profiles of different rostro-caudal sections from a lesioned striatum. Marks show  the position of TH-
ir neurons with a blue star symbol. 
    Fluorescence doble-inmunolabeling colocalization analysis. Co-localization analysis in do-
ble-immunolabeling of TH-ir neurons were carried out in a complete reconstruction of the le-
sioned striatum with a series of 20x photomicrograph with Laser confocal microscopy (Leica), 
each image consisted in a stack of different channels in different planes of Z axis. Image pro-
cessing and analysis were performed with ImageJ, image analysis software (Solís et al, 2014). 
Each channel was separated and the images were transform to grayscale, detected in merge the 
points of co-localization that appear in white. 
 
3.3. Fast scan cyclic voltammetry (FSCV) quantification of striatal dopamine release in 
brain slices. 
 
 
    For measurements of dopamine release, brain slices were prepared from mice after 6-OHDA 
lesion, and 1, 4, 7 and 10 days after chronic L-DOPA treatment (25 mg/kg, i.p., daily for 21 
days). Three mice were used for each experimental condition. 
    Transverse brain slices (450 µm thickness) were prepared from mice using conventional 
methods (Martín & Buño, 2005), and incubated for > 1 h at room temperature (21–24 °C) in 
artificial cerebrospinal fluid (aCSF). The aCSF contained: NaCl 124 mM, KCl 2.69 mM, 
KH2PO4 1.25 mM, MgSO4 2 mM, NaHCO3 26 mM, CaCl2 2 mM and glucose 10 mM, and was 
gassed with 95% O2 and 5% CO2. Slices were transferred to an immersion recording chamber 
and superfused (2.5 ml/min) with gassed aCSF warmed to 32-34 ºC. Following 1 h of equilibra-
tion, a bipolar tungsten stimulating electrode with a tip separation of 200 µM (A-M Systems, 
Inc., Carlsborg, WA, USA) was placed in the dorsolateral striatum as we indicated previously 
(Granado et al., 2011; Ares-Santos et al., 2012) (Fig. 18). A carbon fibre electrode (CFE; 10 µm 
diameter; 50 µm exposed length) was placed 100-200 µm from stimulating electrode. FSCV at 
the CFE was used to detect changes in extracellular concentrations of dopamine following elec-
trical stimulation of the brain slice. Stimuli were single biphasic pulses (20 V, 500 µs) delivered   
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via a 2100 isolated pulse stimulator (A-M Systems). Stimulus intervals between pulses were not 
less than 5 min. FSCV was carried out using a three electrode voltage-clamp amplifier (VAMP-
1, Registim LLC, Coral Gables, FL, USA). The working electrode was connected to active 
CFE, an Ag/AgCl was used as reference electrode, and a platinum wire was used as auxiliary 
electrode. Using the common reference and auxiliary electrodes, a brief sawtooth voltage wave-
form with a voltage scan rate of 400 V/s was applied consecutively every 200 ms to working 
CFE electrode. The sawtooth had four phases: 0 to -1 V, to +1.4 V, to -1 V to 0 V. Changes in 
extracellular dopamine were determined by monitoring the current at the peak oxidation poten-
tial for dopamine. Subtracting the current obtained before stimulation from the current obtained 
in the presence of dopamine created background-subtracted cyclic voltammograms. Current 
was digitized at 10 kHz using PowerLab 4/25 T (AD Instruments, Bella Vista, Australia) acqui-
sition system. Data were acquired and analysed with Scope software (AD Instruments). Elec-
trodes were calibrated with dopamine standards of known concentration in the recording cham-
ber before and after each use. The average of the pre- and post-calibration measurements was 
used as the calibration factor. 
 
 
 
 
 
 
 
 
 
 
      
    Note: FSCV were performed in collaboration with Dr. Eduardo D. Martín and Dra. Idaira 
Oliva in his laboratory (Labortory of Neurophysiology and Synaptic Plasticity, PC y TA, ID-
INE, UCLM, Albacete). 
Figure 18. FSCV quantification of striatal dopamine release in brain slices. Left, schematic diagram illustrat-
ing the placement of the carbon recording electrode and the bipolar stimulating electrode in the dorsolateral stria-
tum. Right, fast-scan cyclic voltammetry voltage waveform at 400V/s scan rate (upper trace), and subtracted volt-
ammograms for 1µM of dopamine (lower trace). Adapted from Granado et al., 2011. 
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4. STATISTICAL ANALYSIS.  
 
 
    Behavioural values: Data are presented as mean ± SEM.   
Learning experiments: To assess genotype and trial differences in the Barnes maze, 
Morris water maze, active or passive avoidance, and fear conditioning, test were per-
formed using repeated-measures, two-way ANOVA where genotype (WT and Drd1a-/-  
or Drd2-/-) and time (day of trials for passive avoidance or freezing test) were entered as 
independent variables. Relevant differences were analysed pair-wise by post-hoc com-
parisons with Tukeys’s test.  
Recognition memory, sensorimotor and emotional test: one way ANOVA followed by 2
-tailed Student´s t-test.   
 
 
   Western blotting and immunohistochemical studies: Data are presented as mean ± SEM. The 
results was analysed using Student’s t test.   
 
 
    Electrophysiology: EMG and hippocampal activity, and 1V rectangular pulses corresponding 
to CS and US presentations, were stored digitally on a computer through an analog/digital con-
verter (1410 Plus; CED), at a sampling frequency of 11-22 Hz and an amplitude resolution of 
12 bits. Commercial computer programs (Spike 2 and SIGAVG; CED) were modified to repre-
sent EMG and fEPSP recordings. Data were analysed off-line for quantification of CRs and 
fEPSP slope using custom representation programs (Porras-García et al., 2005; Gruart et al., 
2006). Data are represented as mean ± SEM. Acquire data were analysed using a two-way 
ANOVA, with group, session, or time as the repeated measure. Contrast analysis was added to 
further study significant differences. Regression analysis was used to study the relationship be-
tween the fEPSP slopes and the percentage of CRs.  
 
 
    Stereological quantification: All data are expressed as mean ± S.E.M. The results was ana-
lysed by Student-Newman test. 
 
   Voltammetry: All data are expressed as mean ± SEM. Statistical analysis for quantification 
data analysis was performed using one way ANOVA or t-test Differences in evoked dopamine 
release in treatment groups were stablished using the 2-tailed Student´s t-test.  
 
 
     For all statistical studies, the threshold for statistical significance was set at p < 0.05. 
SigmaPlot 12 software was used for graphing and statistical studies. 
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1. DOPAMINERGIC SIGNALING BY D1R IN HIPPOCAMPUS REGULATES LEARN-
ING AND MEMORY PROCESS 
    1.1. Drd1a-/- mice exhibit impaired spatial learning in the Barnes maze.  
     To confirm the role of D1R in spatial learning, we used the Barnes maze because it is less 
aversive and stressful than the water maze (Barnes, 1979; Harrison et al., 2009). In the Barnes 
maze, WT mice quickly learned to escape the open field and reach the black escape box, as 
shown by the rapid decline in escape latency (Fig. 19). By day 7 of training, escape latency has 
reached a minimum that was maintained throughout the training phase (11 day) and during the 
probe trial, 3 days later (Fig. 21). In contrast, there was no reduction in escape latency for 
Drd1a-/- mice, even after an 11 days training period (Fig. 19).       
 
Figure 19.  Progression of escape latency during the training phase in the Barnes maze. Drd1a-/- mice did 
not reduce escape latency at any time during the experiment (*p < 0.005). Data shows the mean values ± SEM. 
Statistics were determined with repeated-measures two-way ANOVA followed by Tukey’s test for post-hoc anal-
ysis. 
     To rule out the possibility that inactivation of Drd1a increases anxiety levels in these mice, 
masking their capacity to respond in the Barnes maze, we evaluated the immmovility time dur-
ing the first day of training in the Barnes maze, as an indirect measure of anxiety. We chose the 
first day of training because on this day, the two groups showed similar latency times for cross-
ing to the black escape box. WT and Drd1a-/- mice spend similar amounts of time immobile 
during the first day of training (Fig. 20A). In addition, recent work has shown that pharmaco-
logical blockade or genetic inactivation of D1R is implicated in motor hyperactivity and com- 
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pulsive disorders (Ferland et al., 2014; Nakamura et al., 2014), therefore, ruled out that in our 
model  such alterations influence the exploratory behavior and the correct acquisition the escape 
response with the immobility time test and nose pokes response. There are similarities between 
Barnes maze and hole board test (specially designed to measure novelty seeking), we quantified 
the total number of holes that mice explored in a novel situation (day 1 of training) as an indi-
rect measure of motivation through exploratory behavior. Contrary to expectations, we found no 
significant differences between holes explored by Drd1a-/- and their WT littermates (Fig. 20B). 
These data supports our hypothesis that deficits in the Barnes maze are mainly due to a disabil-
ity in the spatial learning and memory process. 
 
Figure 20. Anxiety levels and exploratory behavior are normal in dopamine Drd1a-/- mice at day 1 of train-
ing. A. Immobility during the first day of training in Barnes maze. WT and Drd1a-/- mice showed similar levels of 
immobility. B.  Nº of holes explored during the first day of training in Barnes maze. Nose pokes were similar in 
WT and Drd1a-/- mice. Data shows the mean values ± SEM. 
    In addition, Drd1a-/- mice showed no reduction in escape latency in a probe trial performed 3 
days after training, to evaluate memory consolidation (Fig. 21A), or during the relearning trials, 
when the escape hole was moved to the opposite side of the training arena (Fig. 21B). With the 
previous study in the MWM (Granado et al., 2008) these data indicate that the D1R is required 
for spatial learning in more than one paradigm. Our demonstration that loss of D1R does not 
increase indicators of anxiety supports the notion that our results are attributable to an important 
role of D1R in spatial learning.      
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Figure 22. Pain sensitivity in Drd1a-/- mice. Pain sensitivity thresholds (in seconds, mean ± SEM) of mice in the 
tail-flick test (A), hot plate and plantar test (B). Drd1a-/- mice exhibit lower pain thresholds than WT mice in all 
three test, indicating higher pain sensitivity. Statistics were determined with with Student’s t test . *p<0.05 vs. WT 
mice. 
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Figure 21. Hippocampus-dependent learning is impaired in dopamine Drd1a-/- mice. A. Probe trial performed 
three days after the training phase. Histograms represent the time spent searching for the escape hole. Drd1a-/- mice 
did not reduce searching time during the probe trial (*p<0.005). B. Escape latency during the relearning phase. For 
this test, the escape hole was located opposite to its position in the training phase (*p < 0.001). Statistics were de-
termined with with Student’s t test (A) and repeated-measures two-way ANOVA followed by Tukey’s test for post
-hoc analysis. Data shows the mean values ± SEM 
    1.2. Associative learning is impaired in Drd1a-/- mice  
 
     Previous studies show that D1R antagonist increased sensitivity to pain (Burkey et al., 1999). 
Therefore, as we used an electric shock as aversive stimulus for associative test, we carry out a 
battery of nociceptive test in our mice. Three nociceptive thermal tests were used that impact in 
different degree peripheral or central processing of painful stimuli and measured the latency of 
withdrawal response. We found significantive differences in all three assays, the pain threshold 
was actually lower for Drd1a-/- than WT mice (Fig. 22), indicating that Drd1a-/- mice are more 
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Figure 23. Performance in the passive avoidance test is impaired in Drd1a-/- mice. A. Thresholds for foot 
shock responses. Increasing intensity foot-shocks were delivered to WT and Drd1a-/-  mice, and the threshold for 
each listed behaviour was determined. Thresholds for all three response behaviours were similar in the two geno-
types. B. Avoidance response. Latency refers to the time spent in the light compartment before mice enter the dark 
compartment which was paired with foot-shock in a single training trial. Drd1a-/- mice show partial impairment of 
passive avoidance at both 0.4 and 0.8 mA. *p < 0.01 and **p < 0.001 vs. WT; #p < 0.01 and ##p < 0.001 vs. Pre-
shock (0 h). Data show mean ± SEM. Statistics were determined by repeated-measures two-way ANOVA fol-
lowed by post-hoc analysis with Tukey’s test. 
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sensitive than WT mice. In the tail-flick test  Drd1a-/- mice showed a latency of 1.4 ± 0.2 and 
their WT mice 2.1 ±0.2; in the plantar test Drd1a-/- mice showed 5.6 ± 0.5 vs. WT mice 7.9 ± 
0.5; and in the hot plate test Drd1a-/- mice showed 9.5  ± 0.7 vs. 12.9  ± 1.14, for WT mice.    
 
    Passive avoidance.  Passive avoidance learning depends on multiple cortical and subcortical 
structures, including both dorsal a ventral striatum as well as hippocampus and amygdala 
(Pittinger et al., 2006). In this test, avoidance response or entry latency increases with foot-
shock intensity (Crawley et al., 2007). First we determined the sensitivity to foot-shock for both 
genotypes by gradually increasing foot-shock intensity (0.01-0.6 mA) and monitoring the onset 
of behavioural indicators of pain. WT and Drd1a-/- mice showed similar sensitivity thresholds 
to foot-shock (Fig. 23A), responding with a sudden stare at floor bars, startle response, and 
jumping and vocalization at the same foot-shock intensities in both genotypes. Jumping and 
vocalization responses, indicative of pain threshold, were elicited with 0.12 mA in both groups 
of mice. 
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Figure 24. Active avoidance performance is impaired in dopamine Drd1a-/- mice. A. Progression of active 
avoidance responses during the training phase. Drd1a-/- mice did not increase the number of avoidance responses 
during the training phase (*p < 0.001). B. Time-course of crossing latencies for WT and Drd1a-/- mice during the 
training phase. Drd1a-/- mice did not decrease escape latency at any point during training (*p < 0.001). C. Number 
of inter-trial crosses. From day 3 on, there was no significant difference between WT and Drd1a-/- mice in the 
number of inter-trial crosses. Data shown are mean values ± SEM. Statistics performed with repeated measures 
two-way ANOVA, followed by post-hoc analysis with Tukey’s test.  
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    Passive avoidance experiments were performed with a moderate (0.4 mA) and a strong (0.8 
mA) electric stimulus (Viosca et al., 2009), both well above the pain threshold (Fig. 23B). 
Baseline entry latency times in the passive avoidance test were similar in all experimental 
groups. However, after the training with either 0.4 or 0.8 mA foot-shocks, Drd1a-/- mice exhib-
ited a shorter latency than WT mice (Fig. 23B), indicative of reduced memory strength. When 
animals were tested 24 h after 0.4 mA foot-shock, WT mice showed a latency time of 250 s 
compared with 123 s in Drd1a-/- mice (p< 0.001). With a 0.8 mA shock, this difference was 
smaller but still statistically significant (p< 0.01) (Fig. 23B).  
 
    Two-Way Active avoidance. Dopamine depletion impairs the acquisition and maintenance of 
conditioned avoidance responses (Shannon et al., 1999), suggesting that dopamine receptors are 
involved in this behavior. To determine whether the dopamine D1R plays a role in this associa-
tive learning task, we used the two-way active avoidance paradigm. In his paradigm, WT mice 
learned the avoidance response within the first 2 days of training, while Drd1a-/- mice were una-
ble to learn it, even with an extensive period of training (Fig. 24). Differences between Drd1a-/- 
and WT mice were first evident on the second day of training (*p < 0.001) and persisted 
throughout of avoidance learning in Drd1a-/- mice (Fig. 24). 
 
    The crossing latency reflects how rapidly an animal crosses to the safe compartment after the 
onset of the CS to avoid the foot-shock (Smith et al., 2002). WT animals progressively reduced 
their crossing latency, whereas Drd1a-/- mice did not, again indicating that Drd1a-/- mice were 
unable to learn that the foot-shock would follow the CS (Fig. 24). Differences in latency be-
tween WT and Drd1a-/- mice were first observed on the second day of the training phase (p< 
0.001). 
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    Results obtained in the P-maze test showed a greater number of entries in open arms of the 
maze by Drd1a-/- mice compared to WT (p <0.05) along with a tendency to further exploration 
of these, which indicates the probability that the basal levels of anxiety in these mice are less  
Figure 25. Emotional response in Drd1a-/- mice.  A. Anxiety-like behaviour of Drd1a-/- and WT mice illustrated 
by the number of entries and percentage of total time spent in the open arms of the elevated plus maze test. Drd1a-/- 
mice make more entries in open arms and spend more time but this late one is not statistically significant. These 
results indicate lower anxiety levels than the WT mice (*p < 0.05). B. Porsolt test shows that Drd1a-/- mice spend 
less time immobile than WT mice (*p < 0.05). Data is expressed in seconds, mean ± SEM. Statistics were deter-
mined with Student´s t test. 
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    Except for the first 2 days, we found no difference between WT and Drd1a-/- mice in baseline 
crossing behavior, determined by counting crossings during the ITIs in the training phase or on 
the test day (Fig. 24). Thus, the poor performance of the Drd1a-/- mice in this paradigm suggests 
impaired associative learning rather than changes in locomotor behavior. 
        We found during the first days of training an increase in crossing latency for Drd1a-/- mice 
(Fig. 24B). In fact, most of the mice stop their avoidance responses, close to zero in the last 
days of training (Fig. 24A). If we analyze the response pattern shown in curves (Fig. 24A,B), 
we observed that is similar to that obtained in paradigms of "learned helplessness". In this para-
digm the animals did not found escape from their position and, in consequence, cease to emit 
escape or avoidance responses, being able to develop a depressive features. In order to show 
that this pattern of response is due an important deficit in associative learning and not because 
of previous emotional disturbances in Drd1a-/- mice phenotype, we performed two basic emo-
tional test: The P- Maze, detecting changes in anxiety levels, and the Porsolt test, to detecting 
depressive symptoms in these mice at basal level (Fig. 25). 
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than their WT littermates (Fig. 25A). Similarly, the immobility time in the Posolt test was signi- 
ficantly lower in Drd1a-/- mice than in their WT littermates (Fig. 25B; p < 0.05; WT: 70 ± 18; 
Drd1a-/- : 8.4 ± 3.1), ruling out the possibility of depressive behavior. 
 
 1.3. Recognition memory is impaired in Drd1a-/- mice. 
 
Object Recognition. We studied recognition memory in a task based on the natural ten-
dency of rodent to explore unfamiliar objects, which depends in part on hippocampal integrity 
(Broadbent et al., 2010; Barker & Warbuton, 2011). On the first day, mice were allowed to 
explore two identical objects; after 24 h mice were kept in the arena containing the same ob-
ject as in the day 1 and a new object. We measured the exploration time for the familiar and 
the novel object. Drd1a-/- mice displayed an impairment of memory, as they spent almost the 
same time exploring the familiar and the novel object (12.7 ± 3.4 vs 12.1 ± 1.5, respectively). 
WT mice showed a good recognition memory since they spent less time in exploring the fa-
miliar than the novel object (11.2 ± 3.6 vs. 28.4 ± 5.9, respectfully) (Fig. 26).  
Figure 26. Object recognition test is impaired in Drd1a-/- mice. A. Total exploration time in the test day. B. Per-
centage of exploration time spent exploring familiar and the novel object in the test day (24 h retention interval). 
Data show the mean ± SEM. Statistical significance: *p < 0.05; **p < 0.001 vs. familiar object. Statistics were 
determined with Student´s t test. 
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              The inactivation of Drd2 is possible that modify the anxiety basal response in these mice, 
preventing a better execution in the maze. The immobility time during the first trial was evalu-
ated on the first day of training in the Barnes maze, as an indirect measure of anxiety. Drd2-/- 
mice spent less time immobile than WT (Fig. 27B). 
 
 
 
2. DOPAMINERGIC SIGNALING BY D2R  IN HIPPOCAMPUS REGULATE ASSOCI-
ATIVE LEARNING AND CHANGES IN SYNAPTIC PLASTICITY.  
 
    2.1. The D2R is important for acquisition and consolidation of spatial memory.  
We used the Barnes maze with a similar protocol of D1R experiments to assess the role of 
dopamine D2R in spatial learning and memory. WT mice learned to escape the open field and 
reached the black scape box, as shown the rapid decline in escape latency (Fig. 27A). By day 9 
of training, escape latency has reached a minimum that was maintained throughout the training 
phase (14 day) and during the probe trial, 3 days later. But the Drd2-/- mice had a slower reduc-
tion in escape latency than WT mice (Fig. 27A). 
Figure 27. Inactivation of D2R impaired hippocampus–dependent learning. A. Progression of escape latency 
during the training phase in the Barnes maze Drd2-/-  mice reduce less than WT the escape latency during the ex-
periment (*p< 0.001). B. Immobility during the first day of training. Drd2-/- mice showed a significantly reduced 
immobility time (*p<0.001). Data show the mean values ± SEM. Statistics were determined with repeated-
measures two-way ANOVA followed by Tukey´s test for post hoc analysis (A). 
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    In addition, Drd2-/- mice showed less reduction in escape latency in a probe trial performed 3 
days after training to evaluate memory consolidation (Fig. 28A). During the relearning trials, 
when the escape hole was moved to the opposite side of the training arena, Drd2-/- mice once 
more show similar deficits to the training phase (Fig. 28B). These data indicate that the D2R is 
required for spatial learning. 
Figure 28. Inactivation of Drd2 impaired spatial learning. A. Probe trial performed 3 days after the training 
phase. Histograms represent the time spent searching for the escape hole. The Drd2-/- mice reduce searching time 
during the probe trial, but the latency of WT mice is significantly reduced (*p<0.01). B. Escape latency during the 
relearning phase. For this test, the escape hole was located opposite to its position in the training phase (*p<0.01). 
Data show the mean values ± SEM. Statistics were determined with Student’s t test (A) and repeated-measures two
-way ANOVA followed by Tukey´s test for post hoc analysis (B) 
 
     Although, it has been shown that Drd2-/- mice have no severe motor impairment (Kelly et al., 
1998) recent studies have found hypoactivity in this mice (Nakamura et al., 2014) which may 
lead to reduced exploratory response. Therefore, it was necessary to exclude that the slow ac-
quiring of minimum escape response in the Barnes maze compared to their WT were not due to 
less exploratory response. 
    First, we measured the number of holes explored by Drd2-/- mice (Fig. 29A), quantifying the 
holes explored in the Barnes maze the first day of training. We found that Drd2-/- mice explored 
less holes (8.2 ± 1) than WT mice (11.8 ± 1.4) (Fig. 29A) until day 4 of training in which the 
number of holes explored are similar in both genotypes and are maintained for the rest of train-
ing (Fig. 29B). For these reason, we can not reject that the delay acquisition of Drd2-/- mice is 
due to a lower exploratory response. 
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Figure 29. Exploratory behavior in Drd2-/- mice. A. Number of holes explored during the first day of training. 
Drd2-/- mice showed a significantly reduced exploratory behavior (*p<0.05). B. Modification of errors during the 
training phase in the Barnes maze. Except for the first two days, Drd2-/- mice show similar number of errors than 
WT during the training phase (*p<0.001). Data show the mean values ± SEM. Statistics were determined with Stu-
dent’s t test  
    2.2. A2A receptor antagonist does not improve spatial learning in Drd2
-/- mice. 
    In the previous experiments we could not possible ruled out the possibility that a poor envi-
ronmental exploration could cause the slower execution of Drd2-/- mice on the Barnes maze. 
Therefore, to discharge this influence another spatial maze was performed, the MWM. This test 
requires hippocampal function and suitable motor coordination (Martin & Morris, 2002; Grana-
do et al., 2008). In addition mice were administered caffeine (an A2A receptor antagonist) that 
improves exploratory and motor behavior in these mice even in the absence of D2R (Chen et al., 
2001). After habituation to the water maze with caffeine, mice were given 4 training trials per 
day for 12 consecutive days without caffeine. WT mice quickly learned to reach the platform, 
reaching the minimum escape latency by day 7, with no further significant change in escape 
latency between days 7 and 12 (Fig. 30A). In contrast,  the reduction in escape latency over the 
course of training occurred more slowly in Drd2-/- mice than in their WT mice and did not reach 
the lowest latency level of the WT mice (Fig. 30A).  
    Furthermore, Fig. 30B represents the distance traveled per day the two groups. Both, Drd2-/- 
and WT mice, decreased over training phase as mice were learning the task.  
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    However, Drd2-/- mice from the beginning of the experiment, traveled greater distances to 
search for the platform than WT, further supporting that this deficit is not due to a less environ-
mental exploration and supports an impairment in spatial learning in Drd2-/- mice. These results 
indicate that inactivation of Drd2 does not completely inhibit learning, but impairs it signifi-
cantly, in a way that training is required for Drd2-/- mice to reach the same level of learning that 
their WT.  
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Figure 30. Drd2-/- mice shows slow spatial learning even after pre-exposition to MWM with caffeine. A. Pro-
gression of escape latency during the training phase in the MWM. Drd2-/-  mice reduce less than WT the escape 
latency during the experiment (*p<0.001). B. Distance trail during the training phase decrease through the days, 
but is much higher in Drd2-/-  mice than in WT mice (*p< 0.05). Data show the mean values ± SEM. Statistics were 
determined with repeated-measures two-way ANOVA followed by Tukey´s test for post hoc analysis. 
    Retention was tested at 48 h (Test 1-with caffeine) and 74 h (Test 2-without caffeine) after 
the training period by removing the submerged platform. We measured the percentage of time 
that mice spent in each quadrant of the pool and the number of crosses through the platform lo-
cation site. WT mice spent selectively more time in the target quadrant in Test 1 with caffeine 
(66.3 ± 3.2 %) and in Test 2 without caffeine (50 ± 3.7 %) during retention test than on the first 
day of training (26.3 ±.1.9 %) (Fig. 31B). Although Drd2-/- mice slightly increased their time in 
the target quadrant compared to the first day of training, (25.6 ± 2.5%), in Test1 (56.1 ± 4.3 %) 
and in Test 2 (34.5 ± 3.3%) this increase was significantly lower than that of WT animals (Fig. 
31B, Test 1: p < 0.001, test 2: p < 0.001).  
     Similarly, in the two test probes, Drd2-/- mice made significantly fewer crosses through the 
platform location site than WT mice, in Test 1 with caffeine (8 ± 0.7 vs. 10.2 ± 0.5; p=0.019) 
and in Test 2 without caffeine (6.7 ± 0.5 vs. 9.7 ± 0.7; p=0.002) (Fig. 31A).   
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Figure 31. Drd2-/- mice shows spatial retention deficits.  Probe trial performed after the training phase: 48h later 
with caffeine (15mg/kg) and 74 h without caffeine (saline). A. Histograms represent the number of platform cross-
es both type of mice increase platform crosses during the Tests 1 and 2(*p< 0.001), but the number of crosses of 
WT mice is significantly higher in the two conditions (#p<0.05). B. Histograms represent the percentage of time 
spent in target quadrant. The WT and Drd2-/- mice increase searching time during the tests (*p<0.001), but the val-
ues of WT mice are significantly higher in the two tests (#p<0.05). Data show the mean values ± SEM. Statistics 
were determined with repeated-measures two-way ANOVA followed by and with Student’s t test. 
    Both groups decreased the time spent in the target quadrant and the number of platform 
crosses between Test 1 and Test 2. However, in both conditions, the differences between the 
two groups were maintained, ruling out the possibility of a motor impairment influence. Final-
ly, these results are similar to the results obtained using the Barnes maze, and suggest that Drd2
-/- mice are unable to consolidate the navigation strategies. 
 2.3. Nociceptive threshold of Drd2-/- mice. 
Similar to D1R experiments, as we were going to use an electric shock as aversive stimulus 
for associative test, we carry out a battery of nociceptive test in Drd2-/- and WT mice. Two no-
ciceptive thermal test were used, that impact in different degree peripheral or central processing 
of painful stimuli. It was measure the latency of withdrawal response, we did not find signifi-
cantly differences between Drd2-/- and WT mice in the tail-flick test and the plantar test (Fig. 
32A).  
    In addition, before the associative learning task, we first determined the sensitivity to foot-
shock for both genotypes by gradually increasing foot-shock intensity (0.01-0.6 mA) and moni-
toring the onset of behavioural indicators of sensation or pain. WT and Drd2-/- mice showed 
similar thresholds to foot-shock for all 3 behavioural signs (Fig. 32B): approximately 0.025 for 
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 staring at bars, 0.1 mA for the startle response, and 0.17 mA for jumping.  
Figure 32. Pain sensitivity in Drd2-/- mice. Pain sensitivity thresholds (in seconds, mean ± SEM) of mice in the 
tail-flick test (A), plantar test (B) and sensitivity to shock (C). Thresholds for foot-shock responses. Thresholds for 
all three nociceptive test were similar in both genotypes. 
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     2.4. Associative learning is impaired in Drd2-/- mice  
 
    Two-way Active avoidance. Drd2-/- mice were completely unable to learn in the two way ac-
tive avoidance task, in agreement with similar previous results (Fetsko et al., 2005). While WT 
mice learned the task during the first two days, there was no change in the response of the Drd2-
/- mice throughout the entire 11-day training phase, indicating that these mice did not learn to 
associate the CS with the foot-shock (Fig. 33A). In fact, Drd2-/- mice crossed to the other com-
partment only when the shock was delivered, within 5 s of starting the trial, (Fig. 33B). Differ-
ences in crossing latency between WT and Drd2-/- mice were first observed on the second day 
of training (p < 0.001) and continued over the entire test. ITI crosses were higher, but not sig-
nificantly, in Drd2-/-  than in WT mice for the first three days (Fig. 33C), supporting the conclu-
sion that the poor performance of the Drd2-/- mice in this paradigm is due to impaired associa-
tive learning and not to locomotor activity. 
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Figure 33. Active avoidance performance is impaired in dopamine Drd2-/- mice. A. Progression of active 
avoidance responses during the training phase. Drd2-/- mice did not increase the number of avoidance responses 
during the training phase (*p<0.001). B. Time-course of crossing latencies for WT and Drd2-/- mice during the 
training phase. Drd2-/- mice did not decrease escape latency at any point during training  (*p<0.001). C. Number of 
inter-trial crosses, IT. The number of IT crosses was similar in both genotypes, indicating that Drd2-/-  mice have 
the same crossing ability than WT. Data shown are mean ± SEM. Statistics were performed with repeated-
measures two-way ANOVA, followed by post hoc analysis with Tukey´s test. 
         
         Fear conditioning learning. We studied the role of D2R in a fear conditioning task that 
measures the ability to associate an aversive stimulus, in this case an electric foot-shock (US), 
with a neutral environmental context (CS). This memory depends on hippocampal and amygda-
lar function. In this test, learning is evaluated by the percentage of time that animals freeze 
when re-exposed to the CS. In our experiments, baseline levels of freezing were similar in the 
two genotypes before the shock (Fig. 34A).     
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Figure 34. Performance in the fear conditioning is reduced in Drd2-/- mice. A. After the shock, Drd2-/- mice 
spent significant (*p<0.01) less time freezing than their WT littermates, and 24 h after shock, freezing times were 
still significantly lower in Drd2-/- mice, although the magnitude of the difference was reduced (*p< 0.01). B.  
Freezing time after 3 foot-shocks separated by 2 min to stabilish similar freezing times in both genotypes. C. Daily 
freezing time in the context without foot-shock. The extinction curve was similar for both groups of mice, except 
the last day, in which Drd2-/- mice have higher values indicating lower extinction. Data shown are mean ± SEM. 
Statistics were performed with repeated-measures two-way ANOVA, followed by post hoc analysis with Tukey´s 
test. 
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    However, immediately after the shock, Drd2-/- mice spent significant (p< 0.01) less time 
freezing than their WT littermates, and 24 h after shock, freezing times were still significantly 
lower in Drd2-/- mice, although the magnitude of the difference was reduced (Fig. 34A). 
    We study fear extinction, 48 h after fear conditioning, delivered three consecutive foot-
shocks separated by 2 min to establish similar freezing times in both genotypes (Fig. 34B), as 
described previously (Ortiz et al., 2010). Subsequently, mice were tested for freezing in the US 
context daily for six consecutive days without foot-shock. The extinction curve was similar for 
both groups of mice, with Drd2-/- mice presenting slightly higher values every day. However, 
this difference was only significant on the last day of the experiment, day 6 (Fig. 34C). These 
results indicate that the Drd2-/-  is necessary for normal fear extinction. 
2.5. Emotional response of Drd2-/- mice. 
As we know, dopamine is involved in motivational and emotional aspects, for this reason it 
was necessary evaluate the emotional behavior of Drd2-/- mice. In addition, we find similar re-
sults to Drd1a-/- mice in active avoidance for Drd2-/- mice: an increase in crossing latency and a 
decrease in avoidance responses during the first days of training resulting in most of these stop 
their avoidance responses in last days of training (Fig. 33A,B).Therefore, we performed two 
emotional tests: P-Maze, and Porsolt (Fig. 35).  
 
                                                                                                                                                                                                       85 
Figure 35. Drd2-/- mice show not affect emotional response. A. P-maze: anxiety-like behavior of Drd2-/- and WT 
mice illustrated by the number of entries and percentage of total time spent in the open arms of the elevated plus 
maze. Drd2-/- mice showed similar number of entries and time spent in the open arms. B. Porsolt test: WT and 
Drd2-/- mice showed similar time immobile. Data shows are mean ± SEM. 
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            The results obtained in the number of entries and time spent in the open arms of P-maze were 
not significantly different between Drd2-/- and WT mice (Fig. 35A). In addition, WT and Drd2-/- 
mice showed similar immobility times in Porsolt test (Fig. 35B). These results indicate that 
emotional response was similar in both genotypes. We consider that the pattern of response in 
active avoidance is exclusively due to an importan deficit in associative learning and not to anx-
ious or depressive signs in Drd2-/- mice phenotype.  
 
2.6. In vitro and in vivo siRNA-mediated knock-down of dopamine D2R  
 
    We used Lv-based RNA interference to knock-down D2R expression in adult animals to rule 
out developmental compensatory effects in the absence of the D2R in Drd2
-/- mice. We designed 
three siRNAs sequences targeted against different regions of the Drd2 mRNA. These sequences 
were inserted into the transfer plasmid of the Lv system, and their efficiency at silencing Drd2 
was assessed in STHdh+/Hdh+ cells (Fig. 36A). Then, 4 days after infection, there was a dra-
matic decreased in D2R protein expression in these cells with Lv-Drd2-siRNA mix compared 
with de cells given Lv-GFP alone. Western blotting revealed a 90.3% decrease in D2R protein 
in STHdh+/Hdh+ cells. 
    To assess whether Lv-Drd2-siRNAs can deplete D2R expression in vivo, we stereotaxically 
injected the striatum and hipocampus with the mix of Lv-Drd2-siRNAs (2μl) mix or with Lv-
Mock-GFP as a control. One week after the injection, there were dramatic decreases in D2R 
protein or mRNA (Drd2-/-) levels in these regions in Drd2-siRNA injected mice compared with 
animals given injections of Lv-GFP. We include the striatum in this experiment because the ex-
pression of D2R in this region is higher than in the hippocampus, and this allows us to better 
assessed the capacity of our vectors to silence Drd2. Quantitative RT-PCR revealed an 55% de-
crease in Drd2 mRNA expression in the striatum (Fig. 36B), and western blotting revealed a 
58% decline in D2R protein in Lv-Drd2-siRNAs injected mice and 66% in Drd2
-/- mice (Fig. 
36C). Both decreases were statistically significant compared to Lv-GFP injected mice. We de-
termined the spread of the virus within the hippocampus in the Lv-GFP-injected mice using im-
munohistochemistry and found that particles infected ~2mm2 along the rostrocaudal axis, infect-
ing most of the dorsal hippocampus, including the pyramidal cell layer and dentate gyrus (Fig. 
36D, E). 
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Figure 36. siRNA-mediated Drd2 silencing in vitro and in vivo. A. Drastic reduction of Drd2 protein expression 
cells in vitro after infection with Drd2-siRNA constructs, *p= 0.014. B. Drd2 mRNA levels in striatum 48 h after 
injection of Drd2-siRNAs mixture determined by RT-PCR and expressed as a percentage of Drd2 mRNA expres-
sion in Lv-GFP-injected animals. Injection of Drd2-siRNAs specifically decreased Drd2 mRNA expression. C. 
D2R protein levels were decreased 48 h after injection of siRNAs. D2R protein levels were decreased after injection 
of siRNAs, *p = 0.0049, and levels in Drd2-/- mice were significantly lower *p = 0.021. D. Photomicrograph of a 
coronal brain section illustrating the spread of lentiviral infection in the CA1 layer of the hippocampus of WT mice 
injected with Lv-GFP particles. E. High-magnification image of infected pyramidal cells illustrated in D, E. Statis-
tics were performed by Student’s t test. Scale bar = 100 μm. 
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    2.7. Input/output curves and paired-pulse facilitation in the CA3-CA1 synapse were 
normal in Drd2-/- and in Drd2-siRNA mice. 
 
 
   In order to determine the basal synaptic transmission in the four groups of animals included in 
this study, we measured fEPSPs evoked at the CA3-CA1 synapse by the electrical stimulation 
of Schaffer collaterals at increasing intensities (0.02 mA to 0.4 mA, in 0.02 mA steps) in the 
following groups of alert behaving mice: WT, Drd2-/-, WT mice injected with Lv-Drd2-/--
siRNA (Drd2-siRNA), and WT-Sham. Input-output curves revealed no significant differences 
in basal synaptic transmission between the four groups (Fig. 37A). Interestingly, input-output 
curves collected from the four groups of mouse were best adjusted by sigmoid curves (r ≥ 
0.984; p < 0.001), with no significant differences (p = 0.067) between the four groups. 
   Using the double-pulse test with inter-pulse intervals ranging from 10 to 500 ms, we found a 
significant (p < 0.05) increase in slope of fEPSPs evoked by the 2nd pulse at short time inter-
vals (10-100 ms). There were no significant differences between WT, Drd2-/-, WT-Sham, and 
Drd2-siRNA mice (p = 0.181, Fig. 37B).  
   The stimulus intensities used in the remainder of this study (for the LTP study and for CA3-
CA1 activation during classical eyeblink conditioning) were selected from within a range of 30-
40% of the saturating intensity (i.e., the asymptotic values), but still able of evoking facilitation 
of the second pulse. 
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Figure 37. Input-output curves and paired-pulse facilitation in the CA3-CA1 synapse in WT, Drd2-/-, WT-
Sham and Drd2-siRNA mice. A. Input-output curves collected from the four experimental groups. Stimulus con-
sisted of single pulses presented at increasing intensities in 20 mA steps. Collected data was best adjusted by sig-
moid curves (r ≥ 0.984; p< 0.001; n = 3 animals per group), with no significant (p = 0.067) differences between 
groups. B. Paired-pulse facilitation of fEPSPs recorded in the CA1 area following stimulation of Schaffer collat-
erals. The data shown are mean ± SEM slopes of the second fEPSP expressed as a percentage of the first for the six 
(10, 20, 40, 100, 200, and 500 ms) inter-pulse intervals. The four groups of mouse presented a significant (p < 
0.05) paired-pulse facilitation at short (10-40 ms) inter-pulse intervals, but no significant differences (p = 0.181) 
between groups.  
Results 
 
  
    2.8. LTP evoked at the CA3-CA1 synapse is significantly reduced in behaving Drd2-/- 
and in Drd2-siRNA mice. 
 
     To explore the role of the D2R in hippocampal LTP, we compared CA3-CA1 fEPSPs fol-
lowing HFS of Schaffer collaterals in WT, Drd2-/-, WT-Sham, and Drd2-siRNA mice (Fig. 
38A, B). To determine baseline responses, Schaffer collaterals were stimulated every 20 s for 
15 min. The stimulus consisted of a 100-µs, square, negative-positive pulse. After HFS, the 
same single stimulus was presented every 20 s for 30 min and repeated 24 h later, for 15 min. 
We found LTP in WT and WT-Sham mice for the two recording sessions (Fig. 38A, B).  As 
already reported for the hippocampal CA3-CA1 synapse (Gruart et al., 2006; Madroñal et al., 
2007; Ortiz et al., 2010), 15 min after HFS, the response to the single stimulus in both WT and 
WT-Sham groups was > 150% of baseline values (p < 0.001; white circles, Fig. 38A, B).  
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Figure 38. LTP induction in the CA3-CA1 synapse in WT, Drd2-/-, WT-Sham and Drd2-siRNA mice. A. Rep-
resentative fEPSPs recorded from WT and Drd2-/- animals before (baseline), and 5 min (1) and 24 h (2) after HFS. 
Graphs illustrate the time-course of changes in fEPSPs (mean ± SEM) following HFS stimulation of the Schaffer 
collaterals. The HFS train was presented after 15 min of baseline recordings, at the time marked by the dashed line. 
fEPSPs are given as a percentage of the baseline (100%) slope. WT mice presented a significantly larger LTP than 
Drd2-/-  animals (*p < 0.001). B. Same analysis as in A for WT-Sham and Drd2-siRNA groups. Here again, the 
control group presented a significantly larger LTP than Drd2-siRNA mice (*p < 0.05). 
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    Significant LTP persisted at 24 h post-HFS (p < 0.001; Fig. 38A, B). Although Drd2-/- mice 
showed a small (< 150%) LTP at the CA3-CA1 synapse after HFS (Fig. 38A, black circles), the 
collected fEPSP slopes were significantly smaller (p < 0.001) than values collected from WT 
animals for the two post-HFS sessions. Slopes of fEPSP collected from Drd2-siRNA mice after 
the HFS (Fig. 38B, black squares) were significantly (p < 0.05) smaller than those collected 
from WT-Sham only during the second post-HFS session. Thus, both Drd2-/-and Drd2-siRNA 
mice presented a reduced LTP in the hippocampal CA3-CA1 when compared with their litter-
mate controls. 
    2.9. Classical trace eyeblink conditioning is significantly reduced in Drd2-/- and Drd2-
siRNA mice. 
 
    As illustrated in Fig. 39A,B, the neural premotor circuits involved in the generation of reflex 
eyelid responses function normally in the four groups of animals used in this study (WT, Drd2-/-
, WT-Sham, and Drd2-siRNA). Indeed, reflex eyeblinks evoked by the electrical stimulation of 
the supraorbital nerve were similar to previous descriptions in WT mice (Gruart et al., 2006). 
There were no significant differences between the four groups of mice in the latency and ampli-
tude of reflexively evoked blinks (not illustrated; p ≤ 0.362).   
 
 
Figure 39. Evolution of CA3-CA1 synaptic field potentials in WT, Drd2-/-, WT-Sham and Drd2-siRNA mice. 
A, B, From top to bottom are illustrated the conditioning paradigm, representative EMG and hippocampal record-
ings collected during paired CS-US presentations for WT and Drd2-/- mice (A) and for WT-Sham and Drd2-siRNA 
mice (B). The moment of stimulus presentation at Schaffer collaterals (St.) is indicated, as is the time of delivery of 
CS (dashed line). Data shown were collected during the 9th conditioning session.  
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    In order to investigate the behavioral consequences of the deficit in synaptic plasticity at the 
CA3-CA1 synapse observed in Drd2-/- and Drd2-siRNA mice, we evaluated classical condition-
ing of eyeblink responses in the four groups of experimental animals using a trace paradigm 
(CS, tone; US, shock) with a 500-ms interval between the end of the CS and the beginning of 
the US (Fig. 39A, B).   
    As illustrated in Fig. 40A, WT mice increased the percentage of CRs across the successive 
conditioning sessions, being significantly different from habitation values from the 3rd to the 
10th conditioning sessions (p < 0.001; Fig. 40A).  
 
 
 
Figure 40. Evolution of learning curves in WT, Drd2-/-, WT-Sham and Drd2-siRNA mice. A.B. Percentage of 
eyelid CRs reached by the four experimental groups. The acquisition curve presented by the WT group was signif-
icantly larger than values reached by the Drd2-/- group (A; *p < 0.05). The acquisition curve of the WT-Sham 
group was also significantly larger than that presented by Drd2-siRNA animals (B; *p  < 0.05). C, D. Evolution of 
fEPSPs evoked at the CA3-CA1 synapse across conditioning for WT and Drd2-/- mice (C) and for WT-Sham and 
Drd2-siRNA animals (D). fEPSP slopes are expressed as the percentage of fEPSP slope values collected during 
habituation sessions for each group.  Differences in fEPSP slopes between WT and Drd2-/- groups were statistically 
significant at the indicated sessions (C; *p < 0.05), indicating that activity-dependent synaptic plasticity was se-
verely impaired in both Drd2-/- mice. No significant differences were found between the WT-Sham and Drd2-
siRNA groups (p = 0.154). 
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     This learning curve presented a profile similar to that reported previously in WT mice 
(Takatsuki et al., 2003; Gruart et al., 2006; Ortiz et al., 2010). In contrast, the percentage of 
CRs in the Drd2-/- group increased in a more slowly way, reaching lower asymptotic values than 
their littermate controls (Fig. 40A). Thus, the percentage of CRs presented by the WT group 
was significantly different from that of the Drd2-/- group from the 4th to the 10th conditioning 
sessions (Fig. 40A; p < 0.05). Similarly, WT-Sham animals presented learning curves similar to 
those seen in WT mice, while CRs in Drd2-siRNA mice presented a significantly lower per-
centage of CRs from the 6th to the 10th conditioning sessions (Fig. 40B;  p < 0.05).  
 
  2.1. Learning-dependent changes in CA3-CA1 synaptic strength were reduced in Drd2-/- 
and Drd2-siRNA mice. 
 
    As shown recently in behaving mice, trace eyeblink conditioning is associated with an in-
crease in synaptic strength at the hippocampal CA3-CA1 synapse (Gruart et al., 2006; Madro-
ñal et al., 2007). We evaluated here the effect of D2R loss on fEPSPs evoked at the CA3-CA1 
synapse. Electrical stimulation of Schaffer collaterals 300 ms after CS presentation evoked a 
fEPSP in the CA1 area in all four experimental groups (Fig. 39A,B). Although the stimuli pre-
sented to Schaffer collaterals disrupted the regular theta rhythm recorded in the CA1 area, the 
rhythm reappeared in phase about 200 ms afterwards. The slope of the evoked fEPSPs in-
creased in the four experimental groups over the course of conditioning when Schaffer collat-
eral stimulation took place during the CS-US interval (Fig. 40C,D).  
    Nevertheless, there were clear differences between the two controls (WT and WT-Sham) and 
the two experimental (Drd2-/- and Drd2-siRNA) groups. In agreement with previous studies 
(Gruart et al., 2006; Madroñal et al., 2007; Ortiz et al., 2010), and as illustrated in Fig. 40C, D, 
fEPSP slopes recorded in WT (140%) and WT-Sham (120%) mice were significantly elevated 
over baseline values (p < 0.05) by the 10th conditioning session. In contrast, although the 
slopes of evoked fEPSPs in Drd2-/- (120%) and Drd2-siRNA (110%) mice were elevated over 
baseline, they were smaller than in corresponding control animals (Fig. 40C,D). Collected 
fEPSP slopes were significantly (Fig. 40C; p < 0.05) different between WT and Drd2-/- mice, 
but not (p = 0.154) between WT-Sham and Drd2-siRNA animals. In summary, the decreased 
performance in associative learning tasks noticed in Drd2-/- and Drd2-siRNA mice compared 
with their respective controls was paralleled by a decline in activity-dependent increases in syn-
aptic strength at the CA3-CA1 synapse during classical conditioning of eyelid responses. 
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3. DOPAMINERGIC SIGNALING BY D1R AND D2R IN STRIATUM REGULTES THE 
PHENOTYPIC SHIFT OF A POPULATION OF STRIATAL NEURONS AND MO-
TOR BEHAVIOR. 
 
3.1. L-DOPA treatment dose-dependently increased the number of TH-ir neurons in the 
denervated mouse striatum. 
 
 
In a previous study we demonstrated that TH-ir neurons appear in the lesioned striatum soon 
after denervation and that L-DOPA treatment significantly increased the number of TH-ir cells 
(Darmopil et al., 2008).  
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Figure 41. L-DOPA treatment dose-dependently increased the number of striatal TH-ir neurons in the 6-
OHDA-lesioned striatum. A. Photomicrographs of TH-ir neurons in the lesioned striatum of mice treated for 2 
weeks with saline, 15 mg/kg L-DOPA or 25 mg/kg L-DOPA. Mice were killed 1 h or 10 days after the last L-
DOPA treatment as indicated. Note the increase in the intensity of TH-ir staining and the number of TH-ir neurons 
induced by increasing the L-DOPA dosage. B. Histogram showing the density of TH-ir neurons (mean ± SEM) in 
the 6-OHDA-lesioned striatum of mice treated with L-DOPA or saline. *p<0.001 vs. saline or vs. 15mg/kg L-
DOPA (n = 6), one way ANOVA followed by Student-Newman test. C and D are high magnification images of the 
areas marked in the upper panels. Scale bar = 100 µm for A and 50 µm for C and D. 
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    To see if this effect of L-DOPA is dose-dependent, we examined changes in the density of 
striatal TH-ir neurons after 3 weeks of daily treatment with either 15 mg/kg or 25 mg/kg L-
DOPA. While there was no discernible difference between the two doses in cell body morphol-
ogy of the TH-ir neurons, we observed generally more intense and complete TH-ir of the den-
dritic tree in striatum of mice treated with 25 mg/kg L-DOPA (Fig. 41A): more and longer den-
drites were apparent in these animals. In addition, daily L-DOPA treatment significantly in-
creased the density of TH-ir neurons in the lesioned striatum in a dose-dependent manner (Fig. 
41A,B). Stereological counting confirmed the dose-dependence of the L-DOPA effect: follow-
ing a 3-week treatment with 15 mg/kg L-DOPA, there were 183±33 TH-ir neurons/mm3 in the 
striatum; the number of TH-ir neurons nearly was doubled when the dose was increased to 25 
mg/kg (365±41, Fig. 41B). However, 10 days following L-DOPA withdrawal, the number of 
TH-ir neurons in the striatum decreased significantly, (50±9 TH-ir neurons/mm3 p< 0.001) re-
turning nearly to the basal levels observed in lesioned mice treated with saline, 29±10 TH-ir 
neurons/mm3.   
 
    3.2. The D1R, but not D2R, is important for induction of TH-ir neurons in the denervat-
ed striatum after L-DOPA. 
 
    To establish the role of D1R and D2R in the L-DOPA-induced increase in TH-ir neurons in 
denervated animals, we performed unilateral striatal lesions with 6-OHDA in Drd1a-/- or Drd2-/- 
mice and their WT littermates (Fig. 42). After 3 weeks of daily saline or L-DOPA (25 mg/kg) 
administration, we estimated the number of TH-ir neurons in the lesioned striatum. Unbiased, 
stereological counting revealed 493±30 TH-ir neurons/mm3 in lesioned striatum of L-DOPA-
treated WT control littermates for Drd1a-/- mice, and 676±127 neurons/mm3 in the WT control 
littermates for Drd2-/- mice (Fig. 42). This difference did not reach significance, but indicated 
some variability between groups of animals with different genetic backgrounds. Genetic disrup-
tion of D1R decreased the number of TH-ir neurons (202±33) in the lesioned striatum of L-
DOPA-treated hemiparkinsonian mice by 59% compared with WT littermates (Fig. 42A, C).    
In addition, the intensity of striatal TH-ir staining was much weaker in Drd1a-/- than WT ani-
mals and was localized to the cell soma: there was little or no labelling of dendrites in the stria-
tum of Drd1a-/- mice (Fig. 42A). In contrast, there was no statistical difference in the number of 
TH-ir neurons (505±106) in the lesioned striatum of L-DOPA-treated Drd2-/- hemiparkinsonian 
mice compared to their WT littermates (Fig. 42B,C). Moreover, the intensity of TH staining in 
cell soma and neuropil was also similar in Drd2-/- mice and their WT (Fig. 42B).  
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To demonstrate that the effects we see in the Drd1a-/- and Drd2-/- mice are due exclusively to 
the absence of the receptors rather than to compensatory mechanisms secondary to global D1R 
and D2R deletion, we carried out a similar experiment in 6-OHDA-lesioned WT animals using 
pharmacological blockade of dopamine D1R or D2R families (Fig. 42D). We found that admin-
istration of the D1R antagonist SCH23390 (0.3 mg/kg) 30 min before each L-DOPA dose (25 
mg/kg) significantly reduced (p< 0.005) the number of TH-ir neurons in the lesioned striatum 
(213 ± 43 neurons/mm3) compared to animals treated with L-DOPA alone (402±66). In con-
trast, pre-treatment with raclopride (2 mg/kg), a preferential D2R antagonist, had no significant 
effect on the number of TH-ir neurons in the lesioned striatum of L-DOPA-treated WT mice 
(309 ± 40 neurons/mm3), see Fig. 42D. Thus, either genetic inactivation or pharmacological 
blockade of D1R decreased the number of TH-ir neurons induced by L-DOPA in the dopamine- 
Figure 42. Role of D1R and D2R in the L-DOPA-induced increase in striatal TH-ir neurons in the lesioned 
striatum. A, B. High magnification photomicrographs of TH-ir in coronal sections through the lesioned striatum 
of L-DOPA treated Drd1a-/- (A), or Drd2-/- (B) mice and their corresponding WT hemiparkinsonian littermates. 
C,D, E Histograms show stereological quantification of TH-ir neuron density in coronal sections of lesioned stria-
tum in Drd1a-/- and Drd2-/-
 
mice treated with L-DOPA or saline (C) and in WT lesioned mice treated with saline or 
0.3 mg/kg of SCH23390 or 2 mg/kg of raclopride 30 min before L-DOPA (D) or pretreated with 15 mg/kg of 
simvastatin 3 h before L-DOPA, an inhibitor of ERK activation (E). Data are expressed as mean ± SEM. *p<0.001 
vs. WT and Drd2-/- mice, &p<0.05; ♯p<0.005 vs L-DOPA alone, one way ANOVA followed by Student-Newman 
test in C and D and by Student t test in E (n = 5-7). Scale bar = 100 μm. 
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depleted striatum while genetic inactivation or pharmacological blockade of D2R had no effect. 
Because L-DOPA activates the ERK signalling pathway, through D1R activation, in dener-
vated striatal neurons (Pavón et al., 2006; Schuster et al., 2008), we investigated whether ERK 
is important for the induction of TH-ir neurons by L-DOPA, using simvastatin, an inhibitor of 
ERK activation. We administered 15 mg/kg simvastatin daily for 3 days before starting L-
DOPA treatment and then 3 h before each dose of L-DOPA for 15 days. Following this para-
digm, the number of striatal TH-ir neurons decreased by half compared to animals treated with 
L-DOPA alone (Fig. 42). 
 
 
    3.3. TH-ir neurons induced by L-DOPA do not express D1R or D2R. 
 
     
Figure 43. TH-ir neurons do not colocalize with D1R- or D2R-containing neurons. A. Confocal photomicro-
graphs shows that TH-ir neurons do not colocalize with Drd1a-Tomato or Drd2-GFP neurons in the lesioned stria-
tum. B. Quantification of TH-ir neurons demonstrating that the number of these neurons increases similarly in WT 
and BAC-transgenic mice after L-DOPA treatment, (*p < 0.001). Data are expressed as mean ± SEM. one way 
ANOVA followed by Student t test was used. Scale bar = 50 μm 
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    Although it has been shown that dopamine D1R plays an important role in TH-ir striatal neu-
rons expression, we found that these neurons do not contain D1R or D2R. These studies were 
carried out using Drd1a-Tomato and Drd2-GFP hemilesioned with 6-OHDA. TH-
immunoreactivity did not colocalized with any of the fluorescence probes (tomato red in D1R-
containing neurons, or GFP in D2R-containing neurons) (Fig. 43A), so the response of these 
neurons to D1R activation could be due to an indirect mechanism. We also check the number of 
TH-ir neurons in lesioned striatum of the BAC-transgenic mice to verify that there were no dif-
ferences between the two strains and WT mice lesioned and treated with L-DOPA. We found 
no differences between the three strains (Fig. 43B). 
 
 
    3.4. Ultrastructure of TH-ir neurons. 
 
 
    Previous studies with electron microscopic analysis of TH-ir neurons showed the ultrastruc-
tural features and synaptology of these neurons in monkeys (Mazloom & Smith, 2006) and rats 
(Meredith et al., 1999), but there are not studies in mice. To test if these neurons are similar be-
tween species, we performed ultrastructural studies with a transmission electron microscope 
(TEM) of TH-ir striatal neurons of lesioned mice. 
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Figure 44. Panoramic reconstruction 
of a striatal TH-ir neuron in lesioned 
mice. Micrographs show a TH-ir soma 
with the nucleus, cytoplasm and one 
dendrite. The images that form the re-
construction were taken from a TEM at 
20.000x. 
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    At the electron microscopic level TH-ir cell bodies and dendrites showed strong im-
munostaining (Fig. 44, 45). The DAB deposit was intense and homogeneously distributed 
throughout the cytoplasm, but the nucleus was devoid of immunoreactivity (Fig. 45). In line 
with other studies, cell bodies were small, and the shape was typically round or oval (Fig. 45). 
In all neurons examined, the nuclear membrane was deeply invaginated, a typical ultrastructur-
al characteristic of striatal interneurons (Difiglia et al., 1980) (Fig. 44, 45). Also, these neurons 
have a high number of mitochondria, both features are indicative of a high activity. 
Figure 45. Micrograph of TH-ir perikaryon. Note the intense peroxidase labeling of the cytoplasm. The arrows 
indicate the nuclear invagination, a common ultrastructural feature of striatal interneurons. Scale bar = 2 µm 
    The TH-ir striatal neurons are able to establish a high number of functional synapses of 
asymmetric type (excitatory) (Fig. 46, 47). In addition, the synaptic elements found labelled 
with DAB were mainly postsynaptic (Fig. 47). This may be because identifying presynaptic ter-
minals is particularly difficult for two reasons: a) the DAB signal mask the content of the termi-
nal and no vesicles are displayed or b) low DAB signal difficult to identify the terminal (Fig. 
46). However, detection of postsynaptic elements is easier since postsynaptic membranes, in 
active synapses, have more electrodense appearance.         
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Figure 47. Synaptic connectivity of TH-ir neurons. Images illustrate postsynaptic elements of asymmetric syn-
apses A. A spine immnulabeled with TH indicated by the arrow. B, C, D. Show various examples of TH-
immunoreactives postsynaptic elements. Scale Bar = 0.5 µm. 
    These results indicate that TH-ir neurons have similar morphological characteristics to those 
found in monkeys (Mazloom & Smith, 2006). For his shape and size, we can infer that may be 
GABAergic interneurons, however a minority of these cells are spiny neurons. In this case we 
found very few axon-terminals, this could be because the proportion of dendrites is much higher 
than the axon-terminals. In addition the high number of mitochondria and asymmetric synapses 
indicates that these neurons are functionality and very active as have been shown before 
(Darmopil et al., 2008). 
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Figure 46. TH-immunostained axon-terminal. The 
picture illustrates an axon-terminal immunostained 
with TH (arrow) in the striatum of 6-OHDA lesioned 
mice. Note the presence of numerous vesicles in the 
presynaptic terminal (asterisk), and the electrodense 
membrane in the postsynaptic element. Scale Bar = 
0.25 µm. 
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    3.5. L-DOPA-induced TH-ir neurons in the lesioned striatum with distinct phenotype 
that midbrain dopaminergic neurons. 
 
     Pitx3 is a homeodomain transcription factor expressed in dopaminergic neurons in the brain 
and is essential for the normal development of the midbrain dopaminergic system (Jacobs et al., 
2007, 2009). Inactivation of Pitx3 induces selective loss of dopaminergic neurons in the SNc 
and, as a consequence, major dopamine depletion in the striatum, providing a genetic model of 
PD (Hwang et al., 2003; Ding et al., 2007, 2011). Based on these results, we investigated 
whether the L-DOPA-induced appearance of TH-ir neurons in the dopamine-depleted striatum 
requires Pitx3. We treated Pitx3-deficient aphakia mice with L-DOPA (25 mg/kg) or saline dai-
ly for 21 days.  
 
 
Figure 48. The transcription factor Pitx3 is 
not necessary for L-DOPA-induced TH ex-
pression in striatal TH-ir neurons. A. Photo-
micrographs of coronal sections through dorsal 
striatum of Pitx3-/- mice treated with saline or L-
DOPA. No TH-ir neurons are visible in the stria-
tum of Pitx3-/- mice treated with saline but TH-ir 
striatal neurons are clearly present after 3 weeks 
of daily treatment with 25 mg/kg L-DOPA. B. 
Double-inmmunostaining for TH (green) and 
Pitx3 (red) in coronal sections of Pitx3-/- mice 
striatum and WT mice SN. Note that striatal TH-
ir neurons do not express Pitx3 in contrast to SN 
TH-ir neurons from WT mice. C. Histograms 
show stereological quantification of TH-ir neu-
rons density in coronal sections of lesioned and 
sham-operated-striatum of aphakia mice treated 
with L-DOPA. D. Photomicrographs of coronal 
sections through the 6-OHDA and Sham le-
sioned striatum of aphakia treated with L-
DOPA. Note that the lack of Pitx3 does not alter 
the number of TH-ir neurons per mm3 in the 
lesioned-compared with the sham-operated stria-
tum in the aphakia mice.Scale bar = 200 μm in 
A, 25 μm in B and 400 μm in D. 
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    We observed a large increase in striatal TH-ir neurons after L-DOPA administration while no 
TH-ir neurons were observed in striatum of saline-treated animals (Fig. 48A). Dual immunocy-
tochemistry studies, conducted in parallel with SN coronal sections from a WT animal, con-
firmed that these TH-ir neurons do not express Pitx3 in the aphakia mice, while a strong signal 
was evident in the WT mice (Fig. 48B).  
    To rule out the possibility that Pitx3 plays a role in the appearance of TH-ir neurons after 
striatal injury, we quantified TH-ir neurons in 6-OHDA-lesioned or sham-operated aphakia 
mice treated with L-DOPA. We found no significant differences (Fig. 48, p = 0.2) in the density 
of TH-ir neurons in lesioned and sham-operated aphakia mice. Indeed, in these mice, the lesion 
increased the absolute number of TH-ir neurons in the striatum an also increased the lesioned 
area (Fig. 48) therefore the number of striatal TH-ir neurons per mm3 was not altered compared 
to sham-operated aphakia mice. These results indicate that Pitx3 is not necessary for induction 
of TH-ir neurons in the lesioned striatum by L-DOPA.  
   Another transcription factor that is a critical determinant of midbrain dopaminergic neurons 
during development is Nurr1. It is a member of the orphan nuclear receptor family of transcrip-
tion factors required for the differentiation of mesencephalic dopaminergic neurons. This factor 
induces the expression of dopaminergic genes such as Th (Vergaño-Vera et al., 2014). Similar 
to Pitx3 results, dual immunohistochemistry studies for Nurr1 and TH confirmed that these TH-
ir neurons do not express this transcription factor of midbrain dopaminergic neurons (Fig. 49) 
 
Figure 49. TH-ir neurons do not express the transcription factor Nurr1. A. Photomicrographs of coronal stria-
tal sections of lesioned mice treated with L-DOPA stained with TH (green) and Nurr1 (red). Note that TH-ir neu-
rons do not express Nurr1. B. Shows the specificity of Nurr1 signal in SN with primary antibody (left panel) and 
without (right panel). Scale bar = 200 μm 
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  3.6. Long-duration effects of chronic L-DOPA treatment on forelimb use in hemipar-
kinsonian mice.  
 
To evaluate whether TH-ir neurons in the striatum could be involved in the long-term effica-
cy of chronic L-DOPA treatment, we studied spontaneous forelimb use in the cylinder test at 
various time points before and after lesion and before and after chronic L-DOPA treatment 
(Fig. 50). Forelimb use asymmetry has been used to assess the efficacy of the 6-OHDA lesion 
in mice (Lundblad et al., 2004; Pavón et al., 2006; Darmopil et al., 2009) as well as the motor 
effect of L-DOPA administration (Lundblad et al., 2004). Before lesion, animals use both fore-
limbs equally to support their body weight: the ratio of forelimb use or wall contact for the right 
and left forelimbs was 51.5%. In unilaterally 6-OHDA-lesioned animals, the ratio for use of the 
forelimb contralateral to the lesion decreased to 33.7% (p<0.001 vs. unlesioned animals) illus-
trating the degree of asymmetry in limb use due to the dopamine deficiency in the lesioned stri-
atum. Chronic L-DOPA treatment induced a significant long-term motor improvement in the 
contralateral forelimb, 1 day after the three-week L-DOPA treatment, the ratio of forelimb use 
was similar to that observed in unlesioned animals (50.5%, Fig. 50), indicating a complete re-
covery in this particular motor function (p<0.001 vs. lesioned animals). Although the forelimb 
efficacy eventually decreased again with time, the improvement persisted for at least 4 days af-
ter the end of the L-DOPA treatment (46.7%; p<0.001).  
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Figure 50. Chronic L-DOPA treatment reverses forelimb use asymmetry induced by striatal 6-OHDA le-
sion. Forelimb use asymmetry was measured by the cylinder test in mice before and 3 weeks after unilateral 6-
OHDA lesion. Mice were then treated for 3 weeks with daily administration of L-DOPA (25 mg/kg) and re-
assessed with the cylinder test at 1, 4, 7 and 10 days after L-DOPA withdrawal. Data are expressed as percent ± 
SEM of wall contact performed with the contralateral limb, *p<0.01 vs. lesioned mice treated with saline, n=11, 
one way ANOVA followed by Student-newman test. 
Results 
 
 
 
Later on, after 7 days, we still observed a mild recovery (40.8% p=0.08) but that is not sig-
nificantly different from the values obtained in lesioned mice (33.7%). The positive motor ef-
fect of L-DOPA was no longer detectable 10 days after the L-DOPA treatment: the ratio of con-
tralateral to ipsilateral forelimb use decreased to 38.2%, similar to that observed in lesioned ani-
mals without L-DOPA treatment (Fig. 50). 
 
3.7. Effect of L-DOPA administration on striatal dopamine overflow in hemi-
parkinsonian mice. 
 
    Electrical stimulation of striatal slice preparations induces extrasynaptic dopamine release, 
termed “synaptic overflow”, due to the synchronized firing of numerous dopamine terminals 
(Garris et al., 1994). Therefore, we next examined whether L-DOPA treatment (25 mg/kg) in 
hemiparkinsonian animals modifies extrasynaptic dopamine overflow in the lesioned and un-
lesioned striatum by determining dopamine overflow in striatal slices at 1, 4 and 10 days after 
chronic administration of L-DOPA. In sham lesioned mice, single biphasic electrical stimuli 
(0.5 ms, 20 V) elicited reliable dopamine release reaching a peak of 0.30 ± 0.02 µM in contrala-
teral (Fig. 51 A;  n = 4) and 0.34 ± 0.02 µM in ipsilateral (Fig. 51A; open circles; n = 5) striatal 
slices. Peak overflow was reached within 0.4 s and returned to baseline within 1.4 s (Fig. 51A). 
We next examined dopamine release in the striatum after nigro-striatal denervation. 6-OHDA 
lesioned mice showed an abolition of dopamine overflow in ipsilateral striatum (Fig. 51B; open 
circles; n = 5), accompanied by a significant increase (0.49 ± 0.07 µM) in dopamine overflow 
in contralateral striatum (Fig. 51B; filled circle; n = 5) compared to sham lesioned animals (Fig. 
51A,F). These results suggest that there is compensatory adaptation in the intact side of the stri-
atum in lesioned animals. Interestingly, these changes in both hemispheres were counteracted 
by L-DOPA administration. Thus, 1 day after chronic L-DOPA treatment, dopamine overflow 
was similar in sham-operated and lesioned animals (Fig. 51C,F). This effect of L-DOPA de-
clined significantly by 4 day (Fig. 51D) after the end of L-DOPA treatment and by 10 day, the 
peak of dopamine release was similar to that seen in slices from lesioned animals without L-
DOPA treatment (Fig. 51C,F,G). These results suggest that L-DOPA treatment temporarily re-
stores dopamine overflow in ipsilateral and contralateral striatum after nigrostriatal denervation.  
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Figure 51. Long-term effect of L-DOPA on electrically stimulated striatal dopamine overflow in the lesioned 
and unlesioned striatum. A. Time-course of dopamine overflow evoked by a single intrastriatal stimulus (arrow; 
20 V, 0.5 ms) in contralateral (n = 4) and ipsilateral (n = 5) striatal slices from sham lesioned animals. Inset shows 
voltammogram response for dopamine release before (gray trace) and after (black trace) electrical stimulation. B:  
Same as A but in 6-OHDA lesioned mice. Note the abolition of dopamine overflow in the ipsilateral striatum (n = 
5) and the increase in dopamine overflow in the contralateral striatum (n = 5). C-E: Same as A but in 6-OHDA 
lesioned mice 24 hours (C: contralateral, n = 7; ipsilateral, n = 11), 4 days (D: contralateral, n = 12; ipsilateral, n = 
10) and 10 days (E: contralateral, n = 6; ipsilateral, n = 8) after stopping L-DOPA treatment. F: Bar graph illus-
trates peak dopamine release in different experimental conditions. Significant differences with respect to sham 
lesioned mice are indicated by (*p< 0.05), (**p< 0.01) and (***p< 0.001). Significant differences with respect to 
ispilateral 6-OHDA lesioned animals are indicated by (#p < 0.05) and (###p< 0.001), one way ANOVA followed by 
2-tailed Student´s t test. 
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    The specificity dopamine distribution in brain structures related with motor response, reward/
motivation, learning and memory processes reflects the relevance of dopaminergic system in 
these functions and in the changes of synaptic plasticity associated. These processes could not 
be carried out without a proper functioning that involves primarily the action of D1R and D2R 
as key elements modulating dopaminergic transmission. 
 
1. DOPAMINERGIC  SIGNALING  BY  D1R  IN  HIPPOCAMPUS  REGULATES 
LEARNING AND MEMORY PROCESS. 
 
    The D1R is expressed in the main brain areas implicated in learning and memory process.  
Our findings in different tests indicate that spatial, associative and recognition memory are 
abolished or dramatically reduced in Drd1a-/- mice, but these deficits are not due to motor or 
emotional and motivational disturbances. 
 
1.1. Dopamine D1R is critical for acquisition and consolidation of spatial memory. 
 
    It has been suggested that the Barnes maze discriminates spatial learning more clearly than 
the MWM for mice (Barnes, 1979; Harrison et al., 2009; Patil et al., 2009). Drd1a-/- mice were 
tested in the Barnes maze to consolidate the previous findings that D1R is necessary for spatial 
learning in the MWM. Our results in Barnes maze test are in agreement with previous results 
from our laboratory (Granado et al., 2008) and others (Smith et al., 1998; Xing et al., 2010). 
Unlike a previous water maze study in which Drd1a-/- mice did learn after extended training (El
-Ghundi et al., 1999), we saw no decrease in the escape latency for Drd1a-/- mice in the Barnes 
maze even after extended training. In addition, two indicators of anxiety level, immobility dur-
ing the first day of training in the Barnes maze, and performance in the P-Maze, revealed no 
increase in anxiety in the knockout animals, so it is unlikely that the impaired performance of 
Drd1a-/- mice in the Barnes maze is attributable to an effect of the knockout on anxiety. In addi-
tion, the number of holes explored at day 1 of training was similar to their WT, indicating that 
these animals have similar exploratory behavior. Our results confirm the crucial role of D1R in 
spatial learning.  
 
 
1.2. The D1R is critical for acquisition and consolidation of fear memories. 
 
 
    While spatial memory is hippocampus-dependent, other forms of associative learning also 
depend on the amygdala. To further assess the role of D1R in associative learning, we used two  
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paradigms that evaluate fear memory. In the active avoidance test, Drd1a-/- mice did not de-
crease their escape latency at any point during the training trials. Similar random crossing 
scores for WT and Drd1a-/- mice indicate that this finding is not caused by decreased locomotor 
activity. Furthermore, Drd1a-/- mice stop responding to the conditioned stimulus throughout the 
days of training, exhibiting a pattern of response similar to the “learned helplessnesses” phe-
nomenon (Seligman et al., 1975). However the results in Porsolt test, that assess depressive 
symptom, do not indicate a depressive tendency for these mutant mice at basal level. 
    The results of passive avoidance trials further confirm that this impairment learning was not 
caused by locomotor deficits or freezing. In passive avoidance, Drd1a-/- mice showed some 
learning at 0.4 and in 0.8 mA, but were significantly impaired compared with WT mice 1 and 
24 h after the training. Thus, the avoidance impairment associated with D1R inactivation is like-
ly attributable to abnormal acquisition of learning or to abnormal short term memory retrieval, 
but not to deficits in memory consolidation. These mice showed similar avoidance responses at 
1 and 24 h after the shock, indicating that they are able to retrieve what they have learned. To-
gether, these studies suggest that with moderate intensity stimuli, D1R are important for fear 
conditioning, but at higher intensities, D1R-independent mechanisms predominate. Similar re-
sults were obtained with Egr1 mutant mice, which exhibit deficits in spatial memory that can be 
rescued by extensive training (Jones et al., 2001). 
    In addition, previous studies show that D1R antagonists increase sensitivity to pain (Burkey 
et al., 1999), a decrease in dopamine levels can sensitize to pain and reduce the avoidance re-
sponse. Therefore, we performed three different test to assess pain sensitivity in basal condi-
tions for Drd1a-/- and WT mice. In all test (tail-flick, hot-plate and plantar test) Drd1a-/- mice 
exhibited a lower threshold of response than WT mice. Thus, we carry out the test “sensitivity 
to foot-shock”. We found that Drd1a-/- and WT mice have similar pain sensitivity threshold in-
dicating that sensitivity to electric shock could not affect associative tests performance.  
 
  1.3. Dopamine D1R is critical for recognition memory. 
 
 
    Drd1a-/- mice exhibit similar time in ORT exploring the novel object than the familiar one on 
test day, it is possible that they not recognize any of the objects. The ORT exploits the tendency 
of rodents to spend more time exploring a novel object than a familiar one, suggesting that they 
recognize objects at different locations. This action involves different processes in different 
brain structures, including the hippocampal region. The hippocampus is essential for encoding 
spatial and episodic memories (Ryan et al., 2010), and for novelty detection include ORT, spe-
cially in long-term memory test of the object recognition (Hamond et al., 2004). The role of  
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hippocampus is important in novelty detection for his multiple connections with other brain 
structures because this type of memory involves the comparison of an existing memory with 
new sensory information. CA1 hippocampal region recives dopaminergic proyections from the 
VTA (a part of functional loops detectin novelty, Lisman & Grace, 2005) and from SN 
(Gasbarri et al., 1997). In addition, this kind of memory is impaired in animal models of PD 
and restored by the action of L-DOPA vía D1R (Costa et al., 2012). 
 
    1.4. Dopamine D1R is involved in learning and in the related changes in synaptic 
strength at the hippocampal CA3-CA1 synapse. 
 
 
     The behavioral disturbances found in Drd1a-/- mice are in agreement with previous findings 
in our laboratory. The three processes: associative learning, activity-dependent synaptic plastic-
ity and LTP, seem to be functionally related (Gruart et al., 2006; Madroñal et al., 2007). Our 
previous work shows that D1R does not affect normal transmission, but contributes to synaptic 
plasticity during the acquisition and storage of new information (Ortiz et al., 2010). D1R are 
also necessary for evoking LTP of the CA3-CA1 synapse after HFS of afferent Schaffer collat-
erals (Granado et al., 2008; Ortiz et al., 2010). In addition, acquisition of classically condi-
tioned eyelid responses and the increase in CA3-CA1 synaptic strength across training are se-
verely impaired in Drd1a-/- and  mice injected with lentiviral particles silencing the D1R (Drd1a
-siRNA), suggesting the D1R plays an important role in hippocampal mechanisms related to 
learning and memory (Ortiz et al., 2010). 
 
1.5. Possible molecular mechanisms of D1R-mediated learning and memory process. 
 
    The mechanism by which D1R mediates associative learning are not known. One possibility 
is that D1R-triggered cAMP signaling phosphorylates CREB (cAMP response element-binding 
protein) which activates the histone acetyl transferase enzyme CBP-binding protein (Mayr et 
al., 2001; Alarcón et al., 2004), inducing expression of immediate-early genes, including Egr1 
and Arc, which play a crucial role in reference memory (Guzowsky et al., 2000; Jones et al., 
2001).  Alternatively, D1R could directly phosphorylate NMDA receptors or the Protein kinase 
C ζ isoform in hippocampus and amygdala, potentiating and maintaining synaptic strength 
(Gardner et al., 2001; Impey et al., 2002; Kelleher et al., 2004; Sacktor, 2008) by increasing the 
influx of calcium induced by NMDA receptor activation, as occurs in prefrontal cortex neurons 
(Kruse et al., 2009). Direct interaction between D1R and NMDA receptors within the plasma 
membrane of pyramidal neurons may also occur, since D1R can physically interact with NR1  
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and NR2A subunits, modulating receptor trafficking (Lee et al., 2002; Pei et al., 2004; Fioren-
tini et al., 2006). Co-activation of both receptors increases the presence of GluR1 receptors and 
facilitates their incorporation into synapses in hippocampal neurons (Smith et al., 2005; Gao et 
al., 2006; Sacktor, 2008). It is also possible that D1R is selectively activated by burst firing 
NMDAR-dependent of dopamine neurons, mainly during the presentation of salient events 
(Zweifel et al., 2009). In addition, recent studies demonstrated that D1-like receptor agonists 
promoted the survival of newborn cells in the adult hippocampus (Takamura et al., 2014). 
   These results demonstrate that dopamine D1R has a critical role in learning and memory pro-
cess, and in the subsequent synaptic plasticity changes. However, the D1R activation is princi-
pally attributable to temporally increases of dopamine (Goto & Grace, 2005; Wall et al., 2011), 
and the D2R are may be implicated in mediating the tonic dopamine release (Goto et al., 2007; 
Wall et al., 2011). For this reason it is possible that D2R inactivation affects cognitive functions 
and synaptic plasticity associated process similar to D1R. 
 
 
 
2. DOPAMINERGIC SIGNALING BY D2R IN HIPPOCAMPUS REGULATE ASSOCI-
ATIVE LEARNING AND CHANGES IN SYNAPTIC PLASTICITY. 
    
      Dopamine receptors D1R and D2R are expressed in dopaminergic fibers that inervate hippo-
campal region (Goldsmith & Joyce 1994; Missale et al., 1998; Nguyen et al., 2014). When D2R 
are completely abolished (Drd2-/- mice) or partially inactivated in hippocampal region CA1 
with LV-Drd2-siRNA, associative learning was significantly impaired. Also exists a disturb-
ance in synaptic plasticity process in hippocampus leading a blockade in acquisition of CRs and 
prevents LTP induction in CA3-CA1 synapse.  
 
2.1. Drd2-/- mice exhibit slower spatial learning not due to motor impairment. 
 
 
   Previous studies, with MWM, found that D2R antagonists could improve the performance in 
this spatial test (Setlow & McGaugh, 1999 & 2000). In these studies D2R antagonists was ad-
ministrated to mice after the training affecting consolidation memory process, but not the acqui-
sition. However, in this work the genetic inactivation of D2R in mice elicits differences in ac-
quisition process during the training. 
    Interestingly, we found that Drd2-/- mice despite of exhibit impairment in learning, they were 
able to learn after extended training. Drd2-/- mice showed greater latency of response than WT 
mice in the three phases of Barnes maze experiment (training, test and reversal), that involves a 
delay acquisition in scape response and less spatial learning. On the other hand, we ruled out  
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the possibility that this was due to an emotional, motivational or motor disturbance in Drd2-/- 
mice because the results in P-maze and Porsolt were similar in both genotypes. Only the explor-
atory behavior, immobility time and the number of holes exploring at day 1 of training in 
Barnes maze, exhibit less exploratory activity in Drd2-/- mice, in according with previous stud-
ies in hole board (Hranilovic et al., 2008). So we could not discard with this test, motivational 
and motor disturbances to the full extent. 
    Therefore, we performed other spatial test, the MWM. In this test, mice were administrated 
with caffeine at the day of habituation (day 0) and in Test 1 (48 h), to facilitate the motor re-
sponse and to increase the exploratory behavior (Chen et al., 2001). Nonetheless, Drd2-/- mice 
showed similar learning pattern than in the Barnes maze, but run more distances than the WT 
mice in all training days, ruling out the influence of less exploratory behavior and the hypoloco-
motion in these mice. Also, Drd2-/- mice showed similar results in Test 1 (48 h after the train-
ing) with caffeine, and Test 2 (74 h after the training) without caffeine, the difference between 
the groups were increased. Based on these results we conclude that the delay in the escape re-
sponse is mainly for a deficit in spatial navigation. 
    In addition, a recent work Nguyen et al., 2014, showed important changes in hippocampal 
place cell responses of Drd2-/- mice during manipulations of spatial and familiar environmental 
cues. The place-cell representation of space is essential because is thought to underlie certain 
forms of spatial learning. This group found that Drd2-/- mice, in a familiar environment, have  
reduced number of hippocampal place cell activation and affected the intra-field firing rate, spa-
tial tuning and spatial coherencia in the hippocampus. 
 
 
 
2.2. Dopamine D2R is critical for acquisition and consolidation of associative memories.  
 
 
    To further assess the role of D2R in associative learning, we used two paradigms to evaluate 
fear memories. 
    In active avoidance test, Drd2-/- mice, similar to Drd1a-/- mice, did not decrease their escape 
latency at any time point during the training trials. Similar random crossing scores for WT and 
Drd2-/- mice indicate that this finding is not caused by decreased locomotor activity. In this ex-
periment Drd2-/- mice did not reduce their scape latency during the training trials, displaying a 
response pattern similar to models of learned helplessness (Seligman et al., 1975). However 
Drd2-/- mice showed similar results to WT mice on P-maze and Porsolt test, which indicates 
that this pattern of response cannot be explained by previous emotional disturbances. Also, ac-
cording with other studies, if learning does not occur in early trials the animal can asses the si- 
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tuation as “uncontrollable”, in which case there is a decline in dopamine release that hinder the 
establishment of new memories (Anisman, 1977; Cabib & Puglisi-Allegra, 1994).  
    We use the fear conditioning test to discriminate between hippocampus and amygdala de-
pendent associative learning. Drd2-/- mice showed longer freezing time in contextual 
(hippocampus-dependent) fear conditionings;  this result is supported by similar work (Fadok et 
al., 2009). We found no differences between WT and  Drd2-/-  mice in extinction of fear condi-
tioning in the first five days, only in the final day.  
    The D2R activation is critical for flexibility and reward learning. Similar to these results, oth-
er studies have linked the D2R functions in striatum, amygdala and NAc to aversive conditioned 
learning responses (Nakanishi et al., 2014; Slagter et al., 2015; Brandão et al., 2015). 
    In addition, as we have demonstrated, the response in associative tests was not due to differ-
ences in nociception in agreement with other studies (Mansikka et al., 2005).  
 
 2.3. Dopamine D2R is involved in associative learning and in the related changes in syn-
aptic strength at the hippocampal CA3-CA1 synapse.  
 
    It is widely accepted that hippocampal circuits are involved in the acquisition of classically 
conditioned eyelid responses (Berger et al., 1983; Moyer et al., 1990; Gruart et al., 2006; Ortiz 
et al., 2010). Using unitary in vivo recordings, hippocampal pyramidal cell firing in response to 
CS presentations increases across conditioning sessions (McEchron & Disterhoft, 1997; 
Múnera et al., 2001; McEchron et al., 2003). Eyeblink conditioning, a form of associative 
learning, was recently show to induce a progressive increase in strength at the hippocampal 
CA3-CA1 synapse in awake mice (Gruart et al., 2006; Madroñal et al., 2009) that correlates 
with the progressive increase in conditioned responses.  
    To directly demonstrate the relationship between LTP and associative learning, we studied 
the role of D2R in associative learning and synaptic plasticity in mice. LTP is well-established 
as a form of synaptic memory, but is usually studied under non-physiological conditions. We 
found that D2R are also necessary for evoking and maintenance of LTP at the CA3-CA1 syn-
apse after HFS of afferent schaffer collaterals. Since input-output curves and paired-pulse po-
tentiation were normal in both Drd2-/- and Drd2-siRNA mice. We conclude that the D2R does 
not affect normal transmission but contributes to synaptic plasticity during the acquisition and 
storage of new information.  
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   LTP in vivo results are related with previous classical in vitro studies. Classical studies used a 
pharmacological block of D2R with the antagonist Domperidone. They does not found differ-
ences in LTP-induction, but the LTP-maintenance was abolished (Dunnwiddie et al., 1982; 
Frey et al., 1989, 1990). These authors suggest that an additional stimulation of presynaptic af-
ferents is required for the maintenance of LTP. The L-LTP which depend on dopamine-
mediated signals also requires the induction of an increased protein synthesis. In addition, re-
cent works in vitro shows that the genetic deletion or pharmacologic blockade of D2R inhibit 
the LTP expression in temporal CA1 region (Rocchetti et al., 2014). 
   Further, our approach here is unique in that we simultaneously assess classical eyeblink con-
ditioning and synaptic efficiency by measuring changes in evoked extracellular fEPSPs at the 
CA3-CA1 synapse in awake animals during conditioning. We compared WT mice to Drd2-/- 
mice. In addition, we used siRNA technology to silence D2R in hippocampal adult mice in vivo. 
Our data reveal a functional relationship between acquisition of associative learning and the 
increase in synaptic strength at the CA3-CA1 synapse, by revealing that all two are dramatical-
ly impaired when D2R is eliminated or reduced. 
 
    2.4. Possible molecular mechanisms of D2R-mediated learning and memory process. 
 
   The possible molecular mechanism of D2R mediated the hippocampal synaptic transmission 
is not yet clear. It is possible that genetic deletion and pharmacologic blockade of D2R severely 
impairs NMDA-dependent LTP in CA1, corresponding with remodelling of mesohippocampal 
dopamine fibers and decreases learning and memory task performance. Also, the loss of pre-
synaptic control on dopamine levels for the absence of D2R, may produce an overactivation of 
postsynaptic D1R and a decrease in DAT action (Ares-Santos et al., 2013; Rocchetti et al., 
2014).  
   In addition, previous studies indicate the presence of a synergistic effect between D1R and 
D2R dopamine receptors (Ichihara et al., 1992) that may results in the activation of a third intra-
cellular signaling pathway by the activation of Gq protein, that increasing intracellular calcium 
levels (Lee et al., 2004). Although is not yet proved the existence of these heterodimers in hip-
pocampal neurons. 
   Dopamine receptors also participate in multiple non-Gα protein signaling mechanisms. Dopa-
mine receptors mediated effects can involve Gβ/Gγ proteins as well as other receptors (Missale 
et al., 1998; Beaulie & Gainetdinov, 2011). For example, D2Rs form heterodimers with A2A 
receptors (Canals et al., 2003) and Sigma-1 receptors (Navarro et al., 2013) and recruit protein  
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Kinase A/glycogen synthase kinase 3 (AKT/GSK3) signaling pathways via a slower cAMP-
independent signaling mechanism (Beaulieu et al., 2005, 2007). G-protein-coupled receptor ki-
nases and arrestins, normally associated with receptor desensitization, form a scaffold for D2R 
receptor interactions with protein phosphatase 2A and AKT (Lovestone et al., 2007; Money & 
Stanwood, 2013). 
    Besides, NCS-1 (neural calcium sensor 1) regulates D2R phosphorylation through an interac-
tion with G protein-coupled receptor kinase 2 (GRK2). NCS-1 and D2R are associated in vitro 
and co-localize in monkey and rat striatum (Kabbani et al., 2002), also co-immunoprecipite in 
mouse hippocampal lysates of CA1, CA3 and DG regions (Saab et al., 2009). Previous studies 
show that this interaction between NCS-1 and D2R is critical for LTP facilitation in DG, and 
may also underlie the promotion of specifics forms of exploration and enhancements in spatial 
memory acquisition (Kabbani et al., 2002).  
    Even if basal synaptic transmission is normal in Drd2-/- and Drd2-siRNA mice, previous 
studies found a decrease in the number of spines and synapsis in PFc and hippocampus of Drd2-
/- mice and in mice treated with D2R antagonists (Sugahara & Shiraishi, 1998; Critchlow et al., 
2006; Wang et al., 2009). D2R has been linked to neuronal development during adulthood in 
both dendritic trees and spine density, while D1R is involved in neurogenesis and neuronal mat-
uration process. 
    Finally, several experiments in rodents demonstrated a critical interaction between D2R and 
hippocampal cholinergic signalling. Mice injected with raclopride in ventral hippocampal re-
gion present a decreased cholinergic activity and a poor performance in passive avoidance test 
(Fujishiro et al., 2005). The chronic treatment with no-specific D2R antagonist, haloperidol, 
leads to a decreased of acetyl-cholinergic fibbers in hippocampus and an impairment in spatial 
memory tasks, like MWM in rats (Terry et al., 2003; Parikh et al., 2004).  
 
 
 2.5. D1R and D2R are essential in cognitive dopamine dependent process. 
 
 
    Neurocomputational models propose the role of dopamine as a principal neuromodulator of 
the central nervous system, responsible of the “adaptive navigation” process. These models in-
volve very complex strategies of response to determine the questions: “Where we are?”, 
“Where do we go?” and “How can we go?”. For these functions, dopamine coordinates the 
action of different neurotransmission systems and brain structures, specially PFc, BG and hip-
pocampus (Mizumori et al., 2009).  
    Some of these models propose as central hypothesis a dual response of dopaminergic system 
that determine cognitive functions (Deher & Burnod, 2002). Dopamine would response to a  
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particular input: a) first, a sharp increase for seconds (phasic response), and b) later, a sustained 
response above the basal level for minutes (tonic response). The phasic response directly de-
pend on the firing of dopaminergic neurons, and the tonic phase is independent of this (Schultz, 
2007; Brischoux et al., 2009).  
    The different dopamine levels, which would reach the dopaminergic curve of response, are 
moving into a particular range, out of which functions would not be carried out correctly. This 
effect indicates the possibility of a U-inverted shape dopamine-execution pattern of response. 
Therefore, both high and low levels of dopamine in response to different inputs, may cause a 
less efficient neuromodulation of neuronal noise in information processing, causing a less dis-
tinctive neuronal representations and a poor cognitive performace (Li & Sikström, 2002). 
Through this mechanism, dopamine would be able to focus attention on the strong cortical sig-
nals, promoting an increase in the firing rate of innervated neurons, substracting the neuronal 
signal relative to the background noise and, in consequence, facilitating the adjust of responses 
(Nicola et al., 2000; Bamford et al., 2004). Human studies that relate aging and cognitive func-
tion, suggest that reduction in dopaminergic activity could cause an increment in the neuronal 
noise and decline cognitive functions (Li et al., 2001). In addition, studies in healthy subjects, 
suggest that dopaminergic neuromodulation is critically involved in the synchronization of the 
oscillatory activity that facilitates the access and review the working memory (Breakspear et al., 
2003; Seamans & Yang, 2004; Li et al., 2005). 
    For these reasons, some authors propose that dopaminergic tone could be involved in basic 
processes of consciousness (Palmiter, 2011) as executive functions, implementation of plans, 
directing attention and working memory, all related to the prefrontal cortex and thalamus but 
not rely exclusively on them. Dopaminergic deficit can keep the reflexes intact but provokes 
difficulty managing and adapt the behavior to the environment (Palmiter, 2011), because in-
cludes motivational and arousal aspects. RD Palmiter propose that dopaminergic neurons could 
act modulating glutamatergic inputs of thalamus and cortex; sustaining the dopaminergic tone 
through the actions of D1R and D2R (Palmiter, 2011). 
    D1R and D2R receptors, promote the release of dopamine and maintain the optimum levels 
for the development of dopaminergic response within an optimal range. The D1R would only be 
activated by temporary increases in dopamine (Goto & Grace, 2005; Grace et al., 2007; Wall et 
al., 2011). However, D2R has more affinity for dopamine and would be implicated mediating 
the effects of dopamine tonic release (Goto et al., 2007; Wall et al., 2011). D2R activation may 
serve as a phasic gating signal indicating when new information should be encoded and main-
tained in working memory or when an updating of current representations is needed 
(Glickstein, 2002).  
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3. DOPAMINERGIC SIGNALING BY D1R AND D2R IN STRIATUM REGULATES 
THE PHENOTYPIC SHIFT OF A POPULATION OF STRIATAL NEURONS AND 
MOTOR BEHAVIOR. 
 
    As described above, the action of D1R and D2R are necessary to maintain a suitable dopamin-
ergic balance and, therefore, an effective function of the dopaminergic system processes. 
Previous studies from our laboratory and others have shown that TH-ir neurons are induced 
following unilateral lesion of the striatum and the number and staining intensity of TH-ir neu-
rons is further increased by L-DOPA treatment. However, the mechanisms leading to TH pro-
tein expression after dopaminergic denervation and L-DOPA treatment remain unclear. In the 
present study we have explored the mechanisms of their regulation of TH expression and the 
functional implications of increased TH expression in this cell population. Our results demon-
strated that the induction of TH-ir neurons by L-DOPA is dose-dependent and requires D1R 
function. We further demonstrated a tight spatio-temporal correlation between the presence of 
these striatal TH-ir neurons, the recovery of dopamine overflow and forelimb use induced by L-
DOPA treatment.   
 
3.1. The number of TH-ir neurons in the denervated striatum are increased by L-DOPA 
treatment in a dose-dependent manner. 
 
Although some studies have identified a small number of TH-ir neurons in the caudoputamen 
of normal animals, including monkeys, rats and mice (Dubach et al., 1987), their number in-
creased in parkinsonian human brains (Porritt et al., 2000), and in brains of non-human pri-
mates and rodents following dopamine depletion (Betarbet et al., 1997; Jollivet et al., 2004; 
Tande et al., 2006). L-DOPA treatment further increases the number of TH-ir neurons in hemi-
parkinsonian rats (Mura et al., 1995; Lopez-Real et al., 2003; Jollivet et al., 2004) and mice 
(Darmopil et al., 2008). Similar results have been reported in the caudate nucleus and putamen 
of parkinsonian patients treated with L-DOPA (Porritt et al., 2000). 
In the current study, we demonstrate that the L-DOPA-induced TH-ir neurons increase is dose
-dependent: 25 mg/kg L-DOPA induced nearly twice as many TH-ir neurons as 15 mg/kg L-
DOPA. Although is tempting to propose that the number of TH-ir neurons correlates with the 
severity of dyskinesias as has been reported (Francardo et al., 2011), several of our findings do 
not support it. While L-DOPA-induced TH-ir neurons are evident for more than 4 days, L-
DOPA-induced  dyskinesias do not last for more  than 3 h (Westin et al., 2007; Darmopil et al., 
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2009). While causing only a 47 to 59% reduction in the number of TH-ir neurons. It is also pos-
sible that dopamine produced by striatal TH-ir neurons reduce sensitization of dopamine recep-
tors; in which case, their chronic stimulation by L-DOPA might produce less dyskinesia. 
 We further found that the increase in TH-ir neurons was dependent on continue L-DOPA 
treatment: by 10 days after the final L-DOPA injection, the number of striatal TH-ir neurons 
had returned to baseline and TH-ir neurons were detected only in the ventral striatum or close to 
the remaining dopaminergic fibres, in agreement with previous studies from our laboratory 
(Darmopil et al., 2008). These results indicate that the L-DOPA-induced increase in TH-ir neu-
rons in the dopamine-depleted striatum is a specific and regulated process.  
 As in previous studies in humans, monkeys and rodents (Porritt et al., 2000; Palfi et al., 2002;  
Lopez-Real et al., 2003; Darmopil et al., 2008) the TH-ir neurons that appeared following dopa-
mine depletion in our study were most frequently found close to spared dopaminergic terminals, 
further supporting their dopamine dependency, as these terminals are the most likely site of 
conversion of L-DOPA to dopamine and have higher dopamine turnover. These findings sug-
gest that TH expression in striatal neurons is regulated by L-DOPA and by the local concentra-
tion of dopamine within a very narrow concentration range, because they are undetectable in the 
normal or in completely denervated striatum, but are dose-dependently induced by L-DOPA in 
the partially denervated striatum. 
 
 
    3.2. Induction of TH-ir neurons in lesioned striatum by L-DOPA requires the D1R, but 
not the D2R. 
 
 The effect of L-DOPA on the induction of TH phenotype in striatal neurons was markedly 
diminished in hemi-parkinsonian Drd1a-/- mice: both the increase in number of TH-ir neurons 
and the increase in intensity of staining were blocked. In contrast, neither the number nor the 
staining intensity of striatal TH-ir neurons in L-DOPA-treated hemi-parkinsonian Drd2-/- mice 
was significantly different from their WT littermates. These results are corroborated by our 
studies using pharmacological blockade of the D1R or D2R receptor families and reveal a criti-
cal and specific role for the D1R in the L-DOPA mediated induction of TH phenotype in striatal 
neurons. Results with D1R antagonist are in according with recent studies that demonstrate a 
decrease in the number of TH-ir striatal neurons during the development of striatal innervation 
(Busceti et al., 2012). We showed previously that D1R inactivation completely abolished L-
DOPA-induced ERK activation (Darmopil et al., 2009), thus ERK signalling may play a role in 
induction of TH-ir neurons by L-DOPA. Our finding that simvastatin reduced the number of L-
DOPA-induced TH-ir neurons in the depleted striatum by 50% supports this effect. 
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    Interestingly, following L-DOPA treatment striatal TH-ir cells also express FosB (Darmopil 
et al., 2008) and this induction of FosB is also mediated by D1R stimulation (Darmopil et al., 
2009). Thus, L-DOPA induction of the TH phenotype may be partially mediated by increased 
FosB expression in these neurons, a possibility further suggested by the presence of a FosB 
binding domain (AP-1 site) in the regulatory part of the TH gene (Lewis-Tuffin et al., 2004). In 
addition, some studies shown a positive correlation with an increase in the number of TH-ir stri-
atal neurons, FosB expression and the level of LID in mice models of PD (Francardo et al., 
2011; Smith et al., 2012; Keber et al., 2015). However, previous studies in our laboratory 
demonstrate that LIDs normally disappear 2 h after the L-DOPA injection (Solís et al., 2015; 
Ruiz-DeDiego et al., 2015) but the long-lasting therapeutics effects of L-DOPA associated with 
TH-ir cells founds in these work can last 1 week after the chronic treatment. 
   In addition, it is clearly that D1R is implicate in the expression of striatal TH-ir neurons, but 
our results with Drd1a-Tomato and Drd2-GFP mice, demonstrated that TH-ir neurons not ex-
press D1R or D2R. However, recent studies suggest two possible regulation pathways of TH-ir 
neurons mediated by dopamine: a) A pathway directly related with the fluctuations in dopamine 
levels and b) An indirect pathway related the action of D1R by enhancing the release of acetyl-
choline (Busceti et al., 2012). In this way, a recent study demonstrate that TH-ir neurons ex-
press nicotinic cholinergic receptors, and spikes to brief application of nicotinic agonist (Ibáñez-
Sandoval et al., 2015). Nicotinic receptors are largely restricted to striatal interneurons where 
they exert excitatory effects on GABAergic interneurons firing (English et al., 2011; Koós and 
Tepper, 2002), and are also present on dopaminergic terminals, where it has been proposed that 
they may elicit dopamine release independent of dopaminergic neuronal activity (Cachope et 
al., 2012; Threlfell et al., 2012). 
 
3.3. Ultrastrcuture of striatal TH-ir neurons in mice. 
 
 
    There are only two studies to date that analyse the ultrastructure of TH-ir neurons. The pre-
sent study is the first in the mouse. Our results are similar in some aspects to those found MPTP 
treated monkeys (Mazloom & Smith, 2006), but not in rat (Meredith et al., 1999).  
    Striatal TH-ir neurons in the rat study have a dark nucleus and smooth nuclear envelopes 
(autophagic vesicles). The elevated number of autophagic vesicles and the rupture of mitochon-
dria visible in this TH-ir neurons indicated that the brain tissue dissected for the analysis was an 
infarcted area, unsuitable for the ultrastructure study. However, we are in agreement with the 
presence of TH-immnunostained spines, not found in the monkey study. Inputs to dendritic  
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shafts were found that can make asymmetrical (excitatory) synaptic contacts.  
    On the other hand, results in the monkey study were similar to those found in this study. 
They found that TH-ir neurons have light nuclei with the nuclear membrane deeply invaginated, 
with shape round or oval and small cell bodies. These results demonstrate that the vast majority 
of intrastriatal TH-ir neurons display the ultrastructural features of interneurons (Mazloom & 
Smith, 2006; San Sebastián, 2007). 
 
    3.4. Pitx3 and Nurr1 are not required for L-DOPA-induced TH-ir neurons in the stria-
tum. 
 
The TH gene also contains a Pitx3 binding site (Cazorla et al., 2000; Messmer et al., 2007). 
However, we found that Pitx3 is not necessary for L-DOPA regulation of TH transcription in 
these neurons, as evidenced by our finding that L-DOPA increased the number of striatal TH-ir 
neurons in Pitx3 deficient aphakia mice to a similar degree as in WT mice. Our results in 6-
OHDA-lesioned aphakia mice also rule out the possibility that Pitx3 is required for the increase 
in TH-ir neurons induced by striatal injury. Pitx3 is an important transcription factor in the de-
velopment, maturation and migration of the dopaminergic system in the midbrain (Nunes et al., 
2003; Smidth et al., 2004). However, our results demonstrate that Pitx3 is not necessary for de-
nervation- or L-DOPA-induced TH expression in striatal neurons in adult mice. This may be 
because these striatal TH-ir neurons are not generated from the same progenitors as SNc dopa-
minergic neurons, and they could be derived from other striatal neuronal populations that un-
dergo a phenotypic shift after denervation (Tande et al., 2006; Darmopil et al., 2008; Unal et al., 
2011).   
Supporting the concept that these TH-ir neurons have a distinct phenotype, we also found 
that these neurons do not express Nurr1, a determinant transcription factor of midbrain dopa-
minergic neurons, in contrast with human studies (Cossette et al., 2004). Nurr1 is required for 
the differentiation of mesencephalic dopaminergic neurons, induces the expression of dopamin-
ergic genes such as Th, Vmat 2 and Dat (Vergaño-Vera et al., 2014). In support of this possibil-
ity, 95% of TH-ir neurons also expressed GABA (Unal et al., 2011), which is expressed in all 
types of striatal neurons except cholinergic interneurons. Our results further show that in the 
denervated striatum, L-DOPA is able to trigger and maintain this phenotypic shift by stimulat-
ing and increasing the transcriptional/translational activity of the Th gene. 
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   3.5. Identity of L -DOPA-induced TH-ir neurons in the striatum. 
 
   There is some controversy about the identity of striatal TH-ir neurons. Previous studies indi-
cated that these neurons may be MSNs based on the expression of Darpp32, dynorphin, enkeph-
alin or calbindin markers (Betarbet et al., 1997; Darmopil et al., 2008; Masuda et al., 2011). In 
addition, these same studies and others shown that most of these neurons also express striatal 
interneurons markers such as PV, nNOS, NPY and  especially, GAD-67 (99%) in rodents 
(Betarbet et al., 1997; Mazloom & Smith, 2006; Tande et al., 2006; San Sebastián et al., 2007; 
Darmopil et al., 2008; Busceti et al., 2012). 
   Recent studies that using eGFP-TH BAC transgenic mice identified a much larger population 
of TH-expressing striatal neurons in naïve striatum (Ibañez-Sandoval et al., 2010, 2015; Dep-
buoylu et al., 2014). Whole-cell recordings in striatal slices demonstrated that eGFP-TH neu-
rons comprise four electrophysiologically distinct neurons types whose properties have not 
been reported previously in striatum. Further, based on retrograde labelling, lack of expression 
of interneuronal markers, and GABAergic properties, they concluded that these neurons repre-
sent a previously unidentified subpopulation of TH-expressing interneurons. However, no all 
eGFP-TH neurons are detected at basal conditions. After the 6-OHDA lesion eGFP-TH BAC 
transgenic mice had shown an increase in the number of eGFP-TH neurons in the lesioned stria-
tum (Depbuoylu et al., 2014). As we say previously, the phenotypic shift of TH-ir neurons in 
the striatum is mainly determined by the fluctuations of local dopamine levels.  
   In addition, previous studies demonstrated that striatal gene expression is altered by chronic L
-DOPA treatment (Pavón et al., 2006). Perhaps L-DOPA itself plays some intracellular signal-
ing role in the TH-ir neurons (Ugrumov, 2009). The function of L-DOPA in TH-ir neurons re-
mains unknown, but one possibility is that it is supplied to monoenzymatic AADC cells of the 
striatum or the terminals of nigrostriatal dopaminergic neurons via the aminoacid transporters 
(Ugrumov, 2009) and thereby contributes to dopamine release in a compromised striatum. 
   Nowadays the controversy remains unclear. More experiments are needed to clearly stablish 
the identity of TH-ir neurons in the dopamine depleted striatum. Regardless of their identity, 
our data suggest that these TH-ir neurons may have a beneficial effect in PD, therefore under-
standing the regulation of these neurons in dopamine-depleted striatum is important and is the 
goal of this work. 
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3.6. Time-course of striatal dopamine overflow and improvement in motor function af-
ter chronic L-DOPA treatment in lesioned mice. 
 
Although the function of striatal TH-ir neurons in the dopamine-depleted striatum is un-
known, it has been demonstrated that they produce L-DOPA that can be released by a non-
exocitotoxic mechanism (Weihe et al., 2006), and those TH-ir neurons that express the AADC 
enzyme can also produce dopamine. L-DOPA released by these cells may also be converted to 
dopamine in the nearby remaining dopaminergic terminals. Our voltammetry experiments 
demonstrate a significant decrease in electrically stimulated dopamine release in slices from 
lesioned striatum compared to striatal slices from naïve animals. There was a strong increase, 
almost two-fold, in dopamine release in the contralateral unlesioned striatum of unilaterally le-
sioned animals, indicating that the unilateral lesion affects both hemispheres. Thus, the un-
lesioned striatum increases the synthesis of dopamine in an attempt to compensate for the lack 
of dopamine in the lesioned striatum as indicated previously (Bjorklund & Dunnett, 2007). In-
terestingly, our data show that chronic L-DOPA treatment transiently restores electrically stim-
ulated dopamine overflow in the striatum, so that dopamine overflow in both sides is equal and 
similar to that obtained in the striatum of sham lesioned mice. Stimulated dopamine overflow 
levels remain normal in the contralateral unlesioned striatum even 4 days following L-DOPA 
withdrawal, but there is a significant decrease in dopamine overflow on the lesioned side, alt-
hough it remains greater than in lesioned striatum of mice without L-DOPA treatment. 10 days 
after L-DOPA withdrawal, dopamine overflow levels in both hemispheres reverted to the levels 
obtained in lesioned animals treated with saline. Remarkably, stimulated dopamine overflow in 
the lesioned striatum after L-DOPA correlates with the presence of striatal TH-ir neurons: it is 
highest with L-DOPA treatment and decreases progressively to baseline over the first 10 days 
after the end of L-DOPA treatment. Therefore it is possible that these striatal TH-ir neurons 
contribute to the normalization of stimulated dopamine overflow in the lesioned striatum during 
chronic L-DOPA treatment and for a short period after the treatment ends.      
    The time-course of the effect of L-DOPA on stimulated dopamine overflow and TH-ir neu-
rons also coincides with the time-course of motor improvement that we observed in lesioned 
animals chronically treated with L-DOPA. We found that this treatment temporarily reversed 
the forelimb asymmetry induced by the 6-OHDA lesion, supporting normal motor function in 
the forelimbs for 4 days after L-DOPA withdrawal; however, this effect wore off by 7 to 10 
days after L-DOPA withdrawal. Thus, the period of improvement in motor function overlaps 
with the period of greatest local dopamine overflow in the lesioned striatum and with the pre- 
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sence of the highest number of striatal TH-ir neurons.  
    Interestingly, similar temporal motor improvement was observed in Pitx3-/- after cessation of 
L-DOPA treatment (Beeler et al., 2010) in which we observed similar increase of striatal TH-ir 
neurons. The reversal of forelimb use asymmetry observed during the first 4 days after L-
DOPA treatment suggests that the small amount of dopamine available after chronic L-DOPA 
treatment is sufficient to normalize forelimb asymmetry in mice, whether this dopamine comes 
from the remaining dopamine fibres or from the local TH-ir neurons. It is therefore possible that 
the induction of striatal TH-ir neurons following L-DOPA treatment in denervated mice is re-
sponsible for the temporal improvement in parkinsonian symptoms that we observed after the 
chronic L-DOPA treatment. It has been shown previously that very small numbers of dopamine
-producing cells can reduce parkinsonian symptoms in denervated rats and monkeys following 
carotid body grafts into the striatum (Espejo et al., 1998; San Sebastian et al., 2007). In addition 
our observations are in line with the motor recovery after intrastriatal viral vector injections 
confining TH, and AADC in monkeys (Muramatsu et al., 2002). Altogether our results demon-
strate a tight spatio-temporal correlation between the time-course of striatal dopamine overflow,  
the improvement in motor function and the presence of striatal TH-ir neurons after chronic L-
DOPA treatment in lesioned mice. 
The results presented here suggest that induction of striatal TH-ir neurons might underlie the  
long-term beneficial effect of L-DOPA therapy observed in parkinsonian patients: while the 
anti-parkinsonian effect of L-DOPA eventually disappears after cessation of treatment, patients 
report beneficial effects for some time following L-DOPA withdrawal (Nutt et al., 1995; Fahn, 
2006). Understanding the functional implications and the molecular mechanisms of this pheno-
typic change could contribute to the development of new therapies for Parkinson’s disease with 
the goal of providing a more persistent therapeutic effect than that offered by current drugs.  
 
 
4. FUTURE PERSPECTIVES. 
 
    Most diseases that involving the dopaminergic system elicit changes in the expression and 
function of the main dopamine receptors: D1R and D2R, whose study is necessary to know what 
happens in motor and cognitive functions under physiological and pathophysiological condi-
tions. 
    During aging and in the course of certain neurodegenerative diseases, such as Parkinson or 
Alzheimer, there is a decreased in dopamine levels and a down-regulation of D1R and D2R. 
This phenomenon is normally accompanied with a pathological decline in cognitive and motor  
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functions, that could completely impair patients ability. 
    For these reasons is necessary to continue our research to understand the possible molecular 
mechanisms implicated in the origin of these diseases and the development new therapeutic tar-
gets that improve the quality of life of patients and aging subjects. 
  
 Conclusions 
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1. Dopamine D1R is critical for acquisition and consolidation of spatial memory. 
2. Dopamine D1R is critical for acquisition of associative learning. 
3. Dopamine D1R is critical for recognition memory process. 
4. Dopamine D2R influences in acquisition and consolidation of spatial memory. 
5. Dopamine D2R is critical for acquisition of fear memories. 
6. Dopamine D2R is involved in associative learning and in the related changes in synaptic 
strength at hippocampus. 
7. TH-ir neurons are increased by L-DOPA treatment in a dose-dependent manner. 
8. TH-ir neurons do not express D1R and D2R receptors, but D1R receptors are implicated in 
the expression of these neurons. 
9. TH-ir cells have ultrastructural characteristics of GABAergic striatal interneurons. 
10. TH-ir striatal neurons do not expression Pitx3 and Nurr1, indicating that these neurons 
have different origin that midbrain dopaminergic neurons. 
11. The time-course of the effect of L-DOPA on stimulated dopamine overflow and TH-ir 
neurons similar with the time-course of motor improvement. 
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